TY 2012 Form 990

(A) Name and business address	(B) Description of services	(C) Compensation
TSOIKOBUS ASSOCIATES, 1 BRATTLE SQUARE PO BOX 9114CAMBRIDGEMA02238	ARCHITECTS	529,047
CG ASSOCIATES, 7 CHUCK DRIVEDRACUTMA01826	CONSTRUCTION	561,339
FISH RICHARDSON PC, PO BOX 3295BOSTONMA02241	LEGAL	419,419
LFREP SERVICES LLP, 260 FRANKLIN STBOSTONMA02110	CONSULTING SERVICES	285,900
PRICEWATERHOUSECOOPERS, PO BOX 7247-8001PHILADELPHIAPA19170	AUDIT	272,079
2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization 5

Do not include amounts reported on lines 6b, 7b, 8b, 9b, and 10b of Part VIII.	(A) Total expenses	(B) Program service expenses	(C) Management and general expenses	(D) Fundraising expenses
1	Grants and other assistance to governments and organizations in the United States. See Part IV, line 21	16,535,926	16,535,926
2	Grants and other assistance to individuals in the United States. See Part IV, line 22	0	0
3	Grants and other assistance to governments, organizations, and individuals outside the United States. See Part IV, lines 15 and 16	181,635	181,635
4	Benefits paid to or for members	0	0
5	Compensation of current officers, directors, trustees, and key employees ....	3,391,691	1,088,011	2,303,680
6	Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....	0	0
7	Other salaries and wages	80,352,122	60,331,408	18,939,317	1,081,397
8	Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) ....	1,518,870	1,120,793	374,686	23,391
9	Other employee benefits .......	15,203,484	11,419,588	3,542,826	241,070
10	Payroll taxes ...........	6,507,253	4,801,786	1,605,256	100,211
11	Fees for services (non-employees):
a	Management ......	0	0
b	Legal .........	881,161	613,336	267,825	0
c	Accounting ...........	428,765	166,000	262,765	0
d	Lobbying ...........	212,652	0	212,652	0
e	Professional fundraising services. See Part IV, line 17	278,479			278,479
f	Investment management fees ......	0	0
g	Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) ........	3,509,030	3,273,725	235,305	0
12	Advertising and promotion ....	1,094,568	23,120	1,071,448	0
13	Office expenses .......	2,042,436	1,069,607	857,921	114,908
14	Information technology ......	2,707,950	0	2,707,950	0
15	Royalties ..	0	0
16	Occupancy ...........	9,174,698	944,396	8,230,302	0
17	Travel ............	909,403	656,187	209,351	43,865
18	Payments of travel or entertainment expenses for any federal, state, or local public officials ......	0	0
19	Conferences, conventions, and meetings ....	0	0
20	Interest ...........	2,038,999	1,415,063	623,936
21	Payments to affiliates .......	0	0
22	Depreciation, depletion, and amortization .....	18,645,562	12,940,000	5,705,562	0
23	Insurance ..............	1,114,170	66,652	1,047,518	0
24	Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a	MEDICAL SUPPLIES	32,239,713	32,140,697	99,016	0
b	PHYSICIANS ADMINISTRATION	5,962,667	5,893,359	69,308	0
c	MISCELLANEOUS	8,110,779	5,217,525	2,778,335	114,919
d	ALL OTHER EXPENSES	9,702,357	4,124,835	5,555,057	22,465
e	All other expenses
25	Total functional expenses. Add lines 1 through 24e	222,744,370	164,023,649	56,700,016	2,020,705
26	Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).

Part X Balance Sheet Check if Schedule O contains a response to any question in this Part X ...............
	1	Cashnon-interest-bearing .............	84,562	1	1,374,003
2	Savings and temporary cash investments .........	0	2	0
3	Pledges and grants receivable, net ...........	0	3	0
4	Accounts receivable, net .............	20,951,960	4	21,380,084
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
		20,000	5	10,000
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
		0	6	0
7	Notes and loans receivable, net .............	0	7	0
8	Inventories for sale or use ..............	2,155,473	8	2,302,498
9	Prepaid expenses and deferred charges ..........	3,862,909	9	4,078,975
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	375,862,839
b	Less: accumulated depreciation .....	10b	237,421,178	133,268,256	10c	138,441,661
11	Investments—publicly traded securities ..........	0	11	0
12	Investments—other securities. See Part IV, line 11 .....	0	12	0
13	Investments—program-related. See Part IV, line 11 .....	0	13	0
14	Intangible assets ...............	0	14	0
15	Other assets. See Part IV, line 11 ...........	75,836,493	15	56,462,194
16	Total assets. Add lines 1 through 15 (must equal line 34)......	236,179,653	16	224,049,415
	17	Accounts payable and accrued expenses .........	80,079,903	17	70,433,190
18	Grants payable .................	0	18	0
19	Deferred revenue ................	37,959,380	19	25,513,725
20	Tax-exempt bond liabilities .............	86,480,956	20	83,647,571
21	Escrow or custodial account liability. Complete Part IV of Schedule D..	0	21	0
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........	0	22	0
23	Secured mortgages and notes payable to unrelated third parties ..	0	23	0
24	Unsecured notes and loans payable to unrelated third parties ....	0	24	0
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................	5,816,094	25	7,935,144
26	Total liabilities. Add lines 17 through 25.........	210,336,333	26	187,529,630
		Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............	25,843,320	27	36,519,785
28	Temporarily restricted net assets ...........	0	28	0
29	Permanently restricted net assets ...........	0	29	0
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........		30
31	Paid-in or capital surplus, or land, building or equipment fund .....		31
32	Retained earnings, endowment, accumulated income, or other funds		32
33	Total net assets or fund balances ...........	25,843,320	33	36,519,785
34	Total liabilities and net assets/fund balances ........	236,179,653	34	224,049,415

- TIN:

SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service

Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section
4947(a)(1) nonexempt charitable trust.

Attach to Form 990 or Form 990-EZ. right arrow

See separate instructions.

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Reason for Public Charity Status (All organizations must complete this part.) See instructions.

The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)

A church, convention of churches, or association of churches described in section 170(b)(1)(A)(i).

A school described in section 170(b)(1)(A)(ii). (Attach Schedule E.)

A hospital or a cooperative hospital service organization described in section 170(b)(1)(A)(iii).

A medical research organization operated in conjunction with a hospital described in section 170(b)(1)(A)(iii). Enter the hospital's name, city, and state:

An organization operated for the benefit of a college or university owned or operated by a governmental unit described in

section 170(b)(1)(A)(iv). (Complete Part II.)

A federal, state, or local government or governmental unit described in section 170(b)(1)(A)(v).

An organization that normally receives a substantial part of its support from a governmental unit or from the general public described in section 170(b)(1)(A)(vi). (Complete Part II.)

A community trust described in section 170(b)(1)(A)(vi). (Complete Part II.)

An organization that normally receives: (1) more than 331/3% of its support from contributions, membership fees, and gross

receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of

its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses

acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)

An organization organized and operated exclusively to test for public safety. See section 509(a)(4).

An organization organized and operated exclusively for the benefit of, to perform the functions of, or to carry out the purposes of one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2). See section 509(a)(3). Check the box that describes the type of supporting organization and complete lines 11e through 11h.

Type I

Type II

Type III - Functionally integrated

Type III - Non-functionally integrated

By checking this box, I certify that the organization is not controlled directly or indirectly by one or more disqualified persons other than foundation managers and other than one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2).

If the organization received a written determination from the IRS that it is a Type I, Type II, or Type III supporting organization, check this box ..................................................

Since August 17, 2006, has the organization accepted any gift or contribution from any of the
following persons?

(i) A person who directly or indirectly controls, either alone or together with persons described in (ii)

Yes

and (iii) below, the governing body of the supported organization? ................

11g(i)

(ii) A family member of a person described in (i) above? ......................

11g(ii)

(iii) A 35% controlled entity of a person described in (i) or (ii) above? ................

11g(iii)

Provide the following information about the supported organization(s).

(i) Name of supported organization	(ii) EIN	(iv) Is the organization in col. (i) listed in your governing document?		(v) Did you notify the organization in col. (i) of your support?		(vi) Is the organization in col. (i) organized in the U.S.?		(vii) Amount of monetary support
(i) Name of supported organization	(ii) EIN	Yes	No	Yes	No	Yes	No	(vii) Amount of monetary support


Total

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990EZ.

Cat. No. 11285F

Schedule A (Form 990 or 990-EZ) 2012

Page 2

Part II

Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") ....
2	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......
3	The value of services or facilities furnished by a governmental unit to the organization without charge..
4	Total. Add lines 1 through 3
5	The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..
6	Public support. Subtract line 5 from line 4.

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
7	Amounts from line 4..
8	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...
9	Net income from unrelated business activities, whether or not the business is regularly carried on..
10	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.)..
11	Total support (Add lines 7 through 10).

Gross receipts from related activities, etc. (see instructions) ..................

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization, check this box and stop here........................................ right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2012 (line 6, column (f) divided by line 11, column (f)) .........

Public support percentage for 2011 Schedule A, Part II, line 14 ...............

16a

33 1/3% support test—2012. If the organization did not check the box on line 13, and line 14 is 33 1/3% or more, check this box
and stop here. The organization qualifies as a publicly supported organization ....................... right arrow

33 1/3% support test—2011. If the organization did not check a box on line 13 or 16a, and line 15 is 33 1/3% or more, check this
box and stop here. The organization qualifies as a publicly supported organization ..................... right arrow

17a

10%-facts-and-circumstances test—2012. If the organization did not check a box on line 13, 16a, or 16b, and line 14
is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain
in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported
organization ..................................................... right arrow

10%-facts-and-circumstances test—2011. If the organization did not check a box on line 13, 16a, 16b, or 17a, and line
15 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here.
Explain in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly
supported organization ................................................ right arrow

Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow

Schedule A (Form 990 or 990-EZ) 2012

Page 3

Part III

Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .
2	Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......
3	Gross receipts from activities that are not an unrelated trade or business under section 513..
4	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...
5	The value of services or facilities furnished by a governmental unit to the organization without charge..
6	Total. Add lines 1 through 5.
7a	Amounts included on lines 1, 2, and 3 received from disqualified persons...
b	Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.
c	Add lines 7a and 7b..
8	Public support (Subtract line 7c from line 6.)

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
9	Amounts from line 6...
10a	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..
b	Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.
c	Add lines 10a and 10b.
11	Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.
12	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) ..
13	Total support. (Add lines 9, 10c, 11, and 12.)..

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization,
check this box and stop here............................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2012 (line 8, column (f) divided by line 13, column (f)) .........

Public support percentage from 2011 Schedule A, Part III, line 15 ...............

Section D. Computation of Investment Income Percentage

Investment income percentage for 2012 (line 10c, column (f) divided by line 13, column (f)) ......

Investment income percentage from 2011 Schedule A, Part III, line 17 .............

19a

33 1/3% support tests—2012. If the organization did not check the box on line 14, and line 15 is more than 33 1/3%, and line 17 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ........ right arrow

33 1/3% support tests—2011. If the organization did not check a box on line 14 or line 19a, and line 16 is more than 33 1/3% and line 18 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ..... right arrow

Private foundation. If the organization did not check a box on line 14, 19a, or 19b, check this box and see instructions ..... right arrow

Schedule A (Form 990 or 990-EZ) 2012

Page 4

Part IV

Supplemental Information. Complete this part to provide the explanations required by Part II, line 10; Part II, line 17a or 17b; and Part III, line 12. Also complete this part for any additional information. (See instructions).

Facts And Circumstances Test

Explanation

Schedule A (Form 990 or 990-EZ) 2012

Additional Data

Software ID:
Software Version:

- TIN:

Schedule B
(Form 990, 990-EZ,
or 990-PF)

Department of the Treasury
Internal Revenue Service

Schedule of Contributors

Attach to Form 990, 990-EZ, or 990-PF.

OMB No. 1545-0047

2012

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Organization type (check one):

Filers of:

Section:

Form 990 or 990-EZ

501(c)( ) (enter number) organization

4947(a)(1) nonexempt charitable trust not treated as a private foundation

527 political organization

Form 990-PF

501(c)(3) exempt private foundation

4947(a)(1) nonexempt charitable trust treated as a private foundation

501(c)(3) taxable private foundation

Check if your organization is covered by the General Rule or a Special Rule.
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.

General Rule

For an organization filing Form 990, 990-EZ, or 990-PF that received, during the year, $5,000 or more (in money or
property) from any one contributor. Complete Parts I and II.

Special Rules

For a section 501(c)(3) organization filing Form 990 or 990-EZ that met the 33¹/3% support test of the regulations
under sections 509(a)(1) and 170(b)(1)(A)(vi) and received from any one contributor, during the year, a contribution of the
greater of (1) $5,000 or (2) 2% of the amount on (i) Form 990, Part VIII, line 1h, or (ii) Form 990-EZ, line 1. Complete Parts I and II.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, total contributions of more than $1,000 for use exclusively for religious, charitable,
scientific, literary, or educational purposes, or the prevention of cruelty to children or animals. Complete Parts I, II, and
III.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, contributions for use exclusively for religious, charitable, etc., purposes, but these contributions did
not total to more than $1,000. If this box is checked, enter here the total contributions that were received during
the year for an exclusively religious, charitable, etc., purpose. Do not complete any of the parts unless the General Rule
applies to this organization because it received nonexclusively religious, charitable, etc., contributions of $5,000 or more
during the year ......................... Arrow Bullet

Caution. An organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2 of its Form 990; or check the box on line H of its
Form 990-EZ or on Part I, line 2 of its Form 990-PF, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).

For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.

Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2012)

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Page 2

Name of organization MASSACHUSETTS EYE & EAR INFIRMARY

Part I	Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
RESTRICTED	RESTRICTED RESTRICTED RESTRICTED RESTRICTED, RESTRICTED RESTRICTED	$RESTRICTED	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Page 3

Name of organization MASSACHUSETTS EYE & EAR INFIRMARY

Part II	Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Page 4

Name of organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part III

Exclusively religious, charitable, etc., individual contributions to section 501(c)(7), (8), or (10) organizations
that total more than $1,000 for the year. Complete columns (a) through (e) and the following line entry.
For organizations completing Part III, enter the total of exclusively religious, charitable, etc.,
contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet

$
Use duplicate copies of Part III if additional space is needed.

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527
SchCMd Bullet

Complete if the organization is described below. SchCMd Bullet

Attach to Form 990 or Form 990-EZ.
SchCMd Bullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public
Inspection

If the organization answered “Yes” to Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet

Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet

Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet

Section 527 organizations: Complete Part I-A only.
If the organization answered “Yes” to Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet

Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet

Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered “Yes” to Form 990, Part IV, Line 5 (Proxy Tax) or Form 990-EZ, Part V, line 35c (Proxy Tax), then
Round Bullet

Section 501(c)(4), (5), or (6) organizations: Complete Part III.

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I-A

Complete if the organization is exempt under section 501(c) or is a section 527 organization.

Provide a description of the organization’s direct and indirect political campaign activities in Part IV.

Political expenditures .................................... SchCMd Bullet

Volunteer hours ........................................

Part I-B

Complete if the organization is exempt under section 501(c)(3).

Enter the amount of any excise tax incurred by the organization under section 4955 ......... SchCMd Bullet

Enter the amount of any excise tax incurred by organization managers under section 4955 ...... SchCMd Bullet

If the organization incurred a section 4955 tax, did it file Form 4720 for this year? ..............

Yes No

Was a correction made? .........................................

Yes No

If "Yes," describe in Part IV.

Part I-C

Complete if the organization is exempt under section 501(c), except section 501(c)(3).

Enter the amount directly expended by the filing organization for section 527 exempt function activities SchCMd Bullet

Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ................................... SchCMd Bullet

Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b.. SchCMd Bullet

Did the filing organization file Form 1120-POL for this year? ..........................

Yes No

Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.

(a) Name	(b) Address	(c) EIN	(d) Amount paid from filing organization's funds. If none, enter -0-.	(e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.

For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.

Cat. No. 50084S

Schedule C (Form 990 or 990-EZ) 2012

Page 2

Part II-A

Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).

A Check SchCMd Bullet

if the filing organization belongs to an affiliated group (and list in Part IV each affiliated group member's name, address, EIN, expenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet

if the filing organization checked box A and "limited control" provisions apply.

Limits on Lobbying Expenditures (The term "expenditures" means amounts paid or incurred.)		(b) Affiliated group totals
1a	Total lobbying expenditures to influence public opinion (grass roots lobbying) ......
b	Total lobbying expenditures to influence a legislative body (direct lobbying) .......
c	Total lobbying expenditures (add lines 1a and 1b) ...................
d	Other exempt purpose expenditures ........................
e	Total exempt purpose expenditures (add lines 1c and 1d) ...............
f	Lobbying nontaxable amount. Enter the amount from the following table in both columns.
	If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
	Not over $500,00020% of the amount on line 1e.
	Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
	Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
	Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
	Over $17,000,000$1,000,000.

g	Grassroots nontaxable amount (enter 25% of line 1f) .................
h	Subtract line 1g from line 1a. If zero or less, enter -0-. ................
i	Subtract line 1f from line 1c. If zero or less, enter -0-. ................
j	If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting section 4911 tax for this year? ......................................	Yes No

4-Year Averaging Period Under Section 501(h) (Some organizations that made a section 501(h) election do not have to complete all of the five columns below. See the instructions for lines 2a through 2f on page 4.)
Lobbying Expenditures During 4-Year Averaging Period
	Calendar year (or fiscal year beginning in)	(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) Total

2a	Lobbying nontaxable amount

b	Lobbying ceiling amount (150% of line 2a, column(e))

c	Total lobbying expenditures

d	Grassroots nontaxable amount

e	Grassroots ceiling amount (150% of line 2d, column (e))

f	Grassroots lobbying expenditures

Schedule C (Form 990 or 990-EZ) 2012

Page 3

Part II-B

Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).

For each “Yes” response to lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.

(a)

Yes

(b)

Amount

During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:

Volunteers? .........................................

Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ....

Yes

Media advertisements? ....................................

Mailings to members, legislators, or the public? .........................

Yes

Publications, or published or broadcast statements? .......................

Grants to other organizations for lobbying purposes? .......................

Direct contact with legislators, their staffs, government officials, or a legislative body? ........

Yes

212,652

Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ......

Other activities? ..........................

Total. Add lines 1c through 1i ...............................

212,652

Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....

If "Yes," enter the amount of any tax incurred under section 4912 .................

If "Yes," enter the amount of any tax incurred by organization managers under section 4912 .....

If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? .......

Part III-A

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).

Yes

Were substantially all (90% or more) dues received nondeductible by members? ................

Did the organization make only in-house lobbying expenditures of $2,000 or less? ................

Did the organization agree to carry over lobbying and political expenditures from the prior year? ..........

Part III-B

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered “No” OR (b) Part III-A, line 3, is answered “Yes."

Dues, assessments and similar amounts from members .....................

Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political
expenses for which the section 527(f) tax was paid).

Current year .........................................

Carryover from last year ....................................

Total ............................................

Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .

If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ................................

Taxable amount of lobbying and political expenditures (see instructions) ..............

Part IV

Supplemental Information

Complete this part to provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, line 2; and Part ll-B, line 1. Also, complete this part for any additional information.

Identifier	Return Reference	Explanation
SCHEDULE C, PART II-B, LINE 1(I):		DURING THE FISCAL YEAR ENDED SEPTEMBER 30, 2013, THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") PAID A CONSULTANT TO ASSIST THE INFIRMARY ON BEHALF OF ITSELF AND ITS AFFILIATES, WITH DEVELOPING MEETINGS WITH THE MEMBERS OF THE MASSACHUSETTS LEGISLATURE AND EXECUTIVE BRANCH FOR PURPOSES OF DISCUSSION AROUND STATE HEALTHCARE PAYMENT REFORM, DISCUSSION AROUND MASSACHUSETTS EYE AND EAR REAL ESTATE DEVELOPMENT PLANNING, ASSIST IN PREPARING TESTIMONY FOR PRESENTATION BEFORE ALL RELEVANT COMMITTEES OF THE MASSACHUSETTS GENERAL COURT; DEVELOP LEGISLATIVE STRATEGIES; SERVE AS LIAISON TO GOVERNMENT AGENCIES AS NECESSARY AND MONITOR AND REPORT ON GOVERNMENT PROGRAMS RELATIVE TO HEALTHCARE FINANCING, INCLUDING STATE APPROPRIATIONS AND GRANTS. THE INFIRMARY IS A MEMBER OF CERTAIN TRADE ASSOCIATIONS THAT MAY LOBBY ON ITS BEHALF.

Schedule C (Form 990 or 990EZ) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE D
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Financial Statements

Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b
SchDMd Bullet

Attach to Form 990. SchDMd Bullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.

		(a) Donor advised funds	(b) Funds and other accounts
1	Total number at end of year .........
2	Aggregate contributions to (during year) ...
3	Aggregate grants from (during year) .....
4	Aggregate value at end of year ........

Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............

Yes No

Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................

Yes No

Part II

Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.

Purpose(s) of conservation easements held by the organization (check all that apply).

Preservation of land for public use (e.g., recreation or education) Preservation of an historically important land area

Protection of natural habitat Preservation of a certified historic structure

Preservation of open space

Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.


a	Total number of conservation easements .......................	2a
b	Total acreage restricted by conservation easements ..................	2b
c	Number of conservation easements on a certified historic structure included in (a) .....	2c
d	Number of conservation easements included in (c) acquired after 8/17/06, and not on a historic structure listed in the National Register ....................	2d

Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the tax year SchDMd Bullet

Number of states where property subject to conservation easement is located SchDMd Bullet

Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................

Yes No

Staff and volunteer hours devoted to monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .......................................

Yes No

In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.

If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.

If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:

(i)

Revenues included in Form 990, Part VIII, line 1 ........................ SchDMd Bullet

(ii)

Assets included in Form 990, Part X .............................. SchDMd Bullet

If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:

Revenues included in Form 990, Part VIII, line 1 .......................... SchDMd Bullet

Assets included in Form 990, Part X ............................... SchDMd Bullet

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 52283D

Schedule D (Form 990) 2012

Page 2

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)

Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):

Public exhibition

Loan or exchange programs

Scholarly research

Other

Preservation for future generations

Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.

During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........

Yes No

Part IV

Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.

Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................

Yes No

If "Yes," explain the arrangement in Part XIII and complete the following table:


c	Beginning balance .................................	1c
d	Additions during the year ..............................	1d
e	Distributions during the year .............................	1e
f	Ending balance ...................................	1f

Did the organization include an amount on Form 990, Part X, line 21? .....................

Yes No

If “Yes,” explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ........

Part V

Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.

		(a)Current year	(b)Prior year	b (c)Two years back	(d)Three years back	(e)Four years back
1a	Beginning of year balance ....	89,724,541	86,399,272	60,472,244	60,355,993	60,792,309
b	Contributions ........	2,692,680	1,269,332	29,640,100	736,023	993,556
c	Net investment earnings, gains, and losses	3,521,682	6,139,492	1,622,561	4,138,384	3,611,396
d	Grants or scholarships .....
e	Other expenditures for facilities and programs ........	7,238,556	2,803,513	4,005,052	3,579,845	3,713,026
f	Administrative expenses ....	1,495,683	1,280,042	1,330,581	1,178,311	1,328,242
g	End of year balance ......	87,204,664	89,724,541	86,399,272	60,472,244	60,355,993

Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:

Board designated or quasi-endowment SchDMd Bullet

8.553 %

Permanent endowment SchDMd Bullet

59.035 %

Temporarily restricted endowment SchDMd Bullet

32.411 %

The percentages in lines 2a, 2b, and 2c should equal 100%.

Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes

(i) unrelated organizations ........................

3a(i)

(ii) related organizations ........................

3a(ii)

Yes

If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........

Yes

Describe in Part XIII the intended uses of the organization's endowment funds.

Part VI

Land, Buildings, and Equipment. See Form 990, Part X, line 10.

Description of property		(b)Cost or other basis (other)	(c) Accumulated depreciation	(d) Book value
1a	Land .................	535,324		535,324
b	Buildings ................	176,467,311	106,372,037	70,095,274
c	Leasehold improvements ............	15,196,635	1,332,442	13,864,193
d	Equipment ................	176,275,184	129,661,303	46,613,881
e	Other .................	7,388,385	55,396	7,332,989
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).).......				138,441,661

Schedule D (Form 990) 2012

Page 3

Part VII

InvestmentsOther Securities. See Form 990, Part X, line 12.

(a) Description of security or category (including name of security)		(b)Book value	(c) Method of valuation: Cost or end-of-year market value
(1)Financial derivatives
(2)Closely-held equity interests
Other








Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)

Part VIII

InvestmentsProgram Related. See Form 990, Part X, line 13.

(a) Description of investment type		(b) Book value	(c) Method of valuation: Cost or end-of-year market value









Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)

Part IX

Other Assets. See Form 990, Part X, line 15.

(a) Description				(b) Book value
(1) DUE FROM AFFILIATES				29,070,759
(2) FUNDS HELD FOR RESEARCH				3,731,041
(3) CONSTRUCTION FUND				8,751,806
(4) DEBT SERVICE FUND				174,704
(5) SPECIAL CASH & CAPITAL RESERVE				4,163,350
(6) DEBT SERVICE RESERVES FUND				6,042,298
(7) DEFERRED FINANCING COSTS				1,540,877
(8) CAPITALIZED INTEREST				0
(9) TAX DEFERRED PLAN				971,900
(10) CRICO				2,015,459
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........				56,462,194

Part X

Other Liabilities. See Form 990, Part X, line 25.

1.(a) Description of liability		(b) Book value
Federal income taxes		0
DUE TO AFFILIATES		215,522
ESTIMATE THIRD PARTY SETTLEMEN		4,218,998
PROFESSIONAL LIABILITY RESERVE		2,528,724
ASSET RETIREMENT OBLIGATION		0
TAX DEFERRED LIABILITY		971,900




Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)		7,935,144
2. Fin 48 (ASC 740) Footnote. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII .....................................................

Schedule D (Form 990) 2012

Page 4

Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return
1	Total revenue, gains, and other support per audited financial statements .......		1
2	Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a	Net unrealized gains on investments ..........	2a
b	Donated services and use of facilities .........	2b
c	Recoveries of prior year grants ...........	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d .....................		2e
3	Subtract line 2e from line 1.....................		3
4	Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b .	4a
b	Other (Describe in Part XIII.) ...........	4b
c	Add lines 4a and 4b.......................		4c
5	Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ......		5

Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return
1	Total expenses and losses per audited financial statements ...........		1
2	Amounts included on line 1 but not on Form 990, Part IX, line 25:
a	Donated services and use of facilities ..........	2a
b	Prior year adjustments ..............	2b
c	Other losses ................	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d......................		2e
3	Subtract line 2e from line 1.....................		3
4	Amounts included on Form 990, Part IX, line 25, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b ..	4a
b	Other (Describe in Part XIII.) ............	4b
c	Add lines 4a and 4b.......................		4c
5	Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ......		5

Part XIII

Supplemental Information

Complete this part to provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.

Identifier	Return Reference	Explanation
SCHEDULE D, PART III, LINE 4:		THE RARE BOOKS COLLECTION CONSISTS MAINLY OF SEVERAL HUNDRED BOOKS IN EACH SPECIALTY OF THE EYE AND EAR AND BOOKS PURCHASED LATER WITH FUNDS FROM ENDOWMENTS SET UP BY THE PEOPLE WHO DONATED THE ORIGINAL COLLECTIONS. THE RARE BOOKS ARE AVAILABLE TO THE SCIENTIFIC, MEDICAL AND ACADEMIC COMMUNITY FOR PURPOSES OF RESEARCH AND EDUCATION. SCHEDULE D, PART V, LINE 4: THE ENDOWMENT FUNCTIONS TO SUPPORT THE MISSION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY TO PROVIDE SUPERIOR PATIENT CARE AND RESEARCH. THE INCOME FROM THE ENDOWMENT FUNDS ARE SUBJECT TO DONOR-IMPOSED STIPULATIONS USUALLY FOR RESEARCH, EDUCATION AND PATIENT CARE.
SCHEDULE D, PART X, LINE 2:		THE MASSACHUSETTS EYE AND EAR INFIRMARY ("INFIRMARY") WAS INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS WITH ITS AFFILIATED ORGANIZATIONS. THE INCOME TAX FOOTNOTE IS AS FOLLOWS: THE FOUNDATION AND ITS AFFILIATES QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER THE INTERNAL REVENUE CODE. THE FOUNDATION, INFIRMARY, ASSOCIATES, SCHEPENS AND EMBANKMENT ARE TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND CIRCLE IS TAX-EXEMPT UNDER 501(C)(25) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT HAS EVALUATED ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND THERE WAS NO IMPACT TO THE FOUNDATION'S FINANCIAL STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 2013.

Schedule D (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE F(Form 990)

Department of the Treasury
Internal Revenue Service

Statement of Activities Outside the United States

Complete if the organization answered "Yes" to Form 990,Part IV, line 14b, 15, or 16. Right pointing arrow large image

Attach to Form 990. Right pointing arrow large image

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

General Information on Activities Outside the United States. Complete if the organization answered “Yes” to Form 990, Part IV, line 14b.

For grantmakers. Does the organization maintain records to substantiate the amount of the grants or

assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used to award

the grants or assistance? ...................................

Yes

For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of grant funds outside
the United States.

Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)

(a) Region		(d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region)	(e) If activity listed in (d) is a program service, describe specific type of service(s) in region	(f) Total expenditures for and investments in region
	Europe (Including Iceland and Greenland)	Program Services	Research	127,843
	North America	Program Services	Research	53,647
	Central America and the Caribbean	Investments		24,200
	North America	Program Services	Conference	2,557
	South America	Program Services	Conference	1,451
	East Asia and the Pacific	Program Services	Conference	9,832
	Europe (Including Iceland and Greenland)	Program Services	Conference	74,374
	South Asia	Program Services	Conference	28,982
	Middle East and North Africa	Program Services	Conference	295








3a	Sub-total .....			323,181
b	Total from continuation sheets to Part I ...
c	Totals (add lines 3a and 3b)			323,181

For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2012

Schedule F (Form 990) 2012

Page 2

Part II

Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered “Yes” to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.

(c) Region	(e) Amount of cash grant	(f) Manner of cash disbursement	(g) Amount of of non-cash assistance
Europe (Including Iceland and Greenland)	127,988	check	0
North America	53,647	CHECK	0

Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .... MediumBullet

Enter total number of other organizations or entities ....................... MediumBullet

Schedule F (Form 990) 2012

Schedule F (Form 990) 2012Page 3

Part III

Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.

Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance		(b) Region	(c) Number of recipients	(d) Amount of cash grant	(e) Manner of cash disbursement	(f) Amount of non-cash assistance	(g) Description of non-cash assistance	(h) Method of valuation (book, FMV, appraisal, other)

Schedule F (Form 990) 2012

Page 4

Part IV

Foreign Forms

Schedule F (Form 990) 2012

Page 5

Part V

Supplemental Information
Complete this part to provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).

Identifier	ReturnReference	Explanation
SCHEDULE F, PART I, LINE 2:		SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE INFIRMARY ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A STATISFACTORY PACE. SCHEDULE F, PART I, LINE 3, COLUMN(F) AND PART II, LINE 1: THE INFIRMARY USES THE ACCRUAL METHOD OF ACCOUNTING AND SEPARATELY IDENTIFIES FOREIGN ACTIVITY ON ITS GENERAL LEDGER.

Schedule F (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE G (Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information Regarding
Fundraising or Gaming Activities

Complete if the organization answered "Yes" to Form 990, Part IV, lines 17, 18, or 19, or if the organization entered more than $15,000 on Form 990-EZ, line 6a. Form 990-EZ filers are not required to complete this part. right arrow

Attach to Form 990 or Form 990-EZ. right arrow

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Fundraising Activities. Complete if the organization answered "Yes" to Form 990, Part IV, line 17.

Indicate whether the organization raised funds through any of the following activities. Check all that apply.

a	Mail solicitations	e	Solicitation of non-government grants
b	Internet and email solicitations	f	Solicitation of government grants
c	Phone solicitations	g	Special fundraising events
d	In-person solicitations

Did the organization have a written or oral agreement with any individual (including officers, directors, trustees

or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?

Yes

If “Yes,” list the ten highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization.

(i) Name and address of individual or entity (fundraiser)		(ii) Activity	(iii) Did fundraiser have custody or control of contributions?		(v) Amount paid to (or retained by) fundraiser listed in col. (i)
			Yes	No
	PURSUANT	ANNUAL FUND		No	85,542
	BRAKELEY BRISCO	CAPITAL CAMPAIGN		No	11,291
	VISION PHILANTHROPY GROUP	CAPITAL CAMPAIGN		No	130,824







Total .................					227,657

List all states in which the organization is registered or licensed to solicit funds or has been notified it is exempt from registration or licensing.

ME, MA, NY

For Paperwork Reduction Act Notice, see the Instructions for Form 990or 990-EZ.

Cat. No. 50083H

Schedule G (Form 990 or 990-EZ) 2012

Page 2

Part II

Fundraising Events. Complete if the organization answered "Yes" to Form 990, Part IV, line 18, or reported more than $15,000 of fundraising event contributions and gross income on Form 990-EZ, lines 1 and 6b. List events with gross receipts greater than $5,000.

			(a) Event #1 (event type)	(b) Event #2 (event type)	(c) Other events (total number)	(d) Total events (add col. (a) through col. (c))
	1	Gross receipts . . .
	2	Less: Contributions . .
	3	Gross income (line 1 minus line 2) . . .
	4	Cash prizes . . .
	5	Noncash prizes . .
	6	Rent/facility costs . .
	7	Food and beverages .
	8	Entertainment . . .
	9	Other direct expenses .
	10	Direct expense summary. Add lines 4 through 9 in column (d) ...........
	11	Net income summary. Combine line 3, column (d), and line 10. ..........

Part III

Gaming. Complete if the organization answered "Yes" to Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.

(a) Bingo

(b) Pull tabs/Instant
bingo/progressive bingo

(c) Other gaming

(d) Total gaming (add col.(a) through col.(c))

Gross revenue . . . .

Cash prizes . . . .

Non-cash prizes . . .

Rent/facility costs . . .

Other direct expenses . .

Volunteer labor . . .

	Yes
	No

	Yes
	No

	Yes
	No

Direct expense summary. Add lines 2 through 5 in column (d) ........... right arrow

Net gaming income summary. Combine lines 1 and 7 in column (d) .......... right arrow

Enter the state(s) in which the organization operates gaming activities:

Is the organization licensed to operate gaming activities in each of these states? ............

YesNo

If "No," explain:

10a

Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? .....

YesNo

If "Yes," explain:

Schedule G (Form 990 or 990-EZ) 2012

Page 3

Does the organization operate gaming activities with nonmembers? .................

YesNo

Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity

formed to administer charitable gaming? ..........................

YesNo

Indicate the percentage of gaming activity operated in:

The organization's facility ......................

13a

An outside facility ........................

13b

Enter the name and address of the person who prepares the organization's gaming/special events books and records:

Name

Address

15a

Does the organization have a contract with a third party from whom the organization receives gaming

revenue? ......................................

YesNo

If "Yes," enter the amount of gaming revenue received by the organization right arrow

$ and the

amount of gaming revenue retained by the third party right arrow

$ .

If "Yes," enter name and address of the third party:

Name

Address

Gaming manager information:

Name

Gaming manager compensation right arrow

Description of services provided right arrow

Director/officer Employee Independent contractor

Mandatory distributions:

Is the organization required under state law to make charitable distributions from the gaming proceeds to

retain the state gaming license? ............................

YesNo

Enter the amount of distributions required under state law distributed to other exempt organizations or spent

in the organization's own exempt activities during the tax year right arrow

Part IV

Supplemental Information. Complete this part to provide the explanations required by Part I, line 2b, columns (iii) and (v), and Part III, lines 9, 9b, 10b, 15b, 15c, 16, and 17b, as applicable. Also complete this part to provide any additional information (see instructions).

Identifier	Return Reference	Explanation
SCHEDULE G, PART I, LINE 2B, COLUMN (V):	DURING THE FISCAL YEAR ENDED SEPTEMBER 20, 2013, THE MASSACHUSETTS EYE	AND EAR INFIRMARY ("THE INFIRMARY") CONTRACTED WITH PURSUANT, A FUNDRAISING CONSULTING COMPANY, TO ASSIST WITH THE FOUNDATION'S MAILING CAMPAIGN BY DRAFTING LETTERS AND WORKING WITH A MAIL HOUSE TO SEND LETTERS AND EMAILS TO PAITENTS ON THE INFIRMARY'S BEHALF. THE INFIRMARY ALSO CONTRACTED WITH BRAKELEY BRISCOE AND VISION PHILANTHROPY TO ASSIST WITH THE INFIRMARY'S CAPITAL FUNDRAISING CAMPAIGN.

Schedule G (Form 990 or 990-EZ) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE H (Form 990)

Department of the Treasury
Internal Revenue Service

Hospitals

Complete if the organization answered "Yes" to Form 990, Part IV, question 20.
MediumBullet

Attach to Form 990. MediumBullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Financial Assistance and Certain Other Community Benefits at Cost

Yes

Did the organization have a financial assistance policy during the tax year? If "No," skip to question 6a ...

Yes

If "Yes," was it a written policy? .......................

Yes

If the organization had multiple hospital facilities, indicate which of the following best describes application of the financial assistance policy to its various hospital facilities during the tax year.

Applied uniformly to all hospital facilities Applied uniformly to most hospital facilities Generally tailored to individual hospital facilities

Answer the following based on the financial assistance eligibility criteria that applied to the largest number of the organization's patients during the tax year.

Did the organization use Federal Poverty Guidelines (FPG) as a factor in determining eligibility for providing free care?

If "Yes," indicate which of the following was the FPG family income limit for eligibility for free care:

Yes

100% 150% 200% Other 400 %

Did the organization use FPG as a factor in determining eligibility for providing discounted care? If "Yes," indicate

which of the following was the family income limit for eligibility for discounted care: .........

Yes

200% 250% 300% 350% 400% Other %

If the organization used factors other than FPG in determining eligibility, describe in Part VI the income based criteria for determining eligibility for free or discounted care. Include in the description whether the organization used an asset test or other threshold, regardless of income, as a factor in determining eligibility for free or discounted care.

Did the organization's financial assistance policy that applied to the largest number of its patients during the tax year provide for free or discounted care to the "medically indigent"? ..............

Yes

Did the organization budget amounts for free or discounted care provided under its financial assistance policy during the tax year? ............................

Yes

If "Yes," did the organization's financial assistance expenses exceed the budgeted amount? ......

Yes

If "Yes" to line 5b, as a result of budget considerations, was the organization unable to provide free or discountedcare to a patient who was eligibile for free or discounted care? ..............

Did the organization prepare a community benefit report during the tax year? ..........

Yes

If "Yes," did the organization make it available to the public? ..............

Yes

Complete the following table using the worksheets provided in the Schedule H instructions. Do not submit these worksheets with the Schedule H.

Financial Assistance and Certain Other Community Benefits at Cost

Financial Assistance and Means-Tested Government Programs		(a) Number of activities or programs (optional)	(b) Persons served (optional)	(c) Total community benefit expense	(d) Direct offsetting revenue	(e) Net community benefit expense	(f) Percent of total expense
a	Financial Assistance at cost (from Worksheet 1) ..			3,500,688	103,938	3,396,750	1.520 %
b	Medicaid (from Worksheet 3, column a) ....			13,547,737	11,201,367	2,346,370	1.050 %
c	Costs of other means-tested government programs (from Worksheet 3, column b) .			3,861,948	3,775,107	86,841	0.040 %
d	Total Financial Assistance and Means-Tested Government Programs .			20,910,373	15,080,412	5,829,961	2.610 %
Other Benefits				452,931	0	452,931	0.200 %
e	Community health improvement services and community benefit operations (from Worksheet 4) ..			452,931	0	452,931	0.200 %
f	Health professions education (from Worksheet 5) ..			7,136,496	1,450,476	5,686,020	2.550 %
g	Subsidized health services (from Worksheet 6) ..	2	624	1,907,390	1,504,778	402,613	0.180 %
h	Research (from Worksheet 7)			38,753,403	946,746	37,806,657	16.970 %
i	Cash and in-kind contributions for community benefit (from Worksheet 8)			0	0	0	0 %
j	Total. Other Benefits ..	2	624	48,250,220	3,902,000	44,348,221	19.900 %
k	Total. Add lines 7d and 7j .	2	624	69,160,593	18,982,412	50,178,182	22.510 %

For Paperwork Reduction Act Notice, see the Instructions for Form 990. Cat. No. 50192T Schedule H (Form 990) 2012

Schedule H (Form 990) 2012

Page

Part II

Community Building Activities Complete this table if the organization conducted any community building activities during the tax year, and describe in Part VI how its community building activities promoted the health of the communities it serves.

		(a) Number of activities or programs (optional)	(b) Persons served (optional)	(c) Total community building expense	(d) Direct offsetting revenue	(e) Net community building expense	(f) Percent of total expense
1	Physical improvements and housing
2	Economic development
3	Community support
4	Environmental improvements
5	Leadership development and training for community members
6	Coalition building
7	Community health improvement advocacy
8	Workforce development
9	Other
10	Total

Part III

Bad Debt, Medicare, & Collection Practices

Section A. Bad Debt Expense

Yes

Did the organization report bad debt expense in accordance with Heathcare Financial Management Association Statement No. 15? ..........................

Yes

Enter the amount of the organization's bad debt expense. Explain in Part VI the methodology used by the organization to estimate this amount. ......

2,681,043

Enter the estimated amount of the organization's bad debt expense attributable to patients eligible under the organization's financial assistance policy. Explain in Part VI the methodology used by the organization to estimate this amount and the rationale, if any, for including this portion of bad debt as community benefit. ......

9,648

Provide in Part VI the text of the footnote to the organization’s financial statements that describes bad debt expense or the page number on which this footnote is contained in the attached financial statements.

Section B. Medicare

Enter total revenue received from Medicare (including DSH and IME).....

39,144,941

Enter Medicare allowable costs of care relating to payments on line 5.....

43,530,661

Subtract line 6 from line 5. This is the surplus (or shortfall)........

-4,385,720

Describe in Part VI the extent to which any shortfall reported in line 7 should be treated as community benefit.Also describe in Part VI the costing methodology or source used to determine the amount reported on line 6.Check the box that describes the method used:

Cost accounting system Cost to charge ratio Other

Section C. Collection Practices

Did the organization have a written debt collection policy during the tax year? ..........

Yes

If "Yes," did the organization’s collection policy that applied to the largest number of its patients during the tax year contain provisions on the collection practices to be followed for patients who are known to qualify for financial assistance? Describe in Part VI.......................

Yes

Part IV

Management Companies and Joint Ventures(owned 10% or more by officers, directors, trustees, key employees, and physicians—see instructions)

(a) Name of entity	(b) Description of primary activity of entity	(c) Organization's profit % or stock ownership %	(d) Officers, directors, trustees, or key employees' profit % or stock ownership %	(e) Physicians' profit % or stock ownership %
1
2
3
4
5
6
7
8
9
10
11
12
13

Schedule H (Form 990) 2012

Page

Part VFacility Information

Section A. Hospital Facilities (list in order of size from largest to smallest—see instructions) How many hospital facilities did the organization operate during the tax year?1 Name, address, and primary website address
1	MASSACHUSETTS EYE & EAR INFIRMARY 243 CHARLES STREET BOSTON,MA02114 http://www.masseyeandear.org/	X	X	X	X

Schedule H (Form 990) 2012

Page

Part VFacility Information (continued)

Section B. Facility Policies and Practices

(Complete a separate Section B for each of the hospital facilities or facility reporting groups listed in Part V, Section A)

	MASSACHUSETTS EYE & EAR INFIRMARY
Name of hospital facility or facility reporting group

For single facility filers only: line Number of Hospital Facility (from Schedule H, Part V, Section A)

Yes

Community Health Needs Assessment (Lines 1 through 8c are optional for tax years begining on or before March 23, 2012)

During the tax year or either of the two immediately preceding tax years, did the hospital facility conduct a community health needs assessment (CHNA)? If "No," skip to line 9....................

Yes

If “Yes,” indicate what the CHNA report describes (check all that apply):

A definition of the community served by the hospital facility

Demographics of the community

Existing health care facilities and resources within the community that are available to respond to the health needs of the community

How data was obtained

The health needs of the community

Primary and chronic disease needs and other health issues of uninsured persons, low-income persons, and minority groups

The process for identifying and prioritizing community health needs and services to meet the community health needs

The process for consulting with persons representing the community’s interests

Information gaps that limit the hospital facility’s ability to assess the community’s health needs

Other (describe in Part VI)

Indicate the tax year the hospital facility last conducted a CHNA: 20 13

In conducting its most recent CHNA, did the hospital facility take into account input from representatives of the community served by the hospital facility, including those with special knowledge of or expertise in public health? If “Yes,” describe in Part VI how the hospital facility took into account input from persons who represent the community, and identify the persons the hospital facility consulted ....................

Yes

Was the hospital facility’s CHNA conducted with one or more other hospital facilities? If “Yes,” list the other hospital facilities in Part VI................................

Did the hospital facility make its CHNA report widely available to the public? .............

If “Yes,” indicate how the CHNA report was made widely available (check all that apply):

Hospital facility’s website

Available upon request from the hospital facility

Other (describe in Part VI)

If the hospital facility addressed needs identified in its most recently conducted CHNA, indicate how (check all that apply to date):

Adoption of an implementation strategy that addresses each of the community health needs identified through the CHNA

Execution of the implementation strategy

Participation in the development of a community-wide plan

Participation in the execution of a community-wide plan

Inclusion of a community benefit section in operational plans

Adoption of a budget for provision of services that address the needs identified in the CHNA

Prioritization of health needs in its community

Prioritization of services that the hospital facility will undertake to meet health needs in its community

Other (describe in Part VI)

Did the hospital facility address all of the needs identified in its most recently conducted CHNA? If “No,” explain in Part VI which needs it has not addressed and the reasons why it has not addressed such needs ........

Did the organization incur an excise tax under section 4959 for the hospital facility's failure to conduct a CHNA as required by section 501(r)(3)? ...........................

If "Yes" to line 8a, did the organization file Form 4720 to report the section 4959 excise tax? ......

If "Yes" to line 8b, what is the total amount of section 4959 excise tax the organization reported on Form 4720 for all of its hospital facilities? $

Schedule H (Form 990) 2012

Page

Part VFacility Information (continued)

Financial Assistance Policy			Yes	No
9	Did the hospital facility have in place during the tax year a written financial assistance policy that:
	Explained eligibility criteria for financial assistance, and whether such assistance includes free or discounted care?	9	Yes
10	Used federal poverty guidelines (FPG) to determine eligibility for providing free care?...........	10	Yes
	If "Yes," indicate the FPG family income limit for eligibility for free care: 400.% If "No," explain in Part VI the criteria the hospital facility used.
11	Used FPG to determine eligibility for providing discounted care?.................	11	Yes
	If “Yes,” indicate the FPG family income limit for eligibility for discounted care: 400.% If "No," explain in Part VI the criteria the hospital facility used.
12	Explained the basis for calculating amounts charged to patients?.................	12	Yes
	If “Yes,” indicate the factors used in determining such amounts (check all that apply):
a	Income level
b	Asset level
c	Medical indigency
d	Insurance status
e	Uninsured discount
f	Medicaid/Medicare
g	State regulation
h	Other (describe in Part VI)
13	Explained the method for applying for financial assistance?...................	13	Yes
14	Included measures to publicize the policy within the community served by the hospital facility?.......	14	Yes
	If “Yes,” indicate how the hospital facility publicized the policy (check all that apply):
a	The policy was posted on the hospital facility’s website
b	The policy was attached to billing invoices
c	The policy was posted in the hospital facility’s emergency rooms or waiting rooms
d	The policy was posted in the hospital facility’s admissions offices
e	The policy was provided, in writing, to patients on admission to the hospital facility
f	The policy was available upon request
g	Other (describe in Part VI)
Billing and Collections
15	Did the hospital facility have in place during the tax year a separate billing and collections policy, or a written financial assistance policy (FAP) that explained actions the hospital facility may take upon non-payment?.......	15	Yes
16	Check all of the following actions against an individual that were permitted under the hospital facility's policies during the tax year before making reasonable efforts to determine the patient’s eligibility under the facility’s FAP:
a	Reporting to credit agency
b	Lawsuits
c	Liens on residences
d	Body attachments
e	Other similar actions (describe in Part VI)
17	Did the hospital facility or an authorized third party perform any of the following actions during the tax year before making reasonable efforts to determine the patient’s eligibility under the facility’s FAP?..........	17		No
	If “Yes,” check all actions in which the hospital facility or a third party engaged:
a	Reporting to credit agency
b	Lawsuits
c	Liens on residences
d	Body attachments
e	Other similar actions (describe in Part VI)

Schedule H (Form 990) 2012

Page

Part VFacility Information (continued)

Indicate which efforts the hospital facility made before initiating any of the actions listed in line 17 (check all that apply):

Notified individuals of the financial assistance policy on admission

Notified individuals of the financial assistance policy prior to discharge

Notified individuals of the financial assistance policy in communications with the patients regarding the patients’ bills

Documented its determination of whether patients were eligible for financial assistance under the hospital facility’s financial assistance policy

Other (describe in Part VI)

Policy Relating to Emergency Medical Care

Yes

Did the hospital facility have in place during the tax year a written policy relating to emergency medical care that requires the hospital facility to provide, without discrimination, care for emergency medical conditions to individuals regardless of their eligibility under the hospital facility’s financial assistance policy?..........

Yes

If “No,” indicate why:

The hospital facility did not provide care for any emergency medical conditions

The hospital facility’s policy was not in writing

The hospital facility limited who was eligible to receive care for emergency medical conditions (describe in Part VI)

Other (describe in Part VI)

Charges to Individuals Eligible for Assistance under the FAP (FAP-Eligible Individuals)

Indicate how the hospital facility determined, during the tax year, the maximum amounts that can be charged to FAP-eligible individuals for emergency or other medically necessary care.

The hospital facility used its lowest negotiated commercial insurance rate when calculating the maximum amounts that can be charged

The hospital facility used the average of its three lowest negotiated commercial insurance rates when calculating the maximum amounts that can be charged

The hospital facility used the Medicare rates when calculating the maximum amounts that can be charged

Other (describe in Part VI)

During the tax year, did the hospital facility charge any FAP-eligible individuals to whom the hospital facility provided emergency or other medically necessary services, more than the amounts generally billed to individuals who had insurance covering such care? ............................

If “Yes,” explain in Part VI.

During the tax year, did the hospital facility charge any FAP-eligible individuals an amount equal to the gross charge for any service provided to that individual? .........................

If “Yes,” explain in Part VI.

Schedule H (Form 990) 2012

Page

Part VFacility Information (continued)

Section C. Other Health Care Facilities That Are Not Licensed, Registered, or Similarly Recognized as a Hospital Facility (list in order of size, from largest to smallest) How many non-hospital health care facilities did the organization operate during the tax year?7
Name and address		Type of Facility (describe)
1	MASSACHUSETTS EYE & EAR STONEHAM ONE MONTVALE AVENUE STONEHAM,MA02180	LICENSED OUTPATIENT LOCATION
2	MASSACHUSETTS EYE & EAR E BRIDGEWATER ONE COMPASS WAY SUITE 100 E BRIDGEWATER,MA02333	LICENSED OUTPATIENT LOCATION
3	MEEI VESTIBULAR CENTER AT BRAINTREE 250 POND STREET 1ST FLOOR BRAINTREE,MA02184	LICENSED OUTPATIENT LOCATION
4	MASSACHUSETTS EYE & EAR QUINCY 500 CONGRESS STREET QUINCY,MA02169	LICENSED OUTPATIENT LOCATION
5	MASSACHUSETTS EYE & EAR AT JOSLIN 1 JOSLIN PLACE BOSTON,MA02215	LICENSED OUTPATIENT LOCATION
6	MASSACHUSETTS EYE & EAR CONCORD 54 BAKER AVE EXTENSION 3RD FL STE CONCORD,MA01742	LICENSED OUTPATIENT LOCATION
7	MASSACHUSETTS EYE & EAR LONGWOOD 800 HUNTINGTON AVENUE BOSTON,MA02115	LICENSED OUTPATIENT LOCATION
8
9
10

Schedule H (Form 990) 2012

Page

Part VI

Supplemental Information

Complete this part to provide the following information.

1	Required descriptions. Provide the descriptions required for Part I, lines 3c, 6a, and 7; Part II; Part III, lines 4, 8, and 9b; Part V, Section A; and Part V, Section B, lines 1j, 3, 4, 5c, 6i, 7, 10, 11, 12h, 14g, 16e, 17e, 18e, 19c, 19d, 20d, 21, and 22.
2	Needs assessment. Describe how the organization assesses the health care needs of the communities it serves, in addition to any needs assessments reported in Part V, Section B.
3	Patient education of eligibility for assistance. Describe how the organization informs and educates patients and persons who may be billed for patient care about their eligibility for assistance under federal, state, or local government programs or under the organization’s financial assistance policy.
4	Community information. Describe the community the organization serves, taking into account the geographic area and demographic constituents it serves.
5	Promotion of community health. Provide any other information important to describing how the organization’s hospital facilities or other health care facilities further its exempt purpose by promoting the health of the community (e.g., open medical staff, community board, use of surplus funds, etc.).
6	Affiliated health care system. If the organization is part of an affiliated health care system, describe the respective roles of the organization and its affiliates in promoting the health of the communities served.
7	State filing of community benefit report. If applicable, identify all states with which the organization, or a related organization, files a community benefit report.
8	Facility reporting group(s). If applicable, for each hospital facility in a facility reporting group provide the descriptions required for Part V, Section B, lines 1j, 3, 4, 5c, 6i, 7, 10, 11, 12h, 14g, 16e, 17e, 18e, 19c, 19d, 20d, 21, and 22.

Identifier	ReturnReference	Explanation
SCHEDULE H, PART II:		THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND IT'S AFFILIATED ORGANIZATIONS (COLLECTIVELY "MEEI") PROVIDED COMMUNITY BUILDING HEALTH IMPROVEMENT ADVOCACY BY PROVIDING EDUCATIONAL OPPORTUNITIES AND SUPPORT, INCLUDING HOSTED SUPPORT GROUPS, FOCUSING ON HEALTH CONDITIONS IN OUR SPECIALTIES TO PATIENTS AND THE PUBLIC. PLEASE SEE PAGE 16 OF THE COMMUNITY BENEFITS PLAN POSTED ON THE MEEI WEBSITE, WWW.MASSEYEANDEAR.ORG, FOR DETAILS.
SCHEDULE H, PART III, LINE 4:		BAD DEBTS ARE WRITTEN OFF AT GROSS CHARGES. FOR UNINSURED CLAIMS (SELF-PAY), BAD DEBTS ARE DISCOUNTED TO COST USING THE HOSPITAL COST ACCOUNTING SYSTEM. ACCOUNTS RECEIVABLE RELATED TO CO-PAYS, DEDUCTIBLES, AND COINSURANCE THAT IS WRITTEN OFF AS BAD DEBT IS ALREADY REPORTED AT COST AND IS DEDUCTED FROM THE INSURANCE-ALLOWED AMOUNT.
SCHEDULE H, PART III, LINE 8:		THE SHORTFALL REPORTED ON PART III, LINE 7 SHOULD BE CONSIDERED COMMUNITY BENEFIT BECAUSE REIMBURSEMENT FROM MEDICARE DOES NOT COVER THE COST OF TREATING PATIENTS. MEEI HAS A POLICY TO TREAT ALL PATIENTS, REGARDLESS OF THE PAYER. AS A PRIMARILY OUT-PATIENT FACILITY, WITH ONLY TWO SPECIALTIES, MEEI CANNOT BENEFIT FROM RELATIVELY HIGHER MEDICARE PAYMENTS FOR SOME SPECIALTIES OR HIGHER INPATIENT MEDICARE REIMBURSEMENT. WITHOUT COMPROMISING PATIENT CARE, MEEI HAS LIMITED MEANS FOR REDUCING COSTS. MEEI USES A COST ACCOUNTING SYSTEM THAT IS COMPRISED OF A STEP-DOWN METHODOLOGY FOR ALLOCATING HOSPITAL OVERHEAD THAT IS SIMILAR TO THAT USED FOR THE MEDICARE COST REPORT. ALL INDIRECT COSTS ARE ALLOCATED TO PATIENT CARE COST CENTER, TEACHING AND RESEARCH. FULLY-LOADED PATIENT CARE COSTS ARE ALLOCATED TO PATIENTS USING BILLED UNITS, UNIT COSTS, AND ALLOCATION ALGORITHMS SPECIFIC TO EACH COST CENTER.
SCHEDULE H, PART III, LINE 9B:		PATIENTS ARE NOTIFIED ON ALL BILLING STATEMENTS OF THE AVAILABILITY OF FINANCIAL ASSISTANCE AND THE CONTACT INFORMATION OF THE APPROPRIATE STAFF MEMBERS WHO ARE AVAILABLE TO ASSIST IN THE PROCESS. MEEI'S POLICY INCORPORATES SPECIFIC BILLING PRACTICES RELATING TO PATIENTS WHO ARE ELGIBILE FOR FINANCIAL ASSISTANCE.
Schedule H, Part V, Section B, Line 3:		To gain a better understanding of needs in Mission Hill specifically, the consultants worked with the Mass. Eye and Ear CB Working Group and with Brigham and Women's Hospital Community Benefits leaders to identify Mission Hill service providers, advocates and educators positioned to speak to the needs of the community. The consultants then conducted ten in-depth interviews with the identified key informants. (See Figure 12 in the official MEEI Community Benefits Report for the key informant interview participants and their organizational affiliations.) Among them was a member of the New England Baptist Hospital, which operates a smaller but highly regarded community benefits program targeting Mission Hill. The experiences of the BWH and New England Baptist provided great insights that informed the assessment and planning processes described below. The interviews yielded important and useful information about neighborhood characteristics, methods for building and sustaining strong relationships in Mission Hill, the needs of the neighborhood, and partnership opportunities. Schedule H, Part V, Section B, Line 5A: The community health needs assessment can be found online at the MEEI website, www.masseyeandear.org. Schedule H, Part V, Section B, Line 6a: The implementation strategy can be found within the community health needs assessment online at the MEEI website, www.masseyeandear.org. Schedule H, Part V, Section B, Line 7: Mass. Eye and Ear's strategies proved successful at achieving our annual targets and supporting our community benefits objectives. The CHNA includes tables that display the expected outcomes/targets established for the year and describe our progress in meeting those targets. In most cases, targets were either met or exceeded. In cases in which targets were not been met, information is provided to explain why our progress fell short of the targets and to describe our quality improvement plans, if needed, to ensure that we are able to meet our targets moving forward. Targets Missed: -At least 50 young adults will received comprehensive eye exams. Only 40 young adults receive exams through vision coalition. -At least 50 people will receive support for and education about glaucoma. Only 43 people received education from annual glaucoma support group before group disbanded during the fiscal year. -Provide self-defense training to at least 10 individuals with blindness or vision impairment. None received training because group disbanded during the fiscal year. -At least one individual will receive reconstructive surgery to address injuries caused by domestic violence. Hospital did not receive any referrals from the R.O.S.E. in FY13. -At least 50 people will be screen for head/neck cancer. We allocated space for 50 patients but only 45 people were screen at the Head and Neck Cancer Screening/Table. -Mass. Eye and Ear patients who need assistance with lodging, food, and other vital necessities will receive help in securing those resources. Only 30 people received assistance securing resources. MEEI believes more people have access to the internet are handling these needs by themselves. We assisted all who requested assistance. SCHEDULE H, PART V, SECTION B, LINE 20D: CHARGES FOR PATIENTS WHO QUALIFY FOR FINANCIAL ASSISTANCE ARE BASED ON THE AVERAGE REIMBURSEMENT OF THE INFIRMARY'S THREE LARGEST PAYERS.
SCHEDULE H, PART VI, LINE 2:		MEEI ENGAGED THE SERVICES OF CONSULTANTS TO WORK CLOSELY WITH THE COMMUNITY BENEFITS (BC) WORKING GROUP THROUGHOUT THE ASSESSMENT AND PLANNING PROCESS, WHICH TOOK PLACE DURING THE FALL 2012/WINTER 2013. DURING THE ASSESSMENT AND PLANNING PROCESSES, THE CB WORKING GROUP MET REGULARLY AND ENGAGED THE FULL COMMITTEE AS NEEDED FOR PROGRESS UPDATES AND INPUT. AFTER THE PLAN WAS DEVELOPED AND APPROVED, MEETINGS DECREASED IN FREQUENCY AND THE GROUPS MET ON AN AS-NEEDED BASIS. FOR MOST MASSACHUSETTS HOSPITALS, COMMUNITY-LEVEL DATA AVAILALBE THROUGH THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH AND BOSTON PUBLIC HEALTH COMMISSION ARE USEFUL IN UNDERSTANDING THE SPECIFIC HEALTH NEEDS OF COMMUNITIES AND THOSE IN WHICH DISPARITIES EXIST. THESE DATA ARE TYPICALLY USED TO SELECT VULNERABLE COMMUNITIES AND POPULATIONS AND TO TARGET SERVICES TO ADDRESS PARTICULAR HEALTH ISSUES AND DISPARITIES. BECAUSE NEITHER THE BOSTON PUBLIC HEALTH COMMISSION NOR THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH COLLECT AND REPORT DATA ON VISION, HEARING AND OTHER HEAD AND NECK CONDITIONS IN MASSACHUSETTS COMMUNITIES, MEEI'S CB COMMITTEE HAD TO RELY ON ITS OWN PATIENT DATA, CENSUS DATA, AND GUIDANCE FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION TO DEFINE ITS TARGET COMMUNITIES AND POPULATIONS AND TO FORMULATE OBJECTIVES FOR ITS COMMUNITY BENEFITS PLAN.
SCHEDULE H, PART VI, LINE 3:		MEEI, AS A FACILITY, WORKS TO ACTIVELY INFORM PATIENTS OF PROGRAMS AND RESOURCES AVAILABLE TO THEM TO HELP WITH FINANCIAL ASSISTANCE. BILLING BROCHURES ARE AVAILABLE IN ALL DEPARTMENTAL WAITING AREAS, WHICH EXPLAIN THE BILLING PROCESS AND THE PATIENT'S OPTIONS FOR FINANCIAL ASSISTANCE. IN ADDITION, THE MEEI EXTERNAL WEBSITE CONTAINS A LINK WHICH HIGHLIGHTS THE BASIC FEDERAL PROGRAMS AND ACCESS TO MEEI'S FINANCIAL COUNSELORS. THE FINANCIAL COUNSELING PROCESS IS DESIGNED TO EVALUATE THE PATIENTS' FINANCIAL ABILITY TO PAY AND TO RECOMMEND AND ASSIST THE PATIENT WITH ENROLLING IN ANY APPLICABLE GOVERNMENT OR PRIVATE PROGRAMS. WHEN ALL AVENUES HAVE BEEN EXHAUSTED, CHARITABLE CARE CRITERIA ARE REVIEWED.
SCHEDULE H, PART VI, LINE 4:		STEP 1: IDENTIFY MEEI'S TARGET AREA AND POPULATIONS FOR ITS COMMUNITY BENEFITS PLAN THE ASSESSMENT TO INFORM THE NEXT MEEI COMMUNITY BENEFIT PLANS BEGAN WITH ANALYSIS OF 12 MONTHS OF PATIENT DATA (APRIL 1, 2011 THROUGH MARCH 31, 2012) TO BETTER UNDERSTAND THE POPULATION SERVED. PATIENTS FROM OUTSIDE OF MASSACHUSETTS WERE EXCLUDED FROM ANALYSES, LEAVING A REPRESENTATIVE SAMPLE OF 65,429 PATIENTS. BELOW, OBSERVATIONS ABOUT PATIENTS' SEX, RACE/ETHNICITY, AGE, SOCIO-ECONOMIC STATUS, AND THEIR GEOGRAPHIC LOCATIONS ARE PROVIDED. THESE DATA WERE USED TO GUIDE THE SELECTION OF COMMUNITIES AND/OR POPULATIONS OF FOCUS. DEMOGRAPHIC CATEGORIES & STATISTICS: SEX: OVER HALF (53.4%) OF PATIENTS INCLUDED IN THE DATA SET ARE FEMALE. RACE/ETHNICITY: ROUGHLY 75% OF PATIENTS IN THE SAMPLE ELECTED TO PROVIDE DATA ABOUT THEIR RACE AND ETHNICITY AT THE TIME OF REGISTRATION AT THE HOSPITAL. FIGURE 1 BELOW SHOWS THE RACIAL/ETHNIC BREAKDOWN OF PATIENTS IN THE DATA SET, THE MAJORITY OF WHOM (60.2%) ARE WHITE. RACIAL/ETHNIC BREAKDOWN: (NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS) AMERICAN INDIAN/ALASKA NATIVE: 125; 0.2% ASIAN: 2,196; 3.4% BLACK/AFRICAN AMERICAN: 4,684; 7.2% HISPANIC: 1,090; 1.7% PACIFIC ISLANDER: 25; <1% WHITE: 39,392; 60.2% OTHER: 1,148; 1.7% UNKNOWN: 16,769; 25.6% TOTAL: 65,429; 100% BECAUSE THERE IS SO MUCH MISSING INFORMATION ABOUT RACE/ETHNICITY, THE DATA WERE NOT PARTICULARLY USEFUL IN IDENTIFYING VULNERABLE POPULATIONS. GEOGRAPHY: NOTE THAT WITHIN DATA SET, SOME PATIENTS WERE LISTED AS LIVING IN BOSTON WITH NO SPECIFIED NEIGHBORHOOD, WHEREAS OTHERS WERE LISTED AS LIVING IN ONE OF BOSTON'S 21 NEIGHBORHOODS. IN FACT, DATA WERE AVAILABLE FOR 11 OF THE 21 NEIGHBORHOODS. RATHER THAN ROLL THE DATA FOR THE 11 NEIGHBORHOODS INTO THE BOSTON NUMBERS, THE CONSULTANTS KEPT THE DATA SEPARATE TO UNDERSTAND WHICH NEIGHBORHOODS HAVE SIGNIFICANT NUMBERS OF MEEI PATIENTS. HOWEVER, IT SHOULD BE NOTED THAT THE ACTUAL NUMBERS ASSOCIATED WITH THOSE NEIGHBORHOODS SHOULD BE HIGHER, AS SOME PATIENTS LIVING IN THOSE NEIGHBORHOODS ARE SIMPLY CLASSIFIED AS LIVING IN BOSTON. OTHER NEIGHBORHOODS OF BOSTON MAY ALSO BE HOME TO LARGE NUMBERS OF MEEI PATIENTS BUT, BECAUSE THEY ARE NOT BROKEN OUT, WE DO NOT KNOW HOW MANY PATIENTS RESIDE IT THOSE NEIGHBORHOODS. OF THE 65,429 MASSACHUSETTS PATIENTS IN THE DATA SET, NEARLY 30% LIVE IN BOSTON AND NEARLY HALF (49.2%) LIVE IN COMMUNITIES INSIDE ROUTE 128 (INCLUDING BOSTON). THE VAST MAJORITY (82.8%) OF PATIENTS ARE FROM COMMUNITIES INSIDE OF ROUTE 495. PERCENT OF MEEI PATIENTS LIVING IN GEOGRAPHIC AREAS OF MASSACHUSETTS: BOSTON/BOSTON NEIGHBORHOODS: 29.5% WITHIN 128 (EXCEPT BOSTON): 19.7% NORTH SHORE: 3.2% INSIDE 495 (BEYOND 128): 30.4% OUTSIDE 495 - CENTRAL: 6.6% OUTSIDE 495 - NORTH: 4.5% WESTERN MA: 5.1% CAPE/ISLANDS: <1% TO IDENTIFY POPULATION CENTERS, THE CONSULTANTS LOOKED FOR THE COMMUNITIES/NEIGHBORHOODS IN WHICH THE LARGEST NUMBERS OF MEEI PATIENTS LIVE. FIFTEEN COMMUNITIES/NEIGHBORHOODS ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS. NEARLY HALF (49.9%) LIVE IN THESE 15 COMMUNITIES. MASSACHUSETTS COMMUNITIES/NEIGHBORHOODS WITH HIGHEST PROPORTION OF MEEI PATIENTS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS; GEOGRAPHIC AREA) BOSTON (NO COMMUNITY SPECIFIED): 12,575; 19.2%; BOSTON JAMAICA PLAIN: 1,007; 1.5%; BOSTON WEST ROXBURY: 817; 1.2%; BOSTON ROSLINDALE: 789; 1.2%; BOSTON HYDE PARK: 780; 1.2%; BOSTON ALLSTON/BRIGHTON: 1,414; 2.2%; BOSTON CHARLESTOWN: 1,188; 1.8%; BOSTON CAMBRIDGE: 4,037; 6.2%; WITHIN 128 LYNN: 3,941; 6.0%; WITHIN 128 WAKEFIELD: 911; 1.4%; WITHIN 128 WOBURN: 933; 1.4%; WITHIN 128 READING/N. READING: 1,180; 1.8%; INSIDE 495 ANDOVER/N. ANDOVER: 1,356; 2.1%; INSIDE 495 FRAMINGHAM: 941; 1.4%; INSIDE 495 WORCESTER: 752; 1.1%; OUTSIDE 495 AGE: THE MASSACHUSETTS ATTORNEY GENERAL IS INTERESTED IN HAVING THE HOSPITAL COMMUNITY BENEFITS PLANS TARGET VULNERABLE POPULATIONS. MEEI HAS CLINICAL EXPERTISE IN SERVING ELDERS AND CHILDREN, POTENTIALLY VULNERABLE POPULATIONS SELECTED BY THE COMMUNITY BENEFITS STEERING COMMITTEE AS PRIORITY POPULATIONS FOR MEEI'S COMMUNITY BENEFITS PLAN BECAUSE OF THE IMPACT OF HEARING/VISION IMPAIRMENT ON CHILDREN'S DEVELOPMENT AND HEARING/VISION IMPAIRMENT AND BALANCE ISSUES ON THE HEALTH AND SAFETY OF ELDERS. THE MEAN AGE OF MEEI PATIENTS IS 46.81 YEARS, WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 106 YEARS OF AGE. PATIENTS AGED 65 AND OVER MAKE UP 23.5% OF THOSE SEEN DURING THE SELECTED TIMEFRAME, WHEREAS THOSE 18 OR YOUNGER CONSTITUTE 13.7% OF THE POPULATION. BELOW SHOWS THE PROPORTION OF PATIENTS IN VARIOUS AGE GROUPS: (AGE GROUP: PERCENTAGE OF TOTAL) <1 YEAR TO 18 YEARS OLD: 13.7% 19 TO 24 YEARS OLD: 5.4% 25 TO 34 YEARS OLD: 10.6% 35 TO 44 YEARS OLD: 12.2% 45 TO 54 YEARS OLD: 16.3% 55 TO 64 YEARS OLD: 18.3% 65 AND OVER: 23.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBER OF MEEI'S SENIOR (65 YEARS AND OLDER) POPULATION. THESE TEN COMMUNITIES ARE HOME TO 34% OF MEEI SENIORS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,820; 11.8% CAMBRIDGE: 1,015; 6.6% DORCHESTER: 540; 3.5% LYNN: 386; 2.5% BRIGHTON: 298; 1.9% FRAMINGHAM: 261; 1.7% JAMAICA PLAIN: 238; 1.5% PEABODY: 237; 1.5% SAUGUS: 227; 1.5% WOBURN: 227; 1.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO ARE LESS THAN 1 YEAR OF AGE THROUGH AGE 18. NEARLY 30% OF THE CHILDREN SERVED BY MEEI DURING THE DESIGNATED TIME PERIOD LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 883; 9.9% LYNN: 370; 4.1% CAMBRIDGE: 350; 3.9% SAUGUS: 192; 2.1% CHARLESTOWN: 175; 2.0% WOBURN: 169; 1.9% HAVERHILL: 143; 1.6% ANDOVER: 141; 1.6% DORCHESTER: 131; 1.4% READING: 129; 1.4% SOCIO-ECONOMIC STATUS: SOCIO-ECONOMIC (SES) IS ANOTHER VARIABLE ASSOCIATED WITH VULNERABLE POPULATIONS. PATIENTS' HEALTH INSURANCE CAN BE USED AS A PROXY FOR SES BECAUSE THERE ARE INCOME ELIGIBILITY REQUIREMENTS IN PLACE FOR PUBLIC PAYERS THAT ALLOW US TO MAKE ASSUMPTIONS ABOUT WHICH PATIENTS ARE LOW INCOME. IT IS IMPORTANT TO NOTE THAT THE NUMBER OF LOW-INCOME PATIENTS SERVED BY MEEI IS LIKELY MUCH HIGHER. IT IS NOT POSSIBLE TO KNOW HOW MANY MASSHEALTH PATIENTS, FOR EXAMPLE, ARE INSURED THROUGH A COMMERCIAL CARRIER WITH A MANAGED CARE CONTRACT WITH MASSHEALTH. ADDITIONALLY, IT IS NOT POSSIBLE TO KNOW WHICH PORTION OF THE SENIORS USING MEDICARE PRODUCTS TO PAY FOR THE SERVICES THEY RECEIVE AT MEEI ARE LOW-INCOME AND WHICH ARE NOT. ALTHOUGH AN IMPERFECT METHOD FOR DETERMINING THE SES OF PATIENTS, THESE ARE THE BEST DATA AVAILABLE FOR THIS PURPOSE. USING PAYER AS PROXY, IT APPEARS THAT JUST OVER 11% OF THE MEEI PATIENTS ARE LOW-INCOME, BROKEN DOWN AS FOLLOWS:
(PUBLIC PAYER: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL)		MASSHEALTH: 3,672; 7.1% HEALTH SAFETY NET: 796; 1.2% MEDICAID: 287; 0.4% BMC HEALTH NET: 143; 0.2% NETWORK HEALTH: 1,493; 2.3% THE AVERAGE AGE OF THESE LOW-INCOME PATIENTS IS 37 WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 96 YEARS OF AGE. IT IS IMPORTANT TO NOTE THAT THE VAST MAJORITY OF SENIORS (65+) ARE EXCLUDED FROM THE ANALYSES BECAUSE MOST SENIORS USE MEDICARE PRODUCTS TO PAY FOR THEIR CARE. TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO HAVE LOW SES. NEARLY 50% OF THE PATIENTS WITH LOW SES LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,102; 17.2% LYNN: 504; 7.9% CAMBRIDGE: 440; 6.9% DORCHESTER: 248; 3.8% LAWRENCE: 198; 3.1% CHARLESTOWN: 160; 2.5% EAST BOSTON: 163; 2.2% SAUGUS: 129; 2.0% LOWELL: 127; 2.0% WORCESTER: 123; 1.9% MEEI SERVES A POPULATION WITH A LARGE AGE RANGE, INCLUDING SIGNIFICANT SENIOR (65+) AND PEDIATRIC (LESS THAN ONE YEAR THROUGH AGE 18) POPULATIONS. USING PATIENT PAYER AS A PROXY FOR SES, AT LEAST 11.2% OF THE PATIENTS HAVE LOW SES. NEARLY HALF OF MEEI'S PATIENTS LIVE IN COMMUNITIES WITHIN ROUTE 128, INCLUDING BOSTON AND SELECT NEIGHBORHOODS. ELEVEN OF THE 15 COMMUNITIES THAT ARE HOME TO THE LARGEST CONCENTRATION OF MEEI PATIENTS ARE WITHIN THIS GEOGRAPHIC AREA. THERE IS OVERLAP IN THE TOP COMMUNITIES FOR THE GENERAL POPULATION OF PATIENTS SEEN DURING THE DESIGNATED TIMEFRAME AND THE VULNERABLE POPULATIONS. THREE ARE AMONG THE TOP COMMUNITIES FOR THE OVERALL POPULATION AND ELDERS, CHILDREN AND THOSE WITH LOW-SES: BOSTON, CAMBRIDGE AND LYNN. TWO OTHERS (DORCHESTER AND SAUGUS) ARE AMONG THE TOP TEN FOR ALL THREE VULNERABLE GROUPS. IT MAY BE POSSIBLE TO MAXIMIZE RESOURCES FOR ADDRESSING THE NEEDS OF PATIENTS OVERALL AND AMONG THE VULNERABLE POPULATIONS BY CONCENTRATING EFFORTS IN COMMUNITIES/NEIGHBORHOODS WITHIN 128, ESPECIALLY THOSE WHERE SUCH OVERLAPS EXIST. A 2010 CENSUS MAP PRODUCED BY THE BOSTON GLOBE AND AVAILABLE ON-LINE SHOWS THAT THE LARGEST CONCENTRATION OF PEOPLE OF COLOR IN MASSACHUSETTS IS IN THE METRO BOSTON AREA. A SIMILAR 2010 CENSUS MAP SHOWS THAT, ALTHOUGH METRO BOSTON IS HOME TO SOME OF THE COMMONWEALTH'S WEALTHIEST COMMUNITIES, IT IS ALSO HOME TO SOME OF THE LOWEST INCOME COMMUNITIES. A THIRD MAP CREATED BY THE GERONTOLOGY INSTITUTE AT THE MCCORMACK GRADUATE SCHOOL OF POLICY AND GLOBAL STUDIES AT THE UNIVERSITY OF MASSACHUSETTS BOSTON SHOWS THAT THE POPULATION OF SENIORS LIVING WITHIN THE METRO BOSTON AREA EXCEEDS THE STATEWIDE AVERAGE. ACCORDING TO THE 2010 CENSUS, 13.8% OF MASSACHUSETTS RESIDENTS ARE AGED 65 AND OLDER. WITHIN THE MAJORITY OF METRO BOSTON COMMUNITIES, SENIORS COMPRISE BETWEEN 15.1% AND 20% OF THE CITY/TOWN POPULATIONS. CONCLUSIONS: BASED ON THE MOST RECENT CENSUS DATA AND MEEI'S OWN PATIENT DATA, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT, ALTHOUGH MEEI CARES FOR PATIENTS FROM ALL OVER THE COMMONWEALTH, THE HOSPITAL'S PRIMARY SERVICE AREA INCLUDES THE COMMUNITIES IN THE METRO-BOSTON AREA (WITHIN THE ROUTE 128 BELT). ANALYSES ALSO SHOWED THAT LARGE NUMBERS OF VULNERABLE (I.E., CHILDREN, ELDERLY AND LOW-INCOME) PATIENTS RESIDE WITHIN THE METRO-BOSTON/128 AREA. THE COMMITTEE FURTHER CONCLUDED THAT, GIVEN THE NUMBER OF LOW INCOME COMMUNITIES AND PROPORTION OF PEOPLE OF COLOR RESIDING WITHIN ITS PRIMARY SERVICE AREA, MEMBERS OF MEEI'S TARGET POPULATION ARE VERY LIKELY TO EXPERIENCE BARRIERS TO CARE RELATED TO DIVERSITY (E.G., LANGUAGE) AND SOCIO-ECONOMIC FACTORS. BECAUSE OF THE FACTORS THAT MAKE CHILDREN, SENIORS AND LOW-INCOME INDIVIDUALS PARTICULARLY VULNERABLE, THESE GROUPS WILL BE PRIORITIZED WITHIN THE COMMUNITY BENEFITS PLAN. ALTHOUGH THE PLAN SHOULD NOT EXCLUDE THOSE LIVING OUTSIDE THE METRO-BOSTON AREA, IT SHOULD EMPHASIZE SERVICES FOR THOSE LIVING WITHIN IT BECAUSE RESIDENTS ARE SO LIKELY TO EXPERIENCE BARRIERS TO CARE. MEEI SHOULD BUILD UPON A SOLID FOUNDATION OF OUTREACH AND SERVICE PROVISION TO METRO-BOSTON COMMUNITIES AND INCLUDE STRATEGIES FOR IMPROVING ACCESS TO CARE IN THE COMMUNITY BENEFITS PLAN.
STEP 2: ASSESS UNMET NEEDS IN METRO BOSTON AND AMONG THE TARGET		POPULATIONS THE CB WORKING GROUP, OTHER MEMBERS OF THE COMMUNITY BENEFITS COMMITTEE, OTHER PROVIDERS AND STAFF AT MEEI, AND EXTERNAL PARTNERS AT ORGANIZATIONS SERVING THE TARGET POPULATIONS AND COMMUNITIES WORKED TOGETHER TO UNDERSTAND THE UNMET NEEDS THAT, AS AN INSTITUTION, MEEI IS UNIQUELY POSITIONED TO ADDRESS BECAUSE OF ITS CLINICAL SERVICES AND EXPERTISE. THROUGH ON-GOING DIALOG AND CONVERSATIONS OVER THE SUMMER AND FALL OF 2012, THE CB WORKING GROUP LED THE PROCESS TO IDENTIFY THE RESOURCE NEEDS. THE NEEDS ARE CONSISTENT WITH THOSE IDENTIFIED IN THE 2010 COMMUNITY BENEFITS PLAN: -TO EXTEND VISION SCREENING AND HEARING EXAMINATIONS AND FOLLOW UP CARE TO INDIVIDUALS WHO HAVE NO OR VERY LIMITED ACCESS TO SUCH SERVICES. -FOR RECONSTRUCTIVE SURGICAL SERVICES FOR SURVIVORS OF DOMESTIC VIOLENCE WHO EXPERIENCED PHYSICAL INJURIES TO THE HEAD AND/OR NECK AS A RESULT OF ABUSE. -FOR EDUCATION, SCREENING AND SUPPORT FOR HEAD AND NECK CANCERS. -FOR EDUCATION AND SUPPORT RELATED TO FACIAL PARALYSIS AND CONDITIONS THAT AFFECT SMELL AND TASTE. -FOR RESOURCES TO IMPROVE ACCESS TO CARE FOR MEMBERS OF THE TARGET COMMUNITIES WHO WOULD BENEFIT FROM MEEI SERVICES BUT WHO ARE UNABLE TO GET THE CARE THEY NEED DUE TO LINGUISTIC OR FINANCIAL ISSUES, LACK OF TRANSPORTATION, OR A LACK OF KNOWLEDGE ABOUT THEIR CONDITIONS AND THE SERVICES TO ADDRESS THEM. -FOR FINANCIAL SUPPORT OF COMMUNITY-BASED NON-PROFITS ENGAGED IN UNIQUE AND HIGH QUALITY WORK TO ADDRESS VISION, HEARING OR OTHER CONCERNS OF THE HEAD AND NECK IN THE TARGET COMMUNITIES AND/OR AMONG THE TARGET POPULATIONS. WITH GROWTH IN THE SENIOR POPULATION, THE INCREASE IN POVERTY OVER THE LAST SEVERAL YEARS, AND THE SMALL NUMBER OF INSTITUTIONS OFFERING THE CLINICAL EXPERTISE AND SERVICES AVAILABLE AT MEEI WITHIN METRO BOSTON, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE NEEDS ARE LIKELY TO PERSIST FOR MANY YEARS TO COME. SOME OF THE IDENTIFIED NEEDS (I.E., THOSE RELATED TO AWARENESS AND EDUCATION) AFFECT LARGE NUMBERS OF PEOPLE IN THE TARGET AREA. OTHERS AFFECT SMALLER GROUPS OF PEOPLE, EITHER BECAUSE POCKETS OF PEOPLE EXPERIENCE IMPEDED ACCESS TO SERVICES THAT ARE OTHERWISE GENERALLY AVAILABLE OR BECAUSE A CLINICAL CONDITION IS RARE AND THE RESOURCES TO ADDRESS IT ARE EXTREMELY LIMITED. CONCLUSION: THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE UNMET NEEDS IDENTIFIED DURING THE METRO BOSTON ASSESSMENT WERE ALIGNED WITH THE CAPABILITIES OF MEEI AND ITS COMMUNITY PARTNERS AND SHOULD BE USED TO FORMULATE GOALS FOR MEEI'S COMMUNITY BENEFITS PLAN. STEP 3: ASSESS NEEDS IN MISSION HILL AS NOTED EARLIER, MEEI DECIDED TO BROADEN ITS COMMUNITY BENEFITS WORK TO PROVIDE TARGETED PROGRAMMING IN MISSION HILL, THE NEIGHBORHOOD IN WHICH ITS NEW OUT-PATIENT FACILITY IS LOCATED. MISSION HILL IS ONE SQUARE MILE, THREE-QUARTERS OF WHICH IS RESIDENTIAL. THE OTHER QUARTER IS COMPRISED OF THE LONGWOOD MEDICAL AREA. ACCORDING TO A REPORT BASED ON 2010 CENSUS DATA, MISSION HILL IS HOME TO 16,305 RESIDENTS, 19.7% OF WHOM ARE HISPANIC/LATINO. JUST UNDER 46% OF THE POPULATION IS A RACE OTHER THAN WHITE. ROUGHLY 21% OF THE MISSION HILL POPULATION IS 19 YEARS OF AGE OR YOUNGER AND 9.1% IS 65 YEARS OF AGE OR OLDER. AN AMERICAN COMMUNITY SURVEY (2005-2009) ESTIMATE REPORT ESTIMATES THAT 3,711 OR 28.1% OF MISSION HILL RESIDENTS WERE BORN OUTSIDE OF THE U.S. AND THAT 48.5% OF THOSE ARE NOT CURRENTLY U.S. CITIZENS. JUST OVER 44% OF RESIDENTS SPEAK A LANGUAGE OTHER THAN OR IN ADDITION TO ENGLISH. OF THOSE WHO SPEAK A LANGUAGE OTHER THAN ENGLISH, 33.2% ARE LINGUISTICALLY ISOLATED BECAUSE THEY SPEAK LITTLE OR NO ENGLISH. IN 2009, AN ESTIMATED 19.3% OF MISSION HILL RESIDENTS EARNED LESS THAN $10,000 A YEAR. MORE THAN HALF (53.6%) EARNED LESS THAN $40,000 PER YEAR. IN CONTRAST, 12.6% EARNED $100,000 OR MORE IN THE SAME 12 MONTHS. ACCORDING TO THE 2010 CENSUS, OF THE 6,332 OCCUPIED HOUSING UNITS IN MISSION HILL, ONLY 11.4% ARE OWNER-OCCUPIED AND 33.6% ARE OCCUPIED BY FAMILIES. SEVERAL HUNDRED HOUSING UNITS IN MISSION HILL ARE OWNED AND RENTED BY THE BOSTON HOUSING AUTHORITY. SENIORS (65+) RESIDE IN 17.8% OF MISSION HILL HOUSEHOLDS WHILE CHILDREN UNDER THE AGE OF 18 ARE IN 16.9% OF HOUSEHOLDS. MISSION HILL IS HOME TO MORE THAN 20 HEALTH CARE, RESEARCH AND ACADEMIC INSTITUTIONS. MISSION HILL IS A SMALL BUT DIVERSE COMMUNITY. ALTHOUGH, HOME TO SOME OF THE CITY'S LARGEST EMPLOYERS AND SEVERAL HUNDRED MIDDLE AND UPPER INCOME RESIDENTS, MISSION HILL IS PRIMARILY A NEIGHBORHOOD OF LOWER-INCOME FAMILIES. SENIORS AND CHILDREN MAKE UP ROUGHLY 30% OF THE MISSION HILL POPULATION. TO LEARN ABOUT MEEI'S PATIENTS WHO RESIDE IN MISSION HILL, THE CONSULTANTS ANALYZED DATA FROM THE LARGER DATA SET FOR PATIENTS WHOSE ZIP CODE IS 02120 (THE ZIP CODE FOR MISSION HILL). DURING THE TIMEFRAME FROM WHICH PATIENT DATA WERE DRAWN, MEEI CARED FOR 263 PATIENTS WHO LIVE IN MISSION HILL (1.6% OF THE MISSION HILL POPULATION). WITH THE NEW FACILITY IN MISSION HILL AND A CONCENTRATED EFFORT TO PROVIDE SERVICES TO THE NEIGHBORHOOD THROUGH ITS COMMUNITY BENEFITS PROGRAMMING, WE EXPECT THAT NUMBER TO RISE OVER THE NEXT THREE YEARS. (SEE FIGURE 11 IN THE OFFICIAL MEEI COMMUNITY BENEFITS REPORT FOR THE DEMOGRAPHICS OF MEEI'S PATIENTS WHO LIVE IN MISSION HILL.) AFTER PROFILING THE DEMOGRAPHICS OF THE NEIGHBORHOOD, THE CONSULTANTS INTERVIEWED TWO SENIOR MANAGERS FOR COMMUNITY BENEFITS AT BRIGHAM AND WOMEN'S HOSPITAL (BWH). BWH IS LOCATED IN THE LONGWOOD MEDICAL AREA, NEIGHBORING MISSION HILL, AND HAS AN EXTENSIVE COMMUNITY BENEFITS PROGRAM THAT INVOLVES NUMEROUS INITIATIVES IN THE MISSION HILL. BOTH SENIOR MANAGERS HAVE SIGNIFICANT EXPERIENCE WORKING IN MISSION HILL AND WERE ABLE TO PROVIDE AN OVERVIEW OF BWH'S EXPERIENCE IN THE NEIGHBORHOOD. BOTH SENIOR MANAGERS SHARED A SYNOPSIS OF FINDINGS FROM THEIR OWN COMMUNITY BENEFITS NEEDS ASSESSMENT IN MISSION HILL. TO GAIN A BETTER UNDERSTANDING OF NEEDS IN MISSION HILL SPECIFICALLY, THE CONSULTANTS WORKED WITH THE MEEI CB WORKING GROUP AND WITH BRIGHAM AND WOMEN'S HOSPITAL COMMUNITY BENEFITS LEADERS TO IDENTIFY MISSION HILL SERVICE PROVIDERS, ADVOCATES AND EDUCATORS POSITIONED TO SPEAK TO THE NEEDS OF THE COMMUNITY. THE CONSULTANTS THEN CONDUCTED TEN IN-DEPTH INTERVIEWS WITH THE IDENTIFIED KEY INFORMANTS. AMONG THEM WAS A MEMBER OF THE NEW ENGLAND BAPTIST HOSPITAL, WHICH OPERATES A SMALLER BUT HIGHLY REGARDED COMMUNITY BENEFITS PROGRAM TARGETING MISSION HILL. THE EXPERIENCES OF THE BWH AND NEW ENGLAND BAPTIST PROVIDED GREAT INSIGHTS THAT INFORMED THE ASSESSMENT AND PLANNING PROCESSES DESCRIBED BELOW. THE INTERVIEWS YIELDED IMPORTANT AND USEFUL INFORMATION ABOUT NEIGHBORHOOD CHARACTERISTICS, METHODS FOR BUILDING AND SUSTAINING STRONG RELATIONSHIPS IN MISSION HILL, THE NEEDS OF THE NEIGHBORHOOD, AND PARTNERSHIP OPPORTUNITIES. THE INTERVIEW DATA WERE ANALYZED FOR COMMON AND DIVERGENT THEMES, WHICH ARE SUMMARIZED BELOW. MISSION HILL WAS DESCRIBED AS A COMMUNITY OF HIGH ECONOMIC NEED AND ONE IN WHICH JOB CREATION, JOB TRAINING, AND YOUTH EMPLOYMENT ARE HIGH PRIORITIES. THE KEY INFORMANTS DESCRIBED MISSION HILL RESIDENTS AS CULTURALLY AND LINGUISTICALLY DIVERSE WITH LARGE POPULATIONS OF HISPANIC, CHINESE, RUSSIAN, SOMALI, AND ETHIOPIAN RESIDENTS. THE COMMUNITY IS ALSO HOME TO A NUMBER OF HIGHLY DEDICATED ADVOCATES WHO ARE DEEPLY COMMITTED TO WORKING WITH INSTITUTIONAL NEIGHBORS TO BENEFIT THE NEIGHBORHOOD AND TO RESOLVE ISSUES AS THEY ARISE. MEEI IS VIEWED IN A POSITIVE LIGHT AND WAS OVERWHELMINGLY WELCOMED TO THE NEIGHBORHOOD. ALL OF THE KEY INFORMANTS EXPRESSED A SINCERE DESIRE TO HELP MEEI AS THE HOSPITAL BECOMES FAMILIAR WITH THE COMMUNITY AND INTRODUCES COMMUNITY BENEFITS PROGRAMS.
MISSION HILL RESIDENTS ACCESS ROUTINE HEALTH CARE SERVICES FROM MANY		SOURCES, INCLUDING THE LOCAL HOSPITAL PRIMARY CARE PRACTICES, COMMUNITY HEALTH CENTERS AND HOSPITAL EMERGENCY ROOMS. DIABETES WAS IDENTIFIED AS A PARTICULAR HEALTH ISSUE OF CONCERN IN MISSION HILL. THE KEY INFORMANTS REPORTED THAT VISION AND HEARING ISSUES ARE NOT ADDRESSED IN A COMPREHENSIVE MANNER IN THE COMMUNITY AND THAT A NEED FOR SUCH CARE EXISTS. THE KEYS TO BUILDING AND SUSTAINING STRONGLY RELATIONSHIPS IN THE COMMUNITY WERE DESCRIBED AS: -BEING A GOOD AND RESPECTFUL NEIGHBOR TO THOSE WHO ABUT THE NEW MEEI FACILITY, INCLUDING HAVING REGULAR DIALOGUE WITH THEM. -HAVING A PRESENCE IN MISSION HILL BY ATTENDING EVENTS. -HAVING A POINT PERSON/LIAISON TO THE NEIGHBORHOOD BEING RESPONSIVE AS NEEDS OR ISSUES ARISE -BEING INCLUSIVE, WORKING TO SERVE THE BROADER COMMUNITY RATHER THAN SPECIFIC ORGANIZATIONS WITHIN IT. -TAKING ADVANTAGE OF OPPORTUNITIES TO PARTNER WITH ORGANIZATIONS AND ADVOCATES IN MISSION HILL, INCLUDING MIKE ROSS, BOSTON CITY COUNCILMAN, WHO LIVES IN MISSION HILL. THE KEY INFORMANTS IDENTIFIED A NUMBER OF NEEDS THAT ARE CONSISTENT WITH MEEI'S CLINICAL EXPERTISE AND COMMUNITY BENEFITS MISSION, INCLUDING: -VISION/HEARING SCREENINGS FOR SENIORS AND FOR CHILDREN (TO COMPLEMENT SCREENINGS OFFERED BY THE BOSTON PUBLIC SCHOOLS) -FOLLOW UP CARE FOR SENIORS AND CHILDREN, INCLUDING FREE/REDUCED COST EYE GLASSES AND HEARING AIDS -EDUCATIONAL PROGRAMS/MATERIALS: -SENIORS: VISION CARE, ESPECIALLY RELATED TO DIABETES, BALANCE/FALLS PREVENTION, HEAD AND NECK ISSUES -YOUTH: HEARING ISSUES RELATED TO PORTABLE DEVICES AND HEADPHONES -TEACHERS: DETECTING HEARING AND VISION ISSUES AMONG STUDENTS AND THE RELATIONSHIP BETWEEN HEARING AND SPEECH. THE INTERVIEW PARTICIPANTS ALSO TALKED ABOUT THE NEED FOR ADDITIONAL JOB TRAINING/EMPLOYMENT OPPORTUNITIES, PARTICULARLY FOR YOUTH. SUGGESTIONS INCLUDED SUMMER JOBS FOR YOUTH, PAID INTERNSHIPS FOR YOUNG PEOPLE, EMPLOYMENT FOR MISSION HILL RESIDENTS AT THE MEEI MAIN CAMPUS AND THE MISSION HILL LOCATION, AND SCHOLARSHIP CONTRIBUTIONS. THE KEY INFORMANTS RECOMMENDED THAT MEEI "PIGGY BACK" ON EXISTING EFFORTS IN MISSION HILL TO REACH THE TARGET POPULATION FOR COMMUNITY BENEFITS INITIATIVES, GOING TO THE PLACE WHERE YOUTH AND SENIORS ALREADY TEND TO MEET (E.G., THE TOBIN COMMUNITY CENTER). THEY ALSO RECOMMENDED WORKING WITH ORGANIZATIONS THAT REPRESENT SENIORS AND CHILDREN FROM ACROSS MISSION HILL (E.G., THE LEGACY PROJECT, THE MISSION HILL YOUTH COLLABORATIVE) TO REACH THE MAXIMUM NUMBER OF YOUNG PEOPLE AND ELDERS IN THE COMMUNITY. THE ORGANIZATIONS IN MISSION HILL HAVE WELL-ESTABLISHED METHODS FOR COMMUNICATING WITH ONE ANOTHER AND WITH RESIDENTS ABOUT EVENTS IN THE COMMUNITY. ALTHOUGH SEVERAL USE EMAIL TO COMMUNICATE WITH THEIR COLLEAGUES IN OTHER ORGANIZATIONS, MOST ALSO DISSEMINATE FLYERS IN THE COMMUNITY TO ADVERTISE PROGRAMMING TO RESIDENTS. SOME ALSO USE PHONE TREES AND GO DOOR TO DOOR. NEWSLETTERS, CALENDARS, MONTHLY ORGANIZATION MEETINGS, AND THE LOCAL NEWSPAPER, THE MISSION HILL GAZETTE, ARE OTHER METHODS FOR SPREADING THE WORD IN MISSION HILL. ALL OF THE KEY INFORMANTS OFFERED TO HELP MEEI PUBLICIZE ITS COMMUNITY BENEFITS OFFERINGS THROUGH THEIR ESTABLISHED LINES OF COMMUNICATION. CONCLUSIONS: BASED ON THE FINDINGS FROM THE NEEDS ASSESSMENT IN MISSION HILL, THE COMMUNITY BENEFITS COMMITTEE DECIDED THAT IN EACH OF THE NEXT THREE YEARS, THE HOSPITAL'S COMMUNITY BENEFITS STRATEGIES IN THE NEIGHBORHOOD WILL INCLUDE THE FOLLOWING: -WORKING WITH THE MISSION HILL LEGACY PROJECT, OFFER A FREE VISION SCREENING TO AT LEAST 25 SENIORS AT ITS NEW LONGWOOD CENTER -WORKING WITH THE TOBIN COMMUNITY CENTER, PROVIDE A FREE EDUCATIONAL SESSION FOR YOUTH ON HEARING LOSS PREVENTION AT THE TOBIN COMMUNITY CENTER LOCATION. (IF IN YEARS 2 AND 3 OF THE PLAN, MEEI AND ITS COMMUNITY PARTNERS DETERMINE THAT SOMETHING DIFFERENT THAN THE ANNUAL VISION SCREENING FOR SENIORS OR HEARING EDUCATION EVENT FOR YOUTH IS NEEDED/PREFERABLE, THE PLAN WILL BE EDITED TO REFLECT SUCH CHANGES. THE OTHER COMMUNITY BENEFITS STRATEGIES ARE LIKELY TO OCCUR IN EACH OF THE THREE YEARS OF THE PLAN.) -WORKING WITH ONE OF THE EXISTING YOUTH EMPLOYMENT PARTNERS OR THE MISSION HILL YOUTH COLLABORATIVE, PROVIDE AN INTERNSHIP OPPORTUNITY TO A YOUNG PERSON IN MISSION HILL AT THE LONGWOOD FACILITY. -CONTINUE TO SUPPORT THE MISSION HILL MAIN STREET ROAD RACE (IN THE FORM OF AN ANNUAL $1000 SPONSORSHIP. -PARTICIPATE IN THE MISSION HILL HEALTH FAIR THAT IS HELD IN JUNE TO PROVIDE INFORMATION ON THE HOSPITAL AND PREVENTION AND TREATMENT OF CLINICAL ISSUES OF THE HEAD AND NECK. -ASSIST THOSE IN NEED OF FOLLOW UP CARE, INCLUDING HEARING AIDS AND GLASSES, TO OBTAIN COVERAGE FOR WHICH THEY ARE ELIGIBLE OR TO ACCESS ASSISTANCE THROUGH THE HOSPITAL (E.G., CHARITABLE CARE, FREE/REDUCE COST EYEGLASSES OR HEARING AID PROGRAMS). MEEI FILES AN ANNUAL COMMUNITY BENEFITS REPORT WITH THE MASSACHUSETTS ATTORNEY GENERAL. WHEN THE REPORTS ARE POSTED, THEY ARE AVAILABLE HERE: HTTP://WWW.MASSEYEANDEAR.ORG/ABOUT-US/OUTREACH/
SCHEDULE H, PART VI, LINE 5:		MEEI'S COMMUNITY BENEFITS STRATEGIES FOR ACHIEVING ITS OBJECTIVES AND ANNUAL TARGETS PROGRAM FALL INTO FOUR MAJOR CATEGORIES: 1. SCREENING AND CLINICAL SERVICES 2. EDUCATION AND SUPPORT 3. ACCESS TO SERVICES/RESOURCES 4. SPONSORSHIPS CATEGORIES 1 AND 2 DRAW ON MEEI'S BROAD CLINICAL AND TEACHING EXPERTISE AND ENCOMPASS THE NEW JOB READINESS STRATEGIES. CATEGORY 3 RESPONDS TO BARRIERS AND OBSTACLES THAT LIMIT ACCESS TO SERVICES. CATEGORY 4 REPRESENTS MEEI'S OPPORTUNITY TO SUPPORT PARTNERS WHOSE MISSIONS ARE ALIGNED WITH THOSE OF MEEI AND WHO ARE PROVIDING SERVICES TO MEEI'S PRIORITY PATIENT GROUPS AND/OR GEOGRAPHIC AREAS. EACH CATEGORY BELOW OFFERS A DESCRIPTION OF THE ASSOCIATED STRATEGIES AND PARTNERSHIPS AND CONCLUDES WITH AN AT-A-GLANCE TABLE THAT DESCRIBES THE NUMBER OF INDIVIDUALS, TARGET AUDIENCE AND GEOGRAPHIC AREA SERVED, THE ATTORNEY GENERAL'S COMMUNITY BENEFITS CATEGORIES ADDRESSED, AND THE COSTS/RESOURCES EXPENDED FOR THE REPORTABLE YEAR FOR EACH STRATEGY IN THE CATEGORY. FISCAL YEAR 2013 WAS YEAR TWO OF MEEI'S THREE-YEAR PLAN. CATEGORY 1: SCREENING & CLINICAL SERVICES MEEI PROVIDES SCREENING AND CLINICAL SERVICES TO A WIDE RANGE OF INDIVIDUALS AND GROUPS, FROM LOW-INCOME CHILDREN TO SENIORS TO SURVIVORS OF DOMESTIC VIOLENCE. SPECIFIC INITIATIVES ARE AS DESCRIBED BELOW: NEIGHBORHOOD HOUSE CHARTER SCHOOL (NHCS) NHCS WAS FOUNDED IN 1995 TO PROVIDE A BETTER EDUCATIONAL OPTION FOR LOW-INCOME BOSTON FAMILIES AND TO INCUBATE INNOVATIVE PRACTICES THAT HAVE THE POTENTIAL TO IMPROVE PUBLIC EDUCATION FOR ALL STUDENTS. TODAY, NHCS SERVES 400 STUDENTS AND IS ONE OF THE MOST SOUGHT AFTER SCHOOLS IN THE CITY, SUCCESSFULLY SERVING A DIVERSE COMMUNITY OF CHILDREN IN GRADES PRE-K THROUGH 8 FROM DORCHESTER AND SURROUNDING BOSTON NEIGHBORHOODS. MEEI'S DEPARTMENTS OF AUDIOLOGY AND OPHTHALMOLOGY PARTNERED WITH NHCS'S SCHOOL NURSE TO OFFER VISION AND HEARING SCREENING TO ALL STUDENTS. CHILDREN WHO NEED FOLLOW-UP CARE RECEIVE IT, FREE IF NECESSARY, AT MEEI. WORKING WITH NHCS' SCHOOL NURSE, MARY MCNULTY-ANGLIN, WE SET A GOAL OF SCREENING ALL CHILDREN IN ADVANCE OF FLU SEASON TO MAXIMIZE THE NUMBER OF CHILDREN IN ATTENDANCE.
CAMP HARBOR VIEW: CREATED IN 2008 TO OFFER BOSTON CHILDREN A TRUE		SUMMER CAMP EXPERIENCE, CAMP HARBOR VIEW IS AN INITIATIVE OF THE NOT-FOR-PROFIT CAMP HARBOR VIEW FOUNDATION, INC. IN PARTNERSHIP WITH THE CITY OF BOSTON AND THE BOYS & GIRLS CLUBS OF BOSTON. THE CAMP OFFERS CHILDREN AGES 11 TO 14 LIVING IN BOSTON'S AT-RISK NEIGHBORHOODS THE OPPORTUNITY TO LEAVE THE CITY DURING THE DAY AND PARTICIPATE IN A FOUR-WEEK SUMMER CAMP PROGRAM. RECOGNIZING MEEI'S EXPERTISE IN VISION SCREENING, MAYOR MENINO REQUESTED THAT MEEI PLAY A ROLE AT CAMP HARBOR VIEW. MEEI HAS BEEN PARTNERING WITH THE CAMP SINCE ITS FIRST SEASON. MEEI STAFF MEMBERS TRAVELED TO CAMP HARBOR VIEW TO CONDUCT ON-SITE VISION SCREENINGS AND IDENTIFY THOSE IN NEED OF FOLLOW-UP CARE. VISION COALITION/YEAR UP BOSTON: THE MISSION OF VISION COALITION MASSACHUSETTS IS TO REMOVE POOR VISION AS AN IMPEDIMENT TO LITERACY, EDUCATION, AND A BETTER WAY OF LIFE. VISION COALITION PROVIDES FREE VISION SCREENINGS AND FREE EYEGLASSES. MEEI PARTNERS WITH VISION COALITION MASSACHUSETTS BY PERFORMING FULL EYE EXAMS AND PROVIDING MEDICAL CARE FOR PARTICIPANTS IN YEAR UP BOSTON, WHICH THE VISION COALITION IDENTIFIED THROUGH SCREENING AS NEEDING VISION CARE. YEAR UP SERVES YOUNG URBAN ADULTS, PROVIDING THEM WITH THE SKILLS, EXPERIENCE, AND SUPPORT THAT WILL EMPOWER THEM TO REACH THEIR POTENTIAL THROUGH PROFESSIONAL CAREERS AND HIGHER EDUCATION. MEEI STAFF MEMBERS GIVE EYE EXAMS TO THESE YOUNG ADULTS, PROVIDE THOSE WHO NEED THEM WITH EYE GLASSES (WHICH ARE PURCHASED AT COST BY VISION COALITION), AND ENSURE THAT THOSE WHO NEED FOLLOW-UP CARE ARE LINKED TO SERVICES. HEAD AND NECK CANCER SCREENING/LECTURE: MEEI'S DEPARTMENTS OF ENT AND SOCIAL WORK COLLABORATE TO OFFER CANCER SCREENING TO THE GENERAL PUBLIC AND TO PROVIDE SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER. SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER HAS A SUPPORT GROUP CHAPTER AT MASSACHUSETTS GENERAL HOSPITAL. MEEI COLLABORATES WITH THIS GROUP AND WITH THE HEAD AND NECK CANCER ALLIANCE TO RAISE AWARENESS DURING ORAL, HEAD AND NECK CANCER AWARENESS WEEK BY HOSTING AN EDUCATION TABLE. R.O.S.E. FUND COLLABORATION: THE R.O.S.E. FUND (REGAINING ONE'S SELF ESTEEM) IS A NON-PROFIT ORGANIZATION CHARTERED TO BREAK THE SILENCE AND THE CYCLE OF DOMESTIC VIOLENCE AND TEEN DATING VIOLENCE AND ABUSE. AMONG ITS MANY ACTIVITIES, THE R.O.S.E. FUND SCREENS AND REFERS TO MEEI SURVIVORS OF DOMESTIC VIOLENCE IN NEED OF RECONSTRUCTIVE SURGERY. MEEI'S SURGEONS PERFORM THESE LIFE-ALTERING SURGERIES FREE OF CHARGE. The Legacy Project: The Legacy Project is a grassroots effort to provide support to seniors who reside in Mission Hill. Leaders of the Legacy Project reach out to seniors living in both public housing developments and to those who are living alone, providing information about services and community events. The Legacy Project also hosts a range of educational sessions and activities in its space at the Tobin Community Center. Activities range from computer classes to exercise and dance to intergenerational forums. The Legacy Project aims to build community through inclusiveness and communication, and partners with Mass. Eye and Ear in its community benefit programming for seniors.
CATEGORY 2: EDUCATION & SUPPORT		MEEI'S CLINICIANS AND SOCIAL WORKERS DELIVER EDUCATION AND SUPPORT TO INDIVIDUALS COPING WITH VARIOUS MEDICAL CONDITIONS OR CHALLENGES (E.G., SINUSITIS, HEARING LOSS, VISION LOSS, FACIAL PARALYSIS) AND ALSO REACH OUT TO PROVIDERS WHO INTERACT WITH SENIORS ACROSS THE COMMONWEALTH. DETAILS ON THESE EDUCATIONAL AND SUPPORT STRATEGIES ARE PRESENTED BELOW: PUBLIC FORUM ON HEARING AND HEARING LOSS: MEMBERS OF MEEI'S AUDIOLOGY DEPARTMENT PRESENTED AN 11TH ANNIVERSARY HAVE YOU HEARD? PUBLIC FORUM FEATURING EDUCATIONAL SESSIONS AND LECTURES ON HEARING AND HEARING LOSS. THIS YEAR'S SESSIONS FOCUSED ON THE MEDICAL AND SURGICAL MANAGEMENT OF HEARING LOSS, AUDIOLOGIC EVALUATION AND MANAGEMENT OF HEARING LOSS, AND SCIENTIFIC ADVANCES IN UNDERSTANDING HEARING AND HEARING LOSS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS AND INDIVIDUALS WITH HEARING LOSS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND THROUGH MEEI PARTNERSHIP WITH THE MASSACHUSETTS COUNCIL ON AGING. MEEI SURVEYS FORUM PARTICIPANTS AND WILL USE THEIR SUGGESTIONS TO DEVELOP THE EDUCATIONAL PROGRAM FOR NEXT YEAR. PUBLIC FORUM ON CONDITIONS THAT AFFECT SMELL AND TASTE: THIS YEAR, MEMBERS OF MEEI'S DEPARTMENT OF ENT OFFERED A SERIES OF LECTURES ON SINUSITIS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND VIA MEEI'S PARTNERSHIP WITH THE MASSACHUSETTS COMMISSION ON AGING. BOSTON CURED CANCER CLUB SUPPORT GROUP: THE BOSTON CURED CANCER GROUP FOR LARYNGECTOMEES SUPPORTS THE REHABILITATION OF LARYNGECTOMEES AND HELPS OFFER UNDERSTANDING TO PATIENTS AND THEIR LOVED ONES. MEEI HAS A STRONG COLLABORATIVE RELATIONSHIP WITH THIS ORGANIZATION, PROVIDING MEETING SPACE AND SPEAKERS FOR THE GROUPS. THE BOSTON CURED CANCER GROUP COMES AND MEETS WITH NEW LARYNGECTOMEES, PROVIDING SUPPORT TO MEEI PATIENTS. PARTICIPANTS IN THE GROUPS, MOSTLY OLDER PEOPLE, ARE LARGELY FROM METRO BOSTON, BUT SOME COME FROM GREATER DISTANCES. FACIAL PARALYSIS SUPPORT GROUP: THE FACIAL PARALYSIS SUPPORT GROUP IS A FORUM FOR INDIVIDUALS WITH FACIAL PARALYSIS AND THOSE CLOSE TO THEM TO MEET AND SHARE THEIR EXPERIENCES AND TO DISCUSS SUPPORT, TREATMENT, COPING AND SELF IMAGE. MEEI HOSTS THIS GROUP MONTHLY, PROVIDING MEETING SPACE AND SOCIAL WORK AND PHYSICIAN SUPPORT. WHILE THE GROUP IS OPEN TO ALL INDIVIDUALS WITH FACIAL PARALYSIS AND THEIR FAMILIES, PARTICIPANTS ARE GENERALLY FROM METRO BOSTON. MEEI PUBLICIZES THE SUPPORT GROUP VIA SOCIAL MEDIA AND THROUGH A PARTNERSHIP WITH THE FACIAL PARALYSIS SUPPORT NETWORK. GLAUCOMA SUPPORT GROUP: THE GLAUCOMA FOUNDATION FUNDS GROUNDBREAKING RESEARCH AND EDUCATES THE PUBLIC ABOUT GLAUCOMA AND THE IMPORTANCE OF EARLY DETECTION TO PREVENT BLINDNESS. THE NEW ENGLAND CHAPTER OF THE GLAUCOMA FOUNDATION HOSTS A SUPPORT GROUP FOR PEOPLE WITH GLAUCOMA, THEIR CAREGIVERS, PROFESSIONALS, AND OTHERS DEDICATED TO IMPROVING THE LIVES OF THOSE WITH THIS DISEASE. MEEI PARTNERS WITH THE GLAUCOMA FOUNDATION TO PROVIDE FREE MEETING SPACE AND PUBLICITY. MEMBERS OF MEEI'S DEPARTMENT OF OPHTHALMOLOGY ARE AVAILABLE AS SPEAKERS FOR THE GROUP. MEEI HELPS PROMOTE THE GROUP BY DISTRIBUTING FLYERS IN THE HOSPITAL'S CLINICS. ATTENDEES ARE GENERALLY SENIORS FROM METRO BOSTON. HEAR @ BOSTON: HEAR@BOSTON, A CHAPTER OF THE HEARING LOSS ASSOCIATION OF AMERICA, IS A COMMUNITY ORGANIZATION THAT HELPS EMPOWER PEOPLE WHO HAVE HEARING LOSS BY FACILITATING OPPORTUNITIES FOR SOCIAL ENGAGEMENT, EDUCATION AND SKILL DEVELOPMENT. MEEI DONATES MONTHLY MEETING SPACE AND MEEI CLINICIANS SERVE AS SPEAKERS FOR MEETINGS AND EVENTS. MANY OF HEAR@BOSTON'S MEMBERS ARE YOUNG PROFESSIONALS BETWEEN THE AGES OF 20 AND 45, BUT THE GROUP ENCOURAGES PEOPLE OF ALL AGES TO JOIN. Mission Hill Community Health Fair: Mass. Eye and Ear, Longwood, was out in full force at the Mission Hill Community Health Fair, an annual wellness event. Mass. Eye and Ear provided safety tips for hearing and vision protection and learned about disease prevention. THYROID EYE DISEASE SUPPORT GROUP: THE MASSACHUSETTS EYE AND EAR INFIRMARY OFFERS A THYROID EYE DISEASE (GRAVES' DISEASE) SUPPORT GROUP, WHICH WILL ALLOW MEMBERS TO EXPRESS THEIR CONCERNS ABOUT THIS CHRONIC ILLNESS TO HELP FORM A SOCIAL CONNECTION WITH OTHERS AND IMPROVE COPING SKILLS. THE OPEN FORUM GIVES MEMBERS THE OPPORTUNITY TO EXCHANGE INFORMATION ABOUT GRAVES' DISEASE AND GIVES PHYSICIAN SPEAKERS A CHANCE TO INFORM MEMBERS OF THE LATEST TREATMENTS. MEEI DONATES MEETING SPACE FOR THIS GROUP, WHICH MEETS QUARTERLY. VISION REHABILITATION: IN THE AREA OF VISION REHABILITATION EDUCATION, MEEI STAFF RESPONDED TO A NUMBER OF REQUESTS FROM ORGANIZATIONS SERVING SENIORS TO PROVIDE SUPPORTIVE EDUCATION RELATED TO VISION REHABILITATION. DRESS FOR SUCCESS: THE MISSION OF DRESS FOR SUCCESS BOSTON IS TO PROMOTE THE ECONOMIC INDEPENDENCE OF DISADVANTAGED WOMEN. THEY DO THIS BY PROVIDING PROFESSIONAL ATTIRE, A NETWORK OF SUPPORT AND THE CAREER DEVELOPMENT TOOLS TO HELP WOMEN THRIVE IN WORK AND IN LIFE. MEEI MAKES AN ANNUAL DONATION TO THIS ORGANIZATION TO HELP ADVANCE ITS EFFORTS IN WORKFORCE DEVELOPMENT AMONG LOW-INCOME WOMEN. 1 TOUCH: MEEI PROVIDES FACILITIES AND SUPPORT FOR THIS ORGANIZATION'S SPECIAL SELF-DEFENSE GROUP THAT ENABLES THE BLIND AND VISUALLY IMPAIRED TO DEFEND THEMSELVES AND NAVIGATE THE WORLD WITH CONFIDENCE. Internships/Coops: Mass. Eye and Ear provides internships and coops to help get young people interested in health care so they can better care for their communities. Partners include the PIC program, John Hancock, YMCA Training, Inc, Northeastern University. The Tobin Community Center: The Tobin Community Center is one of 35 Boston Center for Youth and Families facilities which are located in every neighborhood in Boston. The Center provides recreational space and activities for youth and families, including basketball courts, workout space, a daycare facility, career learning center and a diverse range of programs and activities for all interests. The mission of BCYF is to enhance the quality of life for Boston's residents by supporting children, youth and families through a wide range of programs and services. The Center hosts Mass. Eye and Ear educational sessions. Mission Hill Youth Collaborative: The Mission Hill Youth Collaborative is a grassroots coalition of community-based organizations and institutions that promotes the well-being of the neighborhood's young people and their families through collaborative activities. MHYC brings together youth-serving organizations and institutions to address the needs of the community in light of changing economic and social conditions as well as institutional expansion. The members have advocated for more effective programming, improved resources, and built a support network for the Mission Hill youth workers, youth, and their families. John Hancock MLK Summer Scholars: The MLK Summer Scholars program addresses a critical need in the City of Boston - summer jobs for youth. Mass. Eye and Ear hires young people each summer. In additional to the experience gained on the job, interns get additional support through participation in weekly job readiness and life skills workshops. Mass. Eye and Ear provides a summer job to one MLK Scholar each summer. Boston Private Industry Council (PIC): The PIC is a public-private partnership that connects business, schools, government, labor, and community organizations to create innovative workforce solutions. PIC helps businesses develop the workforce they need and Boston residents gain access to career opportunities and higher incomes. The PIC connects youth and adults with education and employment opportunities. Mass. Eye and Ear hires 12 PIC students as summer interns. CATEGORY 3: ACCESS TO SERVICES/RESOURCES THIS CATEGORY DESCRIBES MEEI STRATEGIES TO MAKE SERVICES AND RESOURCES AVAILABLE TO INDIVIDUALS WHO MIGHT NOT OTHERWISE BE ABLE TO ACCESS THEM. THESE SERVICES AND RESOURCES ARE AS FOLLOWS:
TRANSPORTATION FOR NEEDY PATIENTS: MEEI PROVIDES FREE TAXI		TRANSPORTATION FOR PATIENTS AND FAMILIES IN EMERGENCY SITUATIONS. FREE EYEGLASSES PROGRAM: SOCIAL WORK STAFF, PATIENT FINANCIAL COUNSELORS, AND OPTICAL SHOP STAFF COLLABORATE TO PROVIDE FREE GLASSES TO MEEI PATIENTS WHO MEET INCOME AND OTHER ELIGIBILITY GUIDELINES AND ARE UNABLE TO PAY FOR GLASSES. CONSULTATION FOR NON-MEEI PATIENTS: MEEI'S SOCIAL WORK STAFF PROVIDES INFORMATION AND REFERRAL FOR FINANCIAL RESOURCES, VISION AND HEARING RESOURCES, HOMECARE, AND EDUCATION TO NON-MEEI PATIENTS. SOCIAL WORK CONSULTATIONS FOR PATIENTS NEEDING FINANCIAL ASSISTANCE: THE STAFF FROM MEEI'S DEPARTMENT OF SOCIAL WORK ASSISTS PATIENTS IN SECURING LODGING, MEAL VOUCHERS, PARKING VOUCHERS, AND OTHER SMALL NECESSITIES THAT MAKE IT POSSIBLE FOR PATIENTS AND FAMILIES TO RECEIVE TREATMENT AT MEEI. FINANCIAL COUNSELING ASSISTANCE: THE HOSPITAL'S FINANCIAL COUNSELORS WORK WITH PATIENTS TO ASSESS INSURANCE COVERAGE, IDENTIFY COVERAGE OPTIONS FOR WHICH THE UN/UNDER-INSURED MAY BE ELIGIBLE, AND TO PROVIDE ASSISTANCE IN APPLYING FOR AND ACCESSING COVERAGE. HOWE LIBRARY: MEEI'S RESEARCH LIBRARY STAFF ASSISTS PATIENTS WHO ARE SEEKING INFORMATION ABOUT THEIR MEDICAL CONDITIONS. SERVICES INCLUDE COMPUTER SEARCHING AND RETRIEVAL OF ARTICLES, FINDING BOOKS FOR USERS, AND PROVIDING COMPUTERS, COPIERS, PRINTERS, AND ASSISTANCE TO PEOPLE IN USING THEM. THE HEARING AID CENTER: THE MEEI HEARING AID CENTER PROVIDES SUPPORT, INCLUDING EDUCATION AND EQUIPMENT, TO PATIENTS WITH HEARING LOSS. FOR PATIENTS WHO MEET INCOME GUIDELINES, THESE SERVICES ARE PROVIDED AT NO CHARGE OR AT A REDUCED RATE. FREE PARKING: MEEI OFFERS FREE PARKING TO PATIENTS AND THEIR FAMILIES THAT ENABLES THEM TO COME FOR CARE AND PARTICIPATE IN SUPPORT GROUPS. MEEI ALSO EXTENDS FREE PARKING TO PARTICIPANTS AT COMMUNITY BOATING, A LOCAL NONPROFIT, AND TO SUPPORT GROUPS SUCH AS THE GLAUCOMA SUPPORT GROUP AND HEAR @ BOSTON. CHARITABLE CARE: EACH YEAR, MEEI PROVIDES FREE OR DISCOUNTED CARE TO PATIENTS WHO ARE UNABLE TO COVER THE FULL COST OF THE SERVICES THEY UTILIZE. THIS YEAR THE HOSPITAL PROVIDED $198,116 IN FREE OR DISCOUNTED CARE TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. MEEI MAKES EVERY EFFORT TO IDENTIFY APPROPRIATE INSURANCE COVERAGE FOR PATIENTS AND TO HELP THEM ACCESS THE COVERAGE FOR WHICH THEY ARE ELIGIBLE. HOWEVER, EACH YEAR MEEI PROVIDES CARE TO PATIENTS THAT IS NOT FULLY REIMBURSED. IN 2013, MEEI'S NET CHAIRTY CARE TOTALLED $2,412,274, WHICH INCLUDES THE HEALTH SAFETY NET (HSN) ASSESSMENT AND SHORTFALL, HSN DENIED CLAIMS, AND FREE OR DISCOUNTED CARE PROVIDED TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. THE NET CHARITY CARE PROVIDED EACH YEAR IS A REFLECTION OF MEEI'S AND THE COMMUNITY BENEFITS COMMITTEE'S COMMITMENT TO THE DELIVERY OF HIGH-QUALITY CARE TO PATIENTS AND IS AN IMPORTANT STRATEGY FOR ENSURING ACCESS TO CARE IN THE MEEI COMMUNITY BENEFITS PLAN. CATEGORY 4: SPONSORSHIPS MEEI DESIGNATES A PORTION OF ITS COMMUNITY BENEFITS RESOURCES TO PROVIDE FINANCIAL SUPPORT IN THE FORM OF SPONSORSHIPS TO A SELECT NUMBER OF ORGANIZATIONS WHOSE MISSIONS ALIGN WITH THOSE OF MEEI AND ITS COMMUNITY BENEFITS GOALS, INCLUDING THOSE WHO ADDRESS ISSUES AFFECTED THE TARGET COMMUNITIES AND POPULATIONS OF THE HOSPITAL'S COMMUNITY BENEFIT PLAN. EACH OF THESE ORGANIZATIONS PROMOTES WELLNESS AMONG THEIR TARGET POPULATION AND SERVES PEOPLE FROM ACROSS THE COMMONWEALTH.
SCHEDULE H, PART VI, LINE 7:		LIST OF STATES RECEIVING COMMUNITY BENEFIT REPORT: MA

Schedule H (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

Schedule I
(Form 990)

Department of the Treasury
Internal Revenue Service

Grants and Other Assistance to Organizations,
Governments and Individuals in the United States

Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet

Attach to Form 990

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number
04-2103591

Part I

General Information on Grants and Assistance

Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................

Yes No

Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.

Part II

Grants and Other Assistance to Governments and Organizations in the United States. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21, for any recipient that received more than $5,000. Part II can be duplicated if additional space is needed.

(a) Name and address of organization or government	(b) EIN	(c) IRC Code section if applicable	(d) Amount of cash grant	(h) Purpose of grant or assistance
(1) BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVE BOSTON,MA02115	04-2774441	501(C)(3)	213,066	RESEARCH
(2) BOSTON UNIVERSITY 85 E NEWTON ST M-921 BOSTON,MA02118	04-2103547	501(C)(3)	191,201	RESEARCH
(3) BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS ST BOSTON,MA02115	04-2312909	501(C)(3)	464,633	RESEARCH
(4) OHIO UNIVERSITY 1 PARK PLACE ATHENS,OH45701	31-6402113	501(C)(3)	16,641	RESEARCH
(5) MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT ST BOSTON,MA02114	04-2697983	501(C)(3)	590,145	RESEARCH
(6) MIT DIVISION OF HEALTH 77 MASS AVE CAMBRIDGE,MA02139	04-2103594	501(C)(3)	183,813	RESEARCH
(7) MAYO CLINIC 200 1ST ST SW ROCHESTER,MN55905	41-6011702	501(C)(3)	69,764	RESEARCH
(8) HARVARD UNIVERSITY MASS HALL CAMBRIDGE,MA02138	04-2103580	501(C)(3)	801,506	RESEARCH
(9) UNIVERISITY OF SOUTHERN CALIFORNIA 3720 S FLOWER ST LOS ANGELES,CA90089	95-1642394	501(C)(3)	53,207	RESEARCH
(10) VANDERBILT MEDICAL CENTER 211 KIRKLAND HALL NASHVILLE,TN37240	62-0476822	501(C)(3)	138,101	RESEARCH
(11) WORCESTER POLYTECHNIC INSTITUTE 100 INSTITUTE RD WORCESTER,MA01609	04-2121659	501(C)(3)	282,544	RESEARCH
(12) SCHEPENS EYE RESEARCH INSTITUTE 20 STANIFORD ST BOSTON,MA02114	04-2129889	501(C)(3)	1,725,410	RESEARCH
(13) UNIVERSITY OF MIAMI 1400 NW 10TH AVE MIAMI,FL33136	59-0624458	501(C)(3)	126,374	RESEARCH
(14) UNIVERSITY OF MISSISSIPPI 2500 N STATE ST JACKSON,MS392164505	64-6001159	501(C)(3)	100,154	RESEARCH
(15) BROAD INSTITUTE 7 CAMBRIDGE CENTER CAMBRIDGE,MA02142	26-3428781	501(C)(3)	145,515	RESEARCH
(16) MEDICAL COLLEGE OF WISCONSIN 8701 WATERTOWN PLANK RD MILWAUKEE,WI53226	39-0806261	501(C)(3)	58,768	RESEARCH
(17) CARES 5000 S 5TH AVE HINES,IL60141	36-3334177	501(C)(3)	170,852	RESEARCH
(18) DREXEL UNIVERSITY 3201 ARCH ST 100 PHILADELPHIA,PA19104	23-1352630	501(C)(3)	85,105	RESEARCH
(19) LAWRENCE LIVERMORE NATIONAL SECURITY LLC MS L 397 7000 E AVE LIVERMORE,CA94550	20-5624386	OTHER	10,798	RESEARCH
(20) MASSACHUSETTS EYE AND EAR ASSOCIATES INC 243 CHARLES STREET BOSTON,MA02114	22-2658209	501(C)(3)	9,966,948	INSTITUTIONAL
(21) RHODE ISLAND HOSPITAL 593 Eddy Street Providence,RI029034923	05-0258954	501(c)(3)	237,616	RESEARCH
(22) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SD 9500 Gilman Dr MC0934 San Diego,CA92023	95-6006144	501(c)(3)	36,828	RESEARCH
(23) JOAN&SANFORD IWEILL MEDICAL COLL OF CORNEL UNIV 1305 New York Ave New York,NY10065	15-0532082	501(c)(3)	100,016	RESEARCH
(24) MARSHFIELD CLINICAL RESEARCH FOUNDATION 1000 North Oak Avenue Marshfield,WI54449	39-0452970	501(c)(3)	48,625	RESEARCH
(25) CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE 10900 Euclid Ave Cleveland,OH441067015	34-1018992	501(c)(3)	72,220	RESEARCH
(26) BOSTON MEDICAL CENTER 660 Harrison Ave 2nd Floor Boston,MA021182393	04-3314093	501(c)(3)	36,102	RESEARCH
(27) UNIVERSITY OF WASHINGTON 1730 Minor Ave STE 1360 Seattle,WA98101	91-6001537	501(c)(3)	29,806	RESEARCH
(28) SCHEPENS EYE RESEARCH INSTITUTE 20 STANIFORD ST BOSTON,MA02114	04-2129889	501(C)(3)	570,606	INSTITUTIONAL

Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................ Bullet Image

Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50055P

Schedule I (Form 990) 2012

Page 2

Part III

Grants and Other Assistance to Individuals in the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.

(a)Type of grant or assistance	(b)Number of recipients	(c)Amount of cash grant	(d)Amount of non-cash assistance	(e)Method of valuation (book, FMV, appraisal, other)	(f)Description of non-cash assistance

Part IV

Supplemental Information.

Complete this part to provide the information required in Part I, line 2, Part III, column (b), and any other additional information.

Identifier	Return Reference	Explanation
SCHEDULE I, PART I, LINE 2:		SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE MEEI ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A SATISFACTORY PACE.

Schedule I (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

Schedule J
(Form 990)

Department of the Treasury
Internal Revenue Service

Compensation Information

For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet

Complete if the organization answered "Yes" to Form 990,
Part IV, question 23.
SchJMediumBullet

Attach to Form 990. SchJMediumBullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Questions Regarding Compensation

Yes

Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.

First-class or charter travel Housing allowance or residence for personal use

Travel for companions Payments for business use of personal residence

Tax idemnification and gross-up payments Health or social club dues or initiation fees

Discretionary spending account Personal services (e.g., maid, chauffeur, chef)

If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain....

Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all officers,
directors, trustees, and the CEO/Executive Director, regarding the items checked in line 1a? .......

Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.

Compensation committee Written employment contract

Independent compensation consultant Compensation survey or study

Form 990 of other organizations Approval by the board or compensation committee

During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:

Receive a severance payment or change-of-control payment? ................

Yes

Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........

Yes

Participate in, or receive payment from, an equity-based compensation arrangement? .........

If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.

Only 501(c)(3) and 501(c)(4) organizations only must complete lines 5-9.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 5a or 5b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 6a or 6b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............

Yes

Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................

If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50053T

Schedule J (Form 990) 2012

Page 2

Part II

Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.

For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.

(A) Name and Title		(B) Breakdown of W-2 and/or 1099-MISC compensation			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(1)JOHN R FERNANDEZPRESIDENT	(i) (ii)	640,224 0	169,660 0	810 0	132,843 0	22,198 0	965,735 0	0 0
(2)JOAN W MILLER MDDIRECTOR	(i) (ii)	0 677,686	0 85,486	0 17,833	0 34,495	0 21,811	0 837,311	0 0
(3)JOSEPH B NADOL JR MDDIRECTOR	(i) (ii)	0 685,358	0 70,882	0 25,933	0 34,495	0 28,259	0 844,927	0 0
(4)SUSAN WILLIAMSASST SEC/GENERAL COUNSEL	(i) (ii)	225,529 0	25,509 0	17,574 0	10,660 0	8,404 0	287,676 0	0 0
(5)MAUREEN KELLEYASST SECRETARY	(i) (ii)	168,771 0	3,250 0	362 0	6,857 0	21,405 0	200,645 0	0 0
(6)CAROLANN WILLIAMSCFO & VP FINANCE AND ADMIN	(i) (ii)	286,775 0	73,660 0	408 0	9,982 0	1,520 0	372,345 0	0 0
(7)BARBARA J SCULLYDIRECTOR PROF REV CYCLE	(i) (ii)	164,713 0	5,000 0	216 0	13,123 0	21,336 0	204,388 0	0 0
(8)EILEEN O LOWELLCNO & VP PAT CARE SVS	(i) (ii)	213,674 0	26,744 0	894 0	12,300 0	21,611 0	275,223 0	0 0
(9)ALAN K LONGVP RESEARCH ADMINISTRATION	(i) (ii)	184,720 0	18,768 0	18,220 0	7,541 0	1,006 0	230,255 0	0 0
(10)CHRISTINE REGANVP HUMAN RESOURCES	(i) (ii)	212,782 0	22,758 0	2,209 0	14,039 0	21,336 0	273,124 0	0 0
(11)KENNETH HOLMESCFO MEEA	(i) (ii)	222,140 0	55,150 0	17,813 0	6,857 0	21,762 0	323,722 0	0 0
(12)JEAN E MACQUIDDYVP OTOLARYNGOLOGY	(i) (ii)	231,436 0	16,059 0	2,754 0	24,781 0	9,061 0	284,091 0	0 0
(13)JEFFREY J PIKECHIEF OPERATING OFFICER	(i) (ii)	273,668 0	72,376 0	427 0	10,372 0	8,571 0	365,414 0	0 0
(14)JAVIER BALLOFFETVP OPHTHALMOLOGY	(i) (ii)	225,600 0	68,339 0	19,415 0	14,617 0	21,788 0	349,759 0	0 0
(15)JENNIFER STREETVP COMMUNICATIONS & PLANNING	(i) (ii)	266,009 0	72,514 0	643 0	11,010 0	21,990 0	372,166 0	0 0
(16)MELISSA M PAULCHIEF DEVELOPMENT OFFICER	(i) (ii)	200,784 0	22,548 0	6,163 0	14,440 0	21,695 0	265,630 0	0 0
(17)GLENN W BUNTINGVOICE & SPEECH CLINICAL DIR	(i) (ii)	175,948 0	1,500 0	667 0	14,482 0	23,728 0	216,325 0	0 0
(18)GREGORY J DONNELLYADMIN DIR ANCILLARY SVS	(i) (ii)	167,657 0	8,755 0	148 0	9,468 0	21,129 0	207,157 0	0 0
(19)PETER J CHINETTIFORMER VP FINANCE	(i) (ii)	0 0	0 0	110,893 0	0 0	225 0	111,118 0	0 0
(20)PHILLIP C JOHNSONDIR FINANCIAL OPERATIONS	(i) (ii)	161,964 0	10,000 0	17,658 0	18,137 0	21,382 0	229,141 0	0 0
(21)RALPH T PELOSIDIRECTOR FACILITIES PLANNING	(i) (ii)	163,958 0	8,498 0	1,472 0	6,268 0	208 0	180,404 0	0 0
(22)ALEC CHELOFFCHIEF INFORMATION OFFICER	(i) (ii)	132,958 0	0 0	54,245 0	3,460 0	16,168 0	206,831 0	0 0

Schedule J (Form 990) 2012

Page 3

Part III

Supplemental Information

Complete this part to provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II.
Also complete this part for any additional information.

Identifier	Return Reference	Explanation
SCHEDULE J, PART I, LINE 4A:		In connection with his departure effective May 1, 2011, Peter Chinetti received 12 months of Salary and Benefit continuation. In connection with his departure effective June 30, 2012, Alec Cheloff received 4 months of Salary and Benefit continuation. SCHEDULE J, PART I, LINE 4B: John Fernandez participates in a Deferred Compensation arrangement with Massachusetts Eye and Ear. Under this agreement, Mr. Fernandez will be credited $120,000 for CALENDAR YEAR 2012. Each annual credit will vest on the fourth anniversary of the date such credit was made or upon (1) the attainment of the age of 65 while employed; (2) termination without cause or resignation for good reason; (3) death; (4) disability; or (5) change of control of MASSACHUSETTS Eye and Ear within the meaning of section 409A of the Internal Revenue Code. SCHEDULE J, PART I, LINE 7: The Board of Trustees of the Massachusetts Eye and Ear Infirmary, upon recommendations of the Compensation Committee, approve a bonus program for certain individuals listed on the Schedule J. The program requires that supervisory personnel make the determination of (1) eligibility and (2) amount of bonus dollars based on overall job performance. The CEO of the Infirmary has the authority to (1) overrule recommendations made by supervisors and (2) make bonus determinations for Vice President level personnel. The Compensation Committee of the board has the final authority for bonuses paid to the CEO as well as the Vice Presidents. Total Compensation for listed individuals, including bonus payments, was analyzed by independent compensation consultants, determined to be reasonable compensation, and approved by the Board. No compensation payment can be made in excess of these amounts.

Schedule J (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

Schedule K
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Information on Tax Exempt Bonds

Complete if the organization answered "Yes" to Form 990, Part IV, line 24a. Provide descriptions,
explanations, and any additional information in Part VI.
SchKMediumBullet

Attach to Form 990. SchKMediumBullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number
04-2103591

Part I

Bond Issues

(a) Issuer name		(b) Issuer EIN	(c) CUSIP #	(d) Date issued	(e) Issue price	(f) Description of purpose	(g) Defeased		(h) On behalf of issuer		(i) Pool financing
(a) Issuer name		(b) Issuer EIN	(c) CUSIP #	(d) Date issued	(e) Issue price	(f) Description of purpose	Yes	No	Yes	No	Yes	No
A	MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES	04-2456011	57586EWL1	09-29-2010	63,156,092	FACILITY IMPROVEMENTS		X		X		X
B	MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES	04-2456011	57586ELD1	03-22-2007	20,000,000	FACILITY IMPROVEMENTS		X		X	X
C	MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES	04-2456011	57586ELD1	02-25-2005	13,695,000	FACILITY IMPROVEMENTS		X		X	X

Part II

Proceeds

	A		B		C		D
	1 Amount of bonds retired . . . . . . . . . . . . . .	0		7,815,000		5,902,139
2 Amount of bonds legally defeased . . . . . . . . . . .	0		0		0
3 Total proceeds of issue . . . . . . . . . . . . . .	63,156,092		20,000,000		13,695,000
4 Gross proceeds in reserve funds . . . . . . . . . . . .	4,993,936		121,854		77,930
5 Capitalized interest from proceeds . . . . . . . . . . .	5,191,181		0		0
6 Proceeds in refunding escrows . . . . . . . . . . . .	0		0		0
7 Issuance costs from proceeds . . . . . . . . . . . .	1,360,310		108,810		71,758
8 Credit enhancement from proceeds . . . . . . . . . . .	0		0		0
9 Working capital expenditures from proceeds . . . . . . . . .	0		0		0
10 Capital expenditures from proceeds . . . . . . . . . . .	42,858,859		19,769,336		13,545,312
11 Other spent proceeds . . . . . . . . . . . . . .	0		0		0
12 Other unspent proceeds . . . . . . . . . . . . . .	8,751,806		0		0
13 Year of substantial completion . . . . . . . . . . . .	2010		2010		2009
	Yes	No	Yes	No	Yes	No	Yes	No
14 Were the bonds issued as part of a current refunding issue? . . . . .		X		X		X
15 Were the bonds issued as part of an advance refunding issue? . . . . .		X		X		X
16 Has the final allocation of proceeds been made? . . . . . . . .		X	X		X
17 Does the organization maintain adequate books and records to support the final allocation of proceeds? . . . . . . . . . . . . . .	X		X		X

Part III

Private Business Use

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
1 Was the organization a partner in a partnership, or a member of an LLC, which owned property financed by tax-exempt bonds? . . . . . . .		X		X		X
2 Are there any lease arrangements that may result in private business use of bond-financed property? . . . . . . . . .		X		X		X

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50193E

Schedule K (Form 990) 2012

Page 2

Part III

Private Business Use (Continued)

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
3a Are there any management or service contracts that may result in private business use of bond-financed property? . . . . . . . . . . . .		X		X		X
b If "Yes" to line 3a, does the organization routinely engage bond counsel or other outside counsel to review any management or service contracts relating to the financed property? . . . . . . . . . . . . . . . .
c Are there any research agreements that may result in private business use of bond-financed property? . . . . . . . . . . . . . . .		X		X		X
d If "Yes" to line 3c, does the organization routinely engage bond counsel or other outside counsel to review any research agreements relating to the financed property? .
4 Enter the percentage of financed property used in a private business use by entities other than a section 501(c)(3) organization or a state or local government . .	0%		0%		0%		%
5 Enter the percentage of financed property used in a private business use as a result of unrelated trade or business activity carried on by your organization, another section 501(c)(3) organization, or a state or local government . . . . . . .	%		%		%		%
6 Total of lines 4 and 5 . . . . . . . . . . . . . . .	%		%		%		%
7 Does the bond issue meet the private security or payment test? . . . . .		X		X		X
8a Has there been a sale or disposition of any of the bond financed property to a nongovernmental person other than a 501(c)(3) organization since the bonds were issued?. . . . . . . . . . . . . . . . .
b If “Yes” to line 8a, enter the percentage of bond-financed property sold or disposed of.	%		%		%		%
c If “Yes” to line 8a, was any remedial action taken pursuant to Regulations sections 1.141-12 and 1.145-2? . . . . . . . . . . . . .
9 Has the organization established written procedures to ensure that all nonqualified bonds of the issue are remediated in accordance with the requirements under Regulations sections 1.141-12 and 1.145-2?	X		X		X

Part IV

Arbitrage

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
1 Has the issuer filed Form 8038-T? . . . . .		X	X		X
2 If "No" to line 1, did the following apply? . . . .
a Rebate not due yet? . . . . . . . .	X
b Exception to rebate? . . . . . . . .
c No rebate due? . . . . . . . . . .
If you checked "No rebate due" in line 2c, provide in Part VI the date the rebate computation was performed
3 Is the bond issue a variable rate issue? . . . .		X	X		X
4a Has the organization or the governmental issuer entered into a qualified hedge with respect to the bond issue?		X		X		X
b Name of provider . . . . . . . . .	0		0		0
c Term of hedge . . . . . . . . . .
d Was the hedge superintegrated? . . . . . .
e Was a hedge terminated? . . . . . . .

Schedule K (Form 990) 2012

Page 3

Part IV

Arbitrage (Continued)

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
5a Were gross proceeds invested in a guaranteed investment contract (GIC)? . . . . . . . . .		X		X		X
b Name of provider . . . . . . . . .	0		0		0
c Term of GIC . . . . . . . . . .
d Was the regulatory safe harbor for establishing the fair market value of the GIC satisfied? . . . . .
6 Were any gross proceeds invested beyond an available temporary period? . . . . . . . .		X		X		X
7 Has the organization established written procedures to monitor the requirements of section 148? . . .		X				X

Part V

Procedures To Undertake Corrective Action

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
1 Has the organization established written procedures to ensure that violations of federal tax requirements are timely identified and corrected through the voluntary closing agreement program if self-remediation is not available under applicable regulations?	X		X		X

Part VI

Supplemental Information. Complete this part to provide additional information for responses to questions on Schedule K (see instructions).

Identifier	Return Reference	Explanation
PART I, BOND (A), COLUMN (F):	0	THE PROJECT CONSISTS OF RENOVATION AND IMPROVEMENT OF EXISTING SPACE AND ACQUISITION OF MISCELLANEOUS EQUIPMENT LOCATED IN MEEI'S MAIN CLINICAL BUILDING, INCLUDING BUT NOT LIMITED TO THE FOLLOWING: THE AMBULATORY AND INPATIENT OPERATING ROOMS, THE SINUS CLINIC, THE NEURO-OPTHALMOLOGY CLINIC, THE OTOLARYNGOLOGY LASER CENTER, THE ENT CLINIC FOCUSING ON HEAD AND NECK CONDITIONS, THE PRE-ADMISSION TESTING SUITE, THE OPHTHALMOLOGY OUTPATIENT CLINICS LOCATED ON THE FIRST FLOOR, THE GROUND FLOOR (INCLUDING THE LOBBY AREA, EMERGENCY DEPARTMENT AND RADIOLOGY DEPARTMENT), THE PEDIATRIC OPHTHALMOLOGY CLINIC, THE HEAD AND NECK CLINIC, THE LASER CENTER, THE PEDIATRIC INPATIENT UNIT, THE OPHTHALMOLOGY PLASTICS OUTPATIENT CLINIC, THE OTOLARYNGOLOGY FACULTY OFFICE SUITE AND THE DESIGN AND ARCHITECTURAL FEES RELATING TO THE RECONSTRUCTING OF THE GROUND, FIRST, SECOND AND THIRD FLOORS FOR ADDITIONAL CLINICAL SPACE. IMPROVEMENTS TO EXISTING BUILDING INFRASTRUCTURE. PLANNING AND DESIGN COSTS RELATED TO A REPLACEMENT RESEARCH OR CLINICAL BUILDING TO BE LOCATED AT 309-325 CAMBRIDGE STREET. COSTS OF ISSUANCE AND CAPITALIZED INTEREST ON THE BONDS FINANCING THE PROJECTS DESCRIBED IN THIS SECTION FOR A PERIOD OF UP TO THREE YEARS.
PART I, BOND (B), COLUMN (F):	0	THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES.
PART I, BOND (C), COLUMN (F):	0	THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES.

Schedule K (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

Schedule L
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Transactions with Interested Persons

Complete if the organization answered
"Yes" on Form 990, Part IV, lines 25a, 25b, 26, 27, 28a, 28b, or 28c,
or Form 990-EZ, Part V, line 38a or 40b.
MediumBullet

Attach to Form 990 or Form 990-EZ. MediumBullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Excess Benefit Transactions (section 501(c)(3) and section 501(c)(4) organizations only).
Complete if the organization answered "Yes" on Form 990, Part IV, line 25a or 25b, or Form 990-EZ, Part V, line 40b.

1(a) Name of disqualified person	(c) Description of transaction	(d) Corrected?
1(a) Name of disqualified person	(c) Description of transaction	Yes	No

Enter the amount of tax incurred by organization managers or disqualified persons during the year under section 4958. ........................... Bullet Image

Enter the amount of tax, if any, on line 2, above, reimbursed by the organization ....... Bullet Image

Part II

Loans to and/or From Interested Persons.
Complete if the organization answered "Yes" on Form 990-EZ, Part V, line 38a, or Form 990, Part IV, line 26; or if the organization reported an amount on Form 990, Part X, line 5, 6, or 22

(a) Name of interested person	(b) Relationship with organization	(c) Purpose of loan	(d) Loan to or from the organization?		(e)Original principal amount	(f)Balance due	(g) In default?		(h) Approved by board or committee?		(i)Written agreement?
(a) Name of interested person	(b) Relationship with organization	(c) Purpose of loan	To	From	(e)Original principal amount	(f)Balance due	Yes	No	Yes	No	Yes	No
(1) KENNETH HOLMES		HOUSING		X	50,000	10,000		No		No	Yes





Total ...... $						10,000

Part III

Grants or Assistance Benefitting Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 27.

(a) Name of interested person	(b) Relationship between interested person and the organization	(c) Amount of assistance	(d) Type of assistance	(e) Purpose of assistance

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 50056A

Schedule L (Form 990 or 990-EZ) 2012

Page 2

Part IV

Business Transactions Involving Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 28a, 28b, or 28c.

(a) Name of interested person	(b) Relationship between interested person and the organization	(c) Amount of transaction	(d) Description of transaction	(e) Sharing of organization's revenues?
(a) Name of interested person		(c) Amount of transaction	(d) Description of transaction	Yes	No
(1) JOAN MILLER MD	DRCTR IS LICENSOR TO ORG	244,124	PATENT LICENSE PROCEEDS		No

Part V

Supplemental Information
Complete this part to provide additional information for responses to questions on Schedule L (see instructions).

Identifier	Return Reference	Explanation
SCHEDULE L, PART V, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS		(A) NAME OF PERSON: JOAN MILLER, MD (D) DESCRIPTION OF TRANSACTION: INVENTOR PROCEEDS FOR PATENT RIGHTS ARE MADE IN ACCORDANCE WITH WRITTEN MEEI POLICY IN RESPECT OF INTELLECTUAL PROPERTY.

Schedule L (Form 990 or 990-EZ) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Identifier	Return Reference	Explanation
FORM 990, PART I, LINE 1 & PART III, LINE 1:		THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") IS A NOT-FOR-PROFIT TEACHING HOSPITAL CONDUCTING PATIENT CARE AND RESEARCH. THE INFIRMARY IS A TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL AND AN INTERNATIONAL CENTER FOR RESEARCH. IT HAS THE MOST COMPETITIVE PROGRAM IN THE COUNTRY FOR EYE, EAR, NOSE, AND THROAT RESIDENCY TRAINING AND THE WORLD'S LARGEST OPHTHALMIC FELLOWSHIP PROGRAM. IT IS PART OF A SYSTEM OF RELATED ENTITIES THAT PROVIDE SPECIALIZED MEDICAL CARE COLLECTIVELY KNOWN AS "MASSACHUSETTS EYE AND EAR INFIRMARY" ("MEEI").
FORM 990, PART III, LINE 4A:	RESEARCH	Ophthalmology: - A New, Complete Catalogue: Gene Expression in the Human Retina Published. Michael Farkas, PhD, Eric Pierce, MD, PhD, and investigators in the HMS Ophthalmology Ocular Genomics Institute (OGI) at Mass. Eye and Ear recently published the most thorough description of gene expression in the human retina (BMC Genomics, July 2013). According to researchers, documenting the entirety of these genetic data into a catalogue is crucial for understanding how diseases of the eye develop and lead to vision loss. Investigators used a technique called RNA sequencing (RNA-seq) to identify all of the messenger RNAs (mRNAs) produced in the human retina. This catalog of expressed genes, or transcriptome, revealed that the majority of the 20,000+ genes in the human body are expressed in the retina. The researchers also identified almost 30,000 novel exons (portions of the genome that are used to encode proteins or other genetic elements) and over 100 potential novel genes that had not been identified previously. To date, investigators have identified more than 200 retinal degeneration disease genes, but identification of new exons used in the retina may help find the cause of disease in currently undiagnosed patients. - First Corneal Transplant Performed With Pre-loaded Tissue. Roberto Pineda, II, MD performed a series of groundbreaking procedures in April 2013 when he utilized EndoGlide (Angiotech Pharmaceuticals, Inc.) cartridges pre-loaded at the Lions Eye Institute for Transplant & Research (LEITR) in Tampa, FL for endothelial keratoplasty transplant procedures at the Mass. Eye and Ear. Dr. Pineda utilized donor endothelial tissue that was pre-cut, trephined and pre-loaded into the devices before being sent to the Mass. Eye and Ear for transplantation. In 2012, the LEITR presented a pre-clinical study at the 2012 ARVO Annual Meeting reporting that eye banks are able to safely prepare and load corneal tissue into the EndoGlide cartridges. - Mass. Eye and Ear Joins Global Alliance to Share Genomic and Clinical Data. Massachusetts Eye and Ear is among the nearly 70 leading health care, research, and disease advocacy organizations that have joined together to form an international alliance dedicated to enabling secure sharing of genomic and clinical data. The alliance will support the formation of large, shared datasets that will allow researchers around the globe to identify target pathways and develop transformational therapies for patients. The group will develop methods and policies to share information responsibly, while protecting patient privacy and the public interest. Research Successes: - 238 Proposals - 88 Awards - Total grants awarded: $32,740,597 Retina: - Members of the Angiogenesis Laboratory investigated the mechanism of cell death in retinal degenerations and showed that RIP Kinase mediated programmed necrosis, not apoptosis, is a key mediator of photoreceptor cell loss and damage associated molecular pattern mediated inflammation in animal models of inherited retinal degenerations (IRD) and dry AMD. This can lead to novel therapeutics for dry AMD, IRD, and other retinal disorders. - Researchers from the Angiogenesis Laboratory examined the role of the energy sensor for the cell called AMPK and showed it to regulate vascular cell permeability and angiogenesis. This can lead to a new class of anti-leakage and anti-angiogenesis drugs. - Studied non-chemotherapy drugs for retinoblastoma and showed the role of a small activator of the metabolic and energy sensor AMPK in inhibiting retinoblastoma cell growth in vivo in an animal model. This could lead to gentler therapies for children with retinoblastoma. - Conducted clinicopathologic and immunohistochemical studies of conjunctival large cell acanthoma, epidermoid dysplasia, and squamous papilloma. Showed that conjunctival large cell acanthoma is a morphologically distinctive clonal entity with clinical and immunohistochemical phenotypic characteristics denoting a dysplasia of minimal severity. Because of recurrences without invasion, it requires treatment. - Presented an improved technique of experimental retinal detachment in rodents that result in more reproducible results. - Showed that a simple non-invasive test can be used to monitor a rare inflammatory disease of the retina called ampiginous choroiditis. - Presented a comprehensive review on photoreceptor cell death pathways and neuroprotection strategies in Progress in Retina Eye Research. - Was a participating center in the Age-Related Eye Disease Study 2 (AREDS2), a large multicenter clinical trial funded by the National Eye Institute, which clarified the effectiveness of specific dietary supplement formulations for the treatment of AMD. - Provided pre-clinical evidence that ranibizumab, a vascular endothelial growth factor inhibitor, may prevent vitreoretinopathy (PVR), a serious complication that can occur after surgical repair of retinal detachment. - Demonstrated that converting patients with chronic neovascular AMD to aflibercept (Eylea) results in stabilized vision and improved anatomic outcomes, while allowing injection intervals to be extended. - Showed that CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. - Demonstrated that AMD-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1.
Ocular Genomics Institute (OGI):		- Inherited macular degeneration: In a study published in the journal Human Molecular Genetics, members of the OGI reported for the first time that that the complement system plays a critical role in the early stage of an inherited macular degeneration, in addition to being associated with age-related macular degeneration. This is important because it provides insight into how alterations in complement system components contribute to macular disease. - Human retinal transcriptome: Researchers from the group reported the most thorough description of gene expression in the human retina reported to date. In the study published in the journal BMC Genomics, Drs. Michael Farkas, Eric Pierce and colleagues in the Ocular Genomics Institute at Mass. Eye and Ear reported a complete catalog of the genes expressed in the retina. This is a valuable resource for the vision research community, and the data are available via the OGI website (see http://oculargenomics.meei.harvard.edu/index.php/ret-trans). - Reported that the adeno-associated virus AAV9 selectively targets cone photoreceptors in the non-human primate. - Milestones from the OGI include: Genomics core facility open, and providing research genomics services as well as CLIA-certified genetic diagonstic testing (information available via OGI website; see http://oculargenomics.meei.harvard.edu/index.php/gc and http://oculargenomics.meei.harvard.edu/index.php/gdt, respectively). - Recruited Dr. Xiaowu Gai to lead the Bioinformatics program of the OGI, and establish a Bioinformatics Shared Resource for the Department. Dr. Gai is a talented informaticist, and is currently Director of Biomedical Informatics, Loyola University Chicago Stritch School of Medicine. - The first OGI course "Genetics and genomics of ocular disease," directed by Dr. Janey Wiggs was presented as a satellite meeting of the American Society of Human Genetics. - Berman Gund Laboratory for the Study of Retinal Degenerations - Used whole-genome sequencing to identify pathogenic DNA structural changes and a new disease gene for retinitis pigmentosa. Cornea: - Completed a clinical study evaluating the efficacy of a topical combined anti-PDGF and anti-VEGF therapy in corneal angiogenesis. - Created and validated an ocular redness continuous (0.0 - 100.0) scale using a novel, state-of-the-art computer program. - Completed a study assessing the use of tear osmolarity as a new method to diagnose and monitor dry eye disease. - Developed telomerase-immortalized corneal endothelial cell line which will provide a new tool for the in vitro study of corneal endothelial cell biology and will be made available to the NIH community. - Determined that deficiency in Nrf2-regulated pathway is involved in the pathogenesis of Fuchs endothelial corneal dystrophy. - Determined that corneal limbal fibroblasts can be differentiated into corneal epithelial cells thus serving as a novel source of corneal epithelium usually destroyed in limbal stem cell deficiency disorders. - Demonstrated the presence of the integrin MadCAM-1 in the ocular surface vasculature and determined its role in the recruitment of corneal immune cells. - First human implantation of an intraocular device to measure IOP by telemetry. This may resolve the inability to measure IOP in keratoprosthesis patients. - Conducted the first large scale cataract surgery outcomes review (18,000 cases) in the UK independent sector (private-sector owned treatment centers contracted within the English National Health Service to treat NHS patients free at the point of use). - Demonstrated with live corneal imaging that unilateral corneal infections, including in herpes zoster ophthalmicus, lead to contralateral changes in corneal nerves in the unaffected eye, suggesting neuro-regulatory mechanisms between eyes. - Demonstrated that a drug-eluting contact lens can deliver a therapeutic amount of a glaucoma medication for one month. - Determined that devices used in PROSE treatment can be customized to accommodate any eye with keratoconus or post-LASIK ectasia regardless of disease severity. - Performed first collagen cross-linking in Boston, an experimental treatment for keratoconus, under the auspices of an FDA-sanctioned clinical trial. - Completed a study on worldwide incidence of infections after keratoprosthesis, and evaluation of optimal antibiotics prophylaxis. - Determined risk of light damage to retina during keratoprosthesis surgery. - Received FDA approval for the use of titanium in keratoprosthesis. - Quantified the risk of glaucoma after keratoprosthesis. - Constructed a new glaucoma valve. - Demonstrated radical reduction of complications by using oversized back plates in keratoprosthesis. - Published the largest ever series of pediatric herpes simplex. Demonstrated use of acyclovir in children and recommended treatment and maintenance doses (Liu et al, Ophthalmology 2012). - Demonstrated oversized backplates for KPro associated with better wound anatomy to try to reduce RPM formation (Cruzat et al, Cornea 2013) - MEEI will be a premier site for the upcoming Zoster Eye Disease Study (ZEDS), which will evaluate the effect of long-term systemic antiviral of the ophthalmic complications of shingles. Drs Colby and Langston will serve on the Executive Committee for this study. - Completed and have in press in Cornea clinical study showing that ganciclovir gel (Zirgan) is rapidly effective in healing Herpes zoster pseudodendritic ulcers of the cornea. - Completed clinical study "Patients with Infectious Keratitis Demonstrate Persistent and Long-term Increase in Immune cells and Diminished Subbasal Corneal Nerves After Cessation of Anti-Microbial Therapy -- A Laser in vivo Confocal Microscopy Study." - Demonstrated that a drug-eluting contact lens can deliver a therapeutic amount of a glaucoma medication for one month, published in Biomaterials. - Reported the findings from a large, multi-center study that found that excellent retention of the Type I Boston Kpro - 93% of the 300 Kpro implants were retained at their last follow-up, corresponding to a retention time of 396 patient-years or 1.42 years/keratoprosthesis in Ophthalmology. - Validated measurement of corneal dendritiform cells by in vivo confocal microscopy as a measure to assess ocular surface inflammation - Completed large multi-center clinical trial, demonstrating that combination of contact lenses and contact lens solutions are more important that each factor alone in inducing ocular surface inflammation - Launched grant from the Department of Defense to conduct a multi-center clinical trial to assess the safety and efficacy of an anti-VEGF in patients who are at high-risk for graft rejection following their corneal transplant. - Completed several clinical studies demonstrating that the use of autologous serum tears result in corneal nerve regeneration and in reversal of symptoms of corneal neuralgia and light sensitivity in patients with corneal neuropathies. - Completed a study evaluating the efficacy of a steroid vs. a steroid and antibiotic in patients with ocular inflammation related to dry eye disease - Reported on patients with bilateral corneal ulceration in ocular graft-versus-host disease. - Created novel software programs to quantify ocular surface staining and ocular redness, methodologies which will allow for more accurate measurements of ocular disease and progression. - Generated a large database on patients with ocular graft-versus-host disease. - Developed a surgical safety checklist for refractive procedures in association with the Institute for Safety in Office-based Surgery (ISOBS). - Published a novel method for cross linking ectatic corneas.
Glaucoma:		- Contributed to an international effort reporting on 27 genetic loci that explain variance in central corneal thickness. Six of these loci are also associated with keratoconus and 1 represented a new locus for primary open-angle glaucoma. This work was published in Nature Genetics. - On behalf of the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, glaucoma investigators used a case-only approach to demonstrate that genetic loci in the CDKN2B-AS1 region alter optic nerve vulnerability to glaucomatous damage. - Demonstrated an inverse relation between serum TNF receptor 2 levels and incident normal tension glaucoma among women. This study is based on a case control group nested within a population-based study (the Nurses Health Study) and serum samples on cases were collected prior to when glaucoma treatment was instituted. To the best of our knowledge, this is the first demonstration of a serum biomarker that is associated with a reduced risk of open-angle glaucoma. - Described the results of a randomized trial comparing the impact of fixed combination timolol-dorzolamide to fixed combination timolol-brimonidine in the co-regulation of retinal blood flow and ocular perfusion pressure. - Dr. Emmanuel Buys (MGH) and several members of the Harvard Glaucoma Center of Excellence, described a murine model of open angle glaucoma that is based on knocking out the intracellular receptor for nitric oxide, soluble guanylate cyclase. These mice develop modest, age-related increases in IOP and optic nerve degeneration that mimics the normal tension variant of primary open-angle glaucoma. More significantly, Dr. Buys and co-workers demonstrated that a common variant in the gene region for soluble guanylate cyclase is associated with primary open angle glaucoma that presents with paracentral visual loss. - Led an effort to demonstrate that several of the prostaglandin analogues in current use to treat glaucoma are strongly associated with atrophy of the periorbital fat, upper eyelid ptosis and loss of low eyelid steatoblepharon. - On behalf of the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, investigators evaluated the collective relation between common genetic polymorphisms involved in estrogen metabolism and primary open-angle glaucoma. The work demonstrates that this panel of estrogen metabolizing polymorphisms is associated with primary open glaucoma in women but not in men. - Confirmed that TMCO1 loci are associated with intraocular pressure in conjunction with the GLAUGEN (Glaucoma Genes and Environment) study, the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, and the Age-related Macular Degeneration- Michigan, Mayo, AREDS and Pennsylvania study investigators. - Contributed to the International Consortium of African Ancestry Research in Glaucoma and demonstrated that genetic loci in the CDKN2B-AS1 region are associated with primary-open angle glaucoma among African Americans but not among African people derived from Ghana.
OTOLARYNGOLOGY:		- Benjamin Bleier, M.D., Nicolas Busaba, M.D., Stacey Gray, M.D., and Eric Holbrook, M.D., have co-authored a study on the effectiveness of different treatments of nosebleeds for adults. The study, published in Otolaryngology-Head and Neck Surgery, found that in a limited observation, surgical and/or medical intervention offered the best outcome in adults with nosebleeds. - Albert Edge, Ph.D., is the lead author of a study conducted with hearing researchers at Massachusetts Eye and Ear Infirmary and Harvard Medical School who have, for the first time, regenerated sensory hair cells in the ear, resulting in restored hearing to noise-damaged ears. The Jan. 10, 2013 issue of Neuron features the research study, as well as a video discussion with Dr. Edge. - In a May 2013 issue of Cancer, investigators at Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary, including Edmund Mroz, Ph.D., Aaron Tward, M.D., Ph.D., and James Rocco, M.D., Ph.D., describe how their measure of heterogeneity of cells within a tumor appears to predict treatment outcomes of patients and was a better predictor of survival than most traditional risk factors in a small group of patients with squamous cell carcinoma, the most common type of head and neck cancer. - In a March issue of the Journal of Neuroscience, researchers found that noise exposure is clearly more dangerous than typically thought and gained insight into why it is difficult for some people to hear in "everyday" noisy environments. Stephane Maison, Ph.D. and M. Charles Liberman, Ph.D., were lead authors on this publication. - Led by Daniel Lee, M.D., researchers from the Wilson Auditory Brainstem Implant Program at Massachusetts Eye and Ear are currently conducting the only FDA-approved clinical trial in the U.S. for adult deaf patients who do not have NF2 to receive the ABI. The study was given clearance by the Human Studies Committees of Mass. Eye and Ear and Harvard Medical School in November 2012. A second study for pediatric patients who are deaf but do no have NF2 to receive the ABI was FDA-approved in May 2013. Radiology: - Renee Mitchell, Lead CT/XRAY radiologic technologist, performed high resolution cadaveric sinus scans for Dr. Benjamin Bleier for image guidance during the resident sinus dissection courses. - Renee Mitchell worked with Dr. Yoojin Chung and Jennifer O'Malley on a study with Dr. Bertrand Delgutte who is the principal investigator of these studies, where cochlear implanted rabbits are part of projects investigating neural responses to electrical stimulation and brain plasticity in animal models of human cochlear implants at the Eaton-Peabody Lab. The imaging scans are to ascertain the proper positioning of the CI's in these animals.
FORM 990, PART III, LINE 4B:	EDUCATION	ACADEMIC PROGRAMS: OTOLARYNGOLOGY: - 18 RESIDENTS - 11 CLINICAL FELLOWS - 49 RESEARCH FELLOWS - 2 RESEARCH RESIDENTS OPHTHALMOLOGY: - 23 RESIDENTS - 26 CLINICAL FELLOWS - 102 RESEARCH FELLOWS Ophthalmology: - International Collaborations. The Department continues to build upon existing relationships that HMS Ophthalmology faculty and Chinese colleagues have been cultivating for several years. Faculty from Mass. Eye and Ear and Schepens traveled to China in a series of visits this year to exchange perspectives on research efforts and clinical care and management practices. One key mission of the trip was to strategically and cooperatively identify training opportunities as part of the Department's new International Research & Training program, which is now working smoothly to place trainees in department laboratories. Faculty from Eye and ENT Hospital of Fudan University visited in June for the Annual & Alumni Department meeting and a series of discussions. - Dong Feng Chen, MD, PhD Chair of Women's Eye Health.org is collaborating with associates from Peking University First Hospital to produce an educational TV series about eye disease for Beijing TV. The series complements the organization's worldwide outreach efforts to build awareness of the prevalence of eye disease in women. - The new Office of Global Surgery and Health established at Mass. Eye and Ear partners with training hospitals in underserved countries to improve residency programs in ophthalmology through onsite surgical instruction, remote education innovation and opportunities for research collaboration. - Inaugural HMS Ophthalmology Faculty Retreat. More than 100 Harvard Medical School (HMS) Department of Ophthalmology faculty members joined together for a two-day retreat at Wentworth by the Sea in Newcastle, NH on April 5-6, 2013. The inaugural event united clinicians and scientists from across the department and presented a forum for candid discussion, dialogue and exchange that aimed to coalesce translational efforts and more rapidly advance bench to bedside discovery. The retreat also provided a relaxed and casual "meet-and-greet" venue for faculty. Topics of discussion included overviews of the Department's growing Centers of Excellence and Institutes, expanded international collaborations, strengthened department-industry partnerships, and faculty development efforts. - Faculty Promotions and Appointments: HMS Appointments: - Endowed Professorships: - Patricia D'Amore, PhD, MBA, FARVO, The Charles L. Schepens Professor of Ophthalmology - Dean Eliott, MD, Stelios Evangelos Gragoudas Associate Professor of Ophthalmology - Professor of Ophthalmology: - Darlene Dartt, PhD, FARVO, Schepens/Mass. Eye and Ear - Associate Professor of Ophthalmology: - Don Bienfang, MD, Brigham and Women's Hospital - Assistant Professor of Ophthalmology: - Joseph Ciolino, MD, Mass. Eye and Ear - Suzanne Freitag, MD, Mass. Eye and Ear - Qin Liu, MD, PhD, Mass. Eye and Ear - Vincent Patalano, MD, Cambridge Health Alliance - Luk Vandenberghe, PhD, MSc, Mass. Eye and Ear - Michael Yoon, MD, Mass. Eye and Ear - Instructor in Ophthalmology: - Andrea Cruzat, MD, Schepens/Mass. Eye and Ear - Juan Ding, PhD, Schepens/Mass. Eye and Ear - Tobias Elze, PhD, Schepens/Mass. Eye and Ear - Ahmad Kheirkhah, MD, Schepens/Mass. Eye and Ear - Haijiang Lin, MD, PhD, Mass. Eye and Ear - Eleftherios Paschalis, PhD, MSc, Mass. Eye and Ear - Daniel Sun, PhD, OD, Mass. Eye and Ear - Xiaohong Zhou, MD, PhD, Mass. Eye and Ear - Cornea Center of Excellence hosts three days of unparalleled learning and discussion. The HMS Department of Ophthalmology Cornea Center of Excellence (COE) took center stage on October 17-19th when it hosted its first International Workshop at Mass. Eye and Ear followed by the 28th Biennial Cornea Conference held at the Schepens Starr Center for Scientific Communications. The inaugural International Workshop brought together a multidisciplinary group of more than 20 scholars. Both physicians and scientific researchers presented current research findings, exchanged scientific ideas, and strengthened international collaboration in the field of cornea and ocular surface research. The scientific program focused on virology, immune regulation, ocular surface, new imaging technologies, and regenerative medicine. Notably, Schepens alumnus and Professor and Chair of Ophthalmology at Kyoto Prefectural University of Medicine, Shigeru Kinoshita, MD, PhD, attended the workshop and also presented "Future Therapeutic Modalities for Devastating Ocular Surface and Corneal Disorders" during Grand Rounds earlier in the day. - The 4th Annual Mass. Eye and Ear Vitrectomy Course. The Course received unanimously positive feedback from this year's 48 fellows and six residents who attended from around the country. The free, two-day training intensive, held on July 19-20, 2013 attracted 33 world-class faculty members who joined together to deliver a brief, but comprehensive, introduction to the theory and practice of vitreoretinal surgery. Organized by Dean Eliott, MD, John Loewenstein, MD, and Demetrios Vavvas, MD, PhD, the course consisted of lectures, panel discussions, surgical simulation lab, and surgical wet lab in a setting with low student-to-teacher ratio. Emphasis on hands-on training and close interaction with faculty has made this course a tremendous success since its inauguration. All of the faculty have volunteered to return next year. since its inauguration. All of the faculty have volunteered to return next year.
OTOLARYNGOLOGY:		- Professor: - Christopher Shera, Ph.D. - Associate Professor: - Daniel Lee, M.D. - Assistant Professor: - Benjamin Bleier, M.D. - Robin Lindsay, M.D. - Stephane Maison, Ph.D. - Instructor (promoted from training status): - Mitchell Day, Ph.D. - Mingqian Huang, Ph.D. - Albena Kantardzhieva, Ph.D. - This year the department celebrated the class of 2013 at a June 21st ceremony held in the Meltzer auditorium. Our outstanding graduates included Drs. Sang Kim, Josh Meier, Daniel Roberts, and Josef Shargorodsky. We also welcomed five new residents to the program this year, Drs. Pete Creighton, Taha Jan, Brian Lin, Matthew Naunheim, and George Scangas. - The Department hosted the 12th International Facial Nerve Symposium over the weekend of June 28th, directed by Drs. Tessa Hadlock, Mack Cheney, and Michael McKenna. This four-day, lecture filled symposium included daily keynote addresses on topics ranging from facial nerve reconstruction to social functioning with facial paralysis. - A number of Mass. Eye and Ear physicians attended the International Federation of Otolaryngology Societies (IFOS) meetings in Seoul, Korea in May 2013, including Drs. Michael Rho, Eric Holbrook, Stacey Gray, Derrick Lin, James Rocco, Daniel Lee, Gregory Randolph, Nicolas Busaba, Phillip Song, Ramon Franco, and Head and Neck Surgical Oncology fellow Dr. Alice Lin. The group presented multiple lectures, panels, and courses to an international audience of otolaryngologists, with more than 4,500 attendees. The group plans to create an MEEI program for the next IFOS meeting in Paris in 2017. - Stacey Gray, M.D., was involved in a number of conferences in her field this year, serving as invited speaker and panel moderator for many of these engagements. This year she contributed to the Harvard Macy Institute Program for Educators in the Health Professions, the Combined Otolaryngology Spring Meeting in Orlando, the American Rhinology Society Summer Symposium in Chicago, the International Federation of Oto-Rhino-Laryngological Societies World Congress in Seoul, and the American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. - Christopher Halpin, Ph.D., delivered the keynote address at the Spanish Congress of Audiology, Royal College of Physicians, Seville, titled "Clinical word recognition and audiologic disorders." Dr. Halpin also spoke at the Sociedad Espanola de Otorrhinolaryngology in Madrid, Spain in 2013. - Eric Holbrook, M.D., has been invited to speak and serve as a faculty member for the European Rhinology Society/ISIAN Congress in Amsterdam in 2014. - Richard Lewis, M.D., was an invited speaker on "Central vestibular processing investigated with electrical stimulation of canal ampullary nerves," at the Sensing Motion for Action Symposium in Montreal in July 2013. Dr. Lewis also spoke on "Investigating vestibular function with perceptual threshold testing," at Spaulding Hospital in Boston in April 2013. - Daniel Polley, Ph.D., lectured at the February 2013 meeting for the Association of Research in Otolaryngology on cortical modulation of sound representations in the auditory thalamus. - Gregory Randolph, M.D., served as panel moderator of "Avoidance of Complication in Thyroid/Parathyroid Surgery," and as panelist for "Papillary Carcinoma: prophylactic central neck dissection" at the American Cancer Society meetings. Dr. Randolph also served on the steering committee for the 2nd World Congress on Thyroid Cancer, held in Toronto from July 10th through the 14th in 2013. The Congress is a global multidisciplinary meeting of all specialists involved in the treatment of thyroid nodule disease and thyroid cancer. - Konstantina Stankovic, M.D., Ph.D., presented at the February 2013 Association for Research in Otolaryngology (ARO) meeting on a selection of her unpublished work, including, "Loss of FGF23 signaling results in mixed hearing loss and middle ear malformation," "Molecular network analysis of hearing loss and hypogonadism," "Examining the role of Gtf2ird1 deletion in auditory physiology and behavior in a murine model of Williams-Beuren Syndrome," and "Finding characteristic DFNA9 cochlin-staining eosinophilic deposits in the middle ear." Dr. Stankovic also presented at the American Otologic Society and American Neurotology Society meetings in April 2013 on the following topics, "Metabolomics analysis of pharmacotherapies for sensorineural hearing loss," "Aspirin intake correlates with halted growth of sporatic vestibular schwannoma in vivo," and "Molecular network analysis of sporadic vestibular schwannoma pathobiology highlights actin as a major modulator of tumor growth." Radiology: - The radiologists wrote or participated in 34 papers including:Borodic GE, Caruso PA, Acquadro M, Chick S. "Parry-Romberg Syndrome Vasculopathy and its Treatment with Botulinum Toxin". Ophthal Plast Reconstr Surg May 2013. - Gao Y, Moonis G, Cunnane ME, Eisenberg RL. "Lacrimal Gland Masses". Am J Roentgenol 2013 Sep; 201(3):W371-81. - Lesnik D, Cunnane ME, Zurakowski D, Acar GO, Ecevit C, Mace A, Kamani D, Randolph GW. "Papillary Thyroid Carcinoma Nodal Surgery Directed by a Preoperative Radiographic Map Utilizing CT Scan and Ultrasound in all Primary and Reoperative Patients". Head Neck 2013 Apr; 2:232-77. - Quesnel AM, Moonis G, Appel J, O'Malley JT, McKenna MJ, Curtin HD, Merchant SN. "Correlation of Computed Tomography with Histopathology in Otosclerosis". Otol Neurotol 2013 Jan; 34(1):22-8. - Juliano AF, Ginat D, Moonis G. "Imaging Review of the Temporal Bone-Part I: Anatomy and Inflammatory and Neoplastic Processes". Radiol 2013 Oct; 269(1):17-33. - Ginat D, Freitag SK, Kieff D, Grove A, Fay A, Cunnane ME, Moonis G. "Radiographic Patterns of Orbital Involvement in IgG4-Related Disease". Ophthal Plast Reconstr Surg 2013 Jul-Aug; 29(4):261-6. Ophthal Plast Reconstr Surg 2013 Jul-Aug; 29(4):261-6.
FORM 990, PART III, LINE 4C:	CLINICAL CARE	Ophthalmology: - Mass. Eye and Ear, Longwood. Patient visits to the new Mass. Eye and Ear, Longwood multi-specialty ambulatory care center at 800 Huntington Avenue have climbed steadily since the facility opened its doors to patients in December, 2012. During 10 months in FY13, the Longwood medical team and staff handled nearly nine thousand patient visits. Four additional clinicians joined the practice this fall to keep pace with growth, bringing the number of Longwood practitioners to 13. Clinicians handle a full range of comprehensive and subspecialty services and the facility is fully equipped for surgery, procedures, imaging and diagnostics. The recent expansion to the Longwood Medical Area (LMA) has broadened and enhanced collaborations with LMA HMS Ophthalmology affiliates, neighborhood institutions and the community in general. Joslin Diabetes Center has co-located clinical offices there and Joslin physicians are now providing a full array of high quality, comprehensive and subspecialty eye care to ophthalmology patients who are at-risk for diabetes-related eye complications. Additionally, Mass. Eye and Ear, Longwood's closer proximity to Brigham and Women's (BWH) Hospital is speeding up communication with BWH physicians and the referral community, and providing faster access to care for patients. Led by Mass. Eye and Ear, Longwood Clinical Director, Carolyn Kloek, MD, several open houses were held before and after the Longwood facility opening to introduce the facility and staff to the neighboring hospital and referring physician community. Mass. Eye and Ear, Longwood is now well integrated into the community and is ready resource for nearby medical practices whose clinicians are operating in the facility's new surgical suite and utilizing its ophthalmic imaging and testing resources. - Mass. Eye and Ear and MGH Streamline Care for Patients with Diabetic Eye Disease. Mass. Eye and Ear and Mass General Hospital have collaborated to implement a new, streamlined patient care process for MGH patients who require an OPTOS diabetic eye screening or a diabetic eye exam. A Mass General PCP or nurse practitioner initiates testing by filling out a Mass. Eye and Ear order form and directs patients to Mass. Eye and Ear's Fluorescein Department. MGH patients are given the next available photographer for processing. Images are uploaded to the Mass. Eye and Ear image viewing system and a clinical message is posted in the LMR to alert the MDs reading the test. Once they review and document the result, a clinical message is sent to the referring PCP at Mass. General. Results are provided within one week and - in the event of an abnormal result - Mass. Eye and Ear staff will contact the patient to coordinate an appointment. Patients with normal studies are notified by mail or via Patient Gateway. - Mass. Eye and Ear Expands Optometry Team. Mass. Eye and Ear continues to grow its cadre of optometrists in a strategic move to extend its patient base, partner with MDs to optimize patient scheduling and streamline care to patients. The Optometry service now includes six, full-time members. The two most recent recruits to the service - Mark Bernardo, OD, and Yan Jiang, OD, PhD - have established full-time practices at Mass. Eye and Ear, Longwood. - Mass. Eye and Ear Ranked a Top Specialty Hospital. Since 1990, Mass. Eye and Ear has been one of the top ranked hospitals in the nation for ophthalmology, according to U.S. News & World Report magazine's "America's Best Hospitals" 2013 survey. This year, Mass. Eye and Ear, Massachusetts General Hospital ranked #4 in Ophthalmology. - Mass. Eye and Ear to Release the 4th Annual Quality and Outcomes Report. Mass. Eye and Ear prepared its 4th Annual Quality and Outcomes Report, documenting clinical and surgical outcomes data for key Ophthalmology procedures. The 2013 Quality and Outcomes Report (the third combined Ophthalmology/ENT report) will provide a full view of our highly specialized care and surgery, while cataloguing measures that continue to establish industry benchmarks nationwide. - New Equipment and Technology: - Retina Service: The next-generation Canon Adaptive Optics Scanning Laser Ophthalmoscope (not yet in clinical use) has the potential to resolve individual cone cells in the retina, enabling clinicians to monitor progression of diseases of the retina to a degree never before possible. - Retina/Glaucoma Service: TopCon Swept Source OCT allows the detection and resolution of individual retinal layers and is particularly helpful in retinal diseases such as wet AMD. This new technology has the potential to distinguish single photoreceptors in the retina with the potential for better resolution of sub-RPE images.
COMMUNITY SERVICE:	LOCAL/REGIONAL:	- Support Groups - Mass. Eye and Ear Eye Plastics hosted a quarterly Thyroid Eye Disease support group, which is led by Suzanne Freitag, MD. This support group is run in collaboration with the Graves Disease and Thyroid Foundation along with MGH endocrinology and Dr. Greg Randolph of Mass. Eye and Ear ENT. - Mass. Eye and Ear Vision Rehabilitation Support Group runs weekly for 8 weeks in the Vision Rehabilitation Clinic, and is led by a Mass. Eye and Ear social worker and a social worker who has low vision. - Community Forums, Lectures and Special Events - Ula Jurkunas, MD, and Michael Young, PhD, presented a seminar entitled, "The Stem Cell Stories: Revolutionary Results from Boston-area Researchers," at a free public forum sponsored by the Harvard Stem Cell Institute as part of the International Society for Stem Cell Research's 11th Annual Meeting. The seminar was held at the OMNI Parker House in Boston on June 11, 2013. - On June 22, 2013 Lucy Shen, MD gave a talk to the New England Chapter of the Glaucoma Foundation on the importance and meaning of glaucoma tests. - Screenings - In conjunction with Vision Coalition, Mass. Eye and Ear provided dilated eye exams and eyeglasses for students from the Year Up program in July at both the main campus and at Longwood. Mark Bernardo, OD, Angela DuBois, Myrna Duran, Nolette Ferjuste, Alexander Lascko, Do Lee and Amy Watts, OD participated in this important program. - Community Benefits vision screenings for students at Camp Harbor View (18th Year) were held July 23 and August 9, 2013. Staff from Mass. Eye and Ear and Children's Hospital Ophthalmology Foundation screened 235 children in total, with 78 requiring follow-up care. - A team from Mass. Eye and Ear and Children's Hospital Ophthalmology Foundation visited the Neighborhood House Charter School on October 11, 2013 and provided more than 320 screenings. Mass. Eye and Ear has provided vision and hearing screenings to the children at this Boston school as part of its community benefits program since the school opened in 1995. Dr. Ankoor Shah and Chief Ophthalmic Tech, Shakhsanam Aliyeva led the team of residents, technicians and staff who helped with the event.
OTOLARYNGOLOGY:		- New Equipment and Technology: - An exciting milestone in our educational efforts, construction on our new state-of-the-art otolaryngology surgical training laboratory was completed early this year. The Joseph B. Nadol, Jr., M.D., Otolaryngology Surgical Training Laboratory allows for advanced instruction capabilities in nearly every subspecialty of otolaryngology and will serve as a resource for our residents and fellows, as well as experienced surgeons in continuing medical education. - Derrick Lin, M.D., and James Rocco, M.D., Ph.D., have pioneered efforts toward bringing transoral robotic surgery to appropriate head and neck cancer patients at Mass. Eye and Ear. Drs. Lin and Rocco now offer this treatment using facilities at Winchester Hospital, which is located in the northwest suburb of Boston. Radiology: - New Equipment and Technology: - A trial of a 3D Accuitomo CT system continued through FY13 and will continue in FY14. This is a no cost trial in an effort to work with the manufacturer to improve temporal bone scans and image resolution. Referring MD's have responded positively on the increased quality of images for these non-contrast studies. An evaluation to lease or purchase the system will be performed in FY14. - We are in the final evaluation stage to select a new CT system vendor (GE or Siemens) in an effort to replace the existing Siemens Somatom 40-slice CT system. The current system is nearing end of life and is approaching eight years old. The new CT system will be implemented in FY14.
FORM 990, PART VI, LINE 1A:	THE INFIRMARY'S BYLAWS STATE THE FOLLOWING:	THERE SHALL BE AN EXECUTIVE COMMITTEE CONSISTING OF THOSE INDIVIDUALS WHO ARE SERVING AS MEMBERS OF THE EXECUTIVE COMMITTEE OF THE MEMBER. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWER TO TRANSACT ALL EMERGENCY BUSINESS OF THE CORPORATION DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL ALSO TRANSACT SUCH BUSINESS, PERFORM SUCH DUTIES, AND EXERCISE SUCH POWERS AS MAY BE DIRECTED OR DELEGATED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. THE EXECUTIVE COMMITTEE SHALL KEEP A RECORD OF ITS PROCEEDINGS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE REPORTED TO THE BOARD OF DIRECTORS AT ITS NEXT REGULAR MEETING. FORM 990, PART VI, LINE 7A: THE GOVERNOR OF THE COMMONWEALTH HAS THE AUTHORITY TO APPOINT TWO DIRECTORS. THE BYLAWS OF THE INFIRMARY STATE THAT THE REMAINING DIRECTORS ARE THOSE INDIVIDUALS SERVING AS DIRECTORS OF ITS SOLE MEMBER, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION").
FORM 990, PART VI, LINE 7B:		THE FOUNDATION IS THE SOLE MEMBER OF THE INFIRMARY AND RETAINS THE AUTHORITY TO MAKE DECISIONS REGARDING THE INFIRMARY.
FORM 990, PART VI, LINE 11B:		THE INFIRMARY'S FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS, LLP USING INFORMATION PREPARED BY MANAGEMENT. AFTER THE FORM 990 IS COMPLETED, IT IS REVIEWED BY THE DIRECTOR OF FINANCE OPERATIONS. THE FORM 990 IS THEN PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL AS AUTHORIZED BY THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ARE ALSO GIVEN THE FORM 990 FOR REVIEW WITH TIME TO SUBMIT COMMENTS AND QUESTIONS BEFORE FINAL FILING.
FORM 990, PART VI, LINE 12C:		MEMBERS OF THE STAFF ARE REQUIRED TO DISCLOSE CONFLICTS OF INTEREST TO THEIR CHIEF OF SERVICE OR DEPARTMENT AND DIRECTOR OF LABORATORY/UNIT. MEMBERS OF THE BOARD OF DIRECTORS ARE REQUIRED TO DISCLOSE ANNUALLLY, IN WRITING, ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE OFFICE OF THE INTERNAL LEGAL COUNSEL OBTAINS AND REVIEWS THE ANNUAL CONFLICTS OF INTEREST STATEMENTS SUBMITTED BY MEMBERS OF THE BOARD OF DIRECTORS, AND REPORTS ON THE SAME TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. WITH RESPECT TO INTERESTS DISCLOSED BY BOARD MEMBERS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, THE INTERNAL LEGAL COUNSEL REVIEWS ALL TRANSACTIONS BETWEEN SUCH INTERESTS AND AFFILIATES OF THE INFIRMARY, TO DETERMINE WHETHER THESE TRANSACTIONS WERE CONDUCTED AT ARM'S LENGTH.
FORM 990, PART VI, LINE 15:		THE CHAIRMAN OF THE COMPENSATION COMMITTEE OF THE BOARD OF THE INFIRMARY PRESENTS A RECOMMENDATION TO THE COMPENSATION COMMITTEE WHO HAVE FINAL APPROVAL OF THE CEO'S BASE SALARY AND BONUS AMOUNT. THE CEO RECOMMENDS EXECUTIVE SALARIES TO THE COMPENSATION COMMITTEE OF THE BOARD WHO HAS FINAL AUTHORIZATION TO APPROVE IT. TOTAL COMPENSATION FOR THE CEO, CHIEFS AND VICE PRESIDENTS, INCLUDING BONUS PAYMENTS, INCLUDING COMPARABILITY DATA, IS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS AND IS DETERMINED TO BE REASONABLE.
FORM 990, PART VI, LINE 19:		SUMMARIZED FINANCIAL STATEMENTS ARE AVAILABLE ON THE INFIRMARY'S WEBSITE: WWW.MASSEYEANDEAR.ORG. AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE INFIRMARY'S GOVERNING DOCUMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS ALSO AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: PERIODIC PENSION COST $11,881,769

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990 or 990-EZ) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE R
(Form 990)

Department of the Treasury
Internal Revenue Service

Related Organizations and Unrelated Partnerships

Complete if the organization answered "Yes" to Form 990, Part IV, line 33, 34, 35, 36, or 37.
MediumBullet

Attach to Form 990. MediumBullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Identification of Disregarded Entities (Complete if the organization answered "Yes" to Form 990, Part IV, line 33.)

(a) Name, address, and EIN (if applicable) of disregarded entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Total income	(e) End-of-year assets	(f) Direct controlling entity

Part II

Identification of Related Tax-Exempt Organizations (Complete if the organization answered "Yes" to Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.)

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	(g) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	Yes	No
(1) FDN OF THE MASS EYE & EAR INFIRMARYINC 243 CHARLES STREET BOSTON,MA02114 04-2785453	PARENT	MA	501(C)(3)	9	NA		No
(2) MASSACHUSETTS EYE & EAR ASSOCIATES INC 243 CHARLES STREET BOSTON,MA02114 22-2658209	PATIENT CARE	MA	501(C)(3)	9	FOUNDATION	Yes
(3) CIRCLE COMPANY INC 243 CHARLES STREET BOSTON,MA02114 04-2801791	TITLE HOLDING	MA	501(C)(25)	N/A	FOUNDATION	Yes
(4) EMBANKMENT SERVICES INC 14 DAVID G MUGAR WAY BOSTON,MA02114 04-3272865	SUPPORTNG ORG	MA	501(C)(3)	11 - TYPE 1	FOUNDATION	Yes
(5) MASS EYE & EAR INFIRMARY PENSION PLAN 243 CHARLES STREET BOSTON,MA02114 04-6067238	PENSION PLAN	MA	401(A)	N/A	NA		No
(6) SCHEPENS EYE RESEARCH INSTITUTE INC 20 STANIFORD STREET BOSTON,MA02114 04-2129889	RESEARCH	MA	501(C)(3)	7	FOUNDATION	Yes

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50135Y

Schedule R (Form 990) 2012

Page 2

Part III

Identification of Related Organizations Taxable as a Partnership (Complete if the organization answered "Yes" to Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.)

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code VUBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code VUBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No

Part IV

Identification of Related Organizations Taxable as a Corporation or Trust (Complete if the organization answered "Yes" to Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.)

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	(i) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	Yes	No

Schedule R (Form 990) 2012

Page 3

Part V

Transactions With Related Organizations (Complete if the organization answered "Yes" to Form 990, Part IV, line 34, 35b, or 36.)

Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.

Yes

1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?

a Receipt of (i) interest (ii) annuities (iii) royalties or (iv) rent from a controlled entity . . . . . . . . . . . . . . . . . . . . . . .

b Gift, grant, or capital contribution to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

c Gift, grant, or capital contribution from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

d Loans or loan guarantees to or for related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

e Loans or loan guarantees by related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

f Dividends from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

g Sale of assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

h Purchase of assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

i Exchange of assets with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

j Lease of facilities, equipment, or other assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . .

k Lease of facilities, equipment, or other assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

l Performance of services or membership or fundraising solicitations for related organization(s) . . . . . . . . . . . . . . . . . . . .

m Performance of services or membership or fundraising solicitations by related organization(s) . . . . . . . . . . . . . . . . . . . .

Yes

n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) . . . . . . . . . . . . . . . . . . . . .

o Sharing of paid employees with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

p Reimbursement paid to related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

q Reimbursement paid by related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

r Other transfer of cash or property to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

s Other transfer of cash or property from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.

(a) Name of other organization	(b) Transaction type (a-s)	(c) Amount involved	(d) Method of determining amount involved
(1) CIRCLE COMPANY INC	K	25,000	CASH
(2) CIRCLE COMPANY INC	O	132,054	CASH
(3) CIRCLE COMPANY INC	Q	145,000	CASH
(4) EMBANKMENT SERVICES INC	Q	1,170,593	CASH
(5) EMBANKMENT SERVICES INC	O	1,389,268	CASH
(6) MASSACHUSETTS EYE AND EAR PENSION PLAN	R	8,204,000	CASH
(7) MASSACHUSETTS EYE AND EAR ASSOCIATES INC	Q	28,713,700	CASH
(8) MASSACHUSETTS EYE AND EAR ASSOCIATES INC	B	9,966,948	CASH
(9) MASSACHUSETTS EYE AND EAR ASSOCIATES INC	C	80,395	CASH
(10) SCHEPENS EYE RESEARCH INSTITUTE INC	C	570,606	CASH
(11) SCHEPENS EYE RESEARCH INSTITUTE INC	Q	1,124,366	CASH
(12) SCHEPENS EYE RESEARCH INSTITUTE INC	P	800,674	CASH
(13) MASSACHUSETTS EYE AND EAR ASSOCIATES INC	O	8,739,754	CASH

Schedule R (Form 990) 2012

Page 4

Part VI

Unrelated Organizations Taxable as a Partnership (Complete if the organization answered "Yes" to Form 990, Part IV, line 37.)

Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.

(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(e) Are all partners section 501(c)(3) organizations?		(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code VUBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?
(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	Yes	No	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code VUBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No

Schedule R (Form 990) 2012

Page 5

Part VII

Supplemental Information

Complete this part to provide additional information for responses to questions on Schedule R (see instructions).

Identifier	Return Reference	Explanation
SCHEDULE R, PART V, LINE 15:		CONTRIBUTIONS REPRESENT AMOUNTS CONTRIBUTED BY THE INFIRMARY FOR EMPLOYEE RETIREMENT BENEFITS AS REQUIRED BY THE PENSION PLAN'S FUNDING POLICY.

Additional Data

Software ID:
Software Version:

1	Briefly describe the organization’s mission or most significant activities: SEE SCHEDULE O.
2	Check this box
3	Number of voting members of the governing body (Part VI, line 1a) ........	3	21
4	Number of independent voting members of the governing body (Part VI, line 1b) .....	4	18
5	Total number of individuals employed in calendar year 2011 (Part V, line 2a) ......	5	1,965
6	Total number of volunteers (estimate if necessary) .............	6	279
7a	Total unrelated business revenue from Part VIII, column (C), line 12 ........	7a	0
b	Net unrelated business taxable income from Form 990-T, line 34 .........	7b

		Prior Year	Current Year
8	Contributions and grants (Part VIII, line 1h) .........	33,572,100	39,413,484
9	Program service revenue (Part VIII, line 2g) .........	150,956,667	164,905,375
10	Investment income (Part VIII, column (A), lines 3, 4, and 7d ) ....	665,789	1,067,489
11	Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)	15,017,611	16,279,280
12	Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)...................	200,212,167	221,665,628
13	Grants and similar amounts paid (Part IX, column (A), lines 1–3 )...	15,552,737	16,717,561
14	Benefits paid to or for members (Part IX, column (A), line 4).....	0	0
15	Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)	100,490,121	106,973,420
16a	Professional fundraising fees (Part IX, column (A), line 11e).....	256,235	278,479
b	Total fundraising expenses (Part IX, column (D), line 25) 2,020,705
17	Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e)....	84,181,529	98,774,910
18	Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25)	200,480,622	222,744,370
19	Revenue less expenses. Subtract line 18 from line 12.......	-268,455	-1,078,742
		Beginning of Current Year	End of Year
20	Total assets (Part X, line 16).............	236,179,653	224,049,415
21	Total liabilities (Part X, line 26).............	210,336,333	187,529,630
22	Net assets or fund balances. Subtract line 21 from line 20.....	25,843,320	36,519,785

Sign Here

	Signature of officer	Date

	Type or print name and title


4a	(Code: ) (Expenses $ 44,248,600 including grants of $ 6,979,955 ) (Revenue $ 164,905,375 )
	SEE SCHEDULE O

4b	(Code: ) (Expenses $ 4,305,552 including grants of $ ) (Revenue $ )
	SEE SCHEDULE O

4c	(Code: ) (Expenses $ 115,469,497 including grants of $ 9,737,606 ) (Revenue $ )
	SEE SCHEDULE O

4d	Other program services (Describe in Schedule O.)
	(Expenses $ including grants of $ ) (Revenue $ )
4e	Total program service expenses164,023,649

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)		(D) Reportable compensation from the organization (W- 2/1099-MISC)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and Title
(1) JOHN R FERNANDEZ........................................................................ PRESIDENT	37.0 .......................23.0	X	X	810,694	0	155,041
(2) WYCLIFFE GROUSBECK........................................................................ CHAIR	3.0 .......................7.0	X	X
(3) JONATHAN UHRIG........................................................................ TREASURER	3.0 .......................7.0	X	X
(4) LILY H BENTAS........................................................................ SECRETARY	3.0 .......................7.0	X	X
(5) RICHARD H ALDRICH........................................................................ DIRECTOR	2.0 .......................2.0	X
(6) DEWALT PETE ANKENY........................................................................ DIRECTOR	2.0 .......................6.0	X
(7) JAMES CARLISLE........................................................................ DIRECTOR	2.0 .......................2.0	X
(8) CHARLES DE GUNZBERG........................................................................ DIRECTOR	2.0 .......................6.0	X
(9) SAMUEL FLEMING........................................................................ DIRECTOR	2.0 .......................2.0	X
(10) HARVEY FREISHTAT........................................................................ DIRECTOR	2.0 .......................2.0	X
(11) LYLE HOWLAND........................................................................ DIRECTOR	2.0 .......................2.0	X
(12) DIANE E KANEB........................................................................ DIRECTOR	2.0 .......................2.0	X
(13) JONATHAN KUTCHINS........................................................................ DIRECTOR	2.0 .......................4.0	X
(14) VICTORIA MCCULLOUGH........................................................................ DIRECTOR	2.0 .......................6.0	X
(15) JOAN W MILLER MD........................................................................ DIRECTOR	27.0 .......................33.0	X		0	781,005	56,306
(16) JOSEPH B NADOL JR MD........................................................................ DIRECTOR	29.0 .......................31.0	X		0	782,173	62,754
(17) ANNETTE NOVA........................................................................ DIRECTOR	2.0 .......................6.0	X

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)					(D) Reportable compensation from the organization (W- 2/1099-MISC)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and Title
(18) WILLIAM ROMAN........................................................................ DIRECTOR	2.0 .......................2.0	X
(19) FREDERICK THORNE........................................................................ DIRECTOR	2.0 .......................2.0	X
(20) KATHRYN VECELLIO........................................................................ DIRECTOR	2.0 .......................6.0	X
(21) EUGENE HILL........................................................................ Director	2.0 .......................2.0	X
(22) SUSAN WILLIAMS........................................................................ ASST SEC/GENERAL COUNSEL	49.0 .......................11.0		X				268,612	0	19,064
(23) MAUREEN KELLEY........................................................................ ASST SECRETARY	53.0 .......................7.0		X				172,383	0	28,262
(24) CAROLANN WILLIAMS........................................................................ CFO & VP FINANCE AND ADMIN	49.0 .......................11.0		X				360,843	0	11,502
(25) BARBARA J SCULLY........................................................................ DIRECTOR PROF REV CYCLE	30.0 .......................30.0			X			169,929	0	34,459
(26) EILEEN O LOWELL........................................................................ CNO & VP PAT CARE SVS	60.0 .......................0.0			X			241,312	0	33,911
(27) ALAN K LONG........................................................................ VP RESEARCH ADMINISTRATION	30.0 .......................30.0			X			221,708	0	8,547
(28) CHRISTINE REGAN........................................................................ VP HUMAN RESOURCES	60.0 .......................0.0			X			237,749	0	35,375
(29) KENNETH HOLMES........................................................................ CFO MEEA	30.0 .......................30.0			X			295,103	0	28,619
(30) JEAN E MACQUIDDY........................................................................ VP OTOLARYNGOLOGY	30.0 .......................30.0			X			250,249	0	33,842
(31) JEFFREY J PIKE........................................................................ CHIEF OPERATING OFFICER	60.0 .......................0.0			X			346,471	0	18,943
(32) JAVIER BALLOFFET........................................................................ VP OPHTHALMOLOGY	20.0 .......................40.0			X			313,354	0	36,405
(33) RALPH T PELOSI........................................................................ DIRECTOR FACILITIES PLANNING	60.0 .......................0.0			X			173,928	0	6,476
(34) JENNIFER STREET........................................................................ VP COMMUNICATIONS & PLANNING	60.0 .......................0.0				X		339,166	0	33,000
(35) MELISSA M PAUL........................................................................ CHIEF DEVELOPMENT OFFICER	60.0 .......................0.0				X		229,495	0	36,135
(36) GLENN W BUNTING........................................................................ VOICE & SPEECH CLINICAL DIR	60.0 .......................0.0				X		178,115	0	38,210
(37) GREGORY J DONNELLY........................................................................ ADMIN DIR ANCILLARY SVS	60.0 .......................0.0				X		176,560	0	30,597
(38) PHILLIP C JOHNSON........................................................................ DIR FINANCIAL OPERATIONS	60.0 .......................0.0				X		189,622	0	39,519
(39) PETER J CHINETTI........................................................................ FORMER VP FINANCE	0.0 .......................0.0					X	110,893	0	225
(40) ALEC CHELOFF........................................................................ CHIEF INFORMATION OFFICER	60.0 .......................0.0					X	187,203	0	19,628

1b	Sub-Total................
c	Total from continuation sheets to Part VII, Section A....
d	Total (add lines 1b and 1c)............	5,273,389	1,563,178	766,820

				(A) Total revenue	(B) Related or exempt function revenue	(C) Unrelated business revenue	(D) Revenue excluded from tax under sections 512, 513, or 514
1a	Federated campaigns..1a
b	Membership dues....1b
c	Fundraising events....1c
d	Related organizations...1d		11,585,707
e	Government grants (contributions)1e		17,262,316

f	All other contributions, gifts, grants, and similar amounts not included above1f		10,565,461

g	Noncash contributions included in lines 1a-1f:$
h	Total. Add lines 1a-1f.......			39,413,484
			Business Code
2a	INPATIENT AND OUTPATIENT		900099	144,676,161	144,676,161
b	MISCELLANEOUS REVENUE		900099	6,368,497	6,368,497
c	RESEARCH OVERHEAD		900099	6,680,683	6,680,683
d	HEARING AID CENTERS		900099	3,711,822	3,711,822
e	CAFETERIA/FOOD SERVICE		722210	1,815,212	1,815,212
f	All other program service revenue .			1,653,000	1,653,000
g	Total. Add lines 2a–2f........			164,905,375
3	Investment income (including dividends, interest, and other similar amounts).......			91,517			91,517
4	Income from investment of tax-exempt bond proceeds..			0
5	Royalties...........			16,279,280			16,279,280
		(i) Real	(ii) Personal
6a	Gross rents
b	Less: rental expenses
c	Rental income or (loss)	0	0
d	Net rental income or (loss).......			0
		(i) Securities	(ii) Other
7a	Gross amount from sales of assets other than inventory	975,972
b	Less: cost or other basis and sales expenses
c	Gain or (loss)	975,972
d	Net gain or (loss)..........			975,972			975,972
8a	Gross income from fundraising events (not including $ of contributions reported on line 1c). See Part IV, line 18 ..
	a
b	Less: direct expenses ...b
c	Net income or (loss) from fundraising events..			0
9a	Gross income from gaming activities. See Part IV, line 19 ...
	a
b	Less: direct expenses ...b
c	Net income or (loss) from gaming activities...			0
10a	Gross sales of inventory, less returns and allowances .
	a
b	Less: cost of goods sold ..b
c	Net income or (loss) from sales of inventory..			0
Miscellaneous Revenue			Business Code
11a
b
c
d	All other revenue ....
e	Total. Add lines 11a–11d ......			0
12	Total revenue. See Instructions......			221,665,628	164,905,375		17,346,769


				(A) Beginning of year		(B) End of year
1	Cashnon-interest-bearing .............			84,562	1	1,374,003
2	Savings and temporary cash investments .........			0	2	0
3	Pledges and grants receivable, net ...........			0	3	0
4	Accounts receivable, net .............			20,951,960	4	21,380,084
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
				20,000	5	10,000
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
				0	6	0
7	Notes and loans receivable, net .............			0	7	0
8	Inventories for sale or use ..............			2,155,473	8	2,302,498
9	Prepaid expenses and deferred charges ..........			3,862,909	9	4,078,975
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	375,862,839
b	Less: accumulated depreciation .....	10b	237,421,178	133,268,256	10c	138,441,661
11	Investments—publicly traded securities ..........			0	11	0
12	Investments—other securities. See Part IV, line 11 .....			0	12	0
13	Investments—program-related. See Part IV, line 11 .....			0	13	0
14	Intangible assets ...............			0	14	0
15	Other assets. See Part IV, line 11 ...........			75,836,493	15	56,462,194
16	Total assets. Add lines 1 through 15 (must equal line 34)......			236,179,653	16	224,049,415
17	Accounts payable and accrued expenses .........			80,079,903	17	70,433,190
18	Grants payable .................			0	18	0
19	Deferred revenue ................			37,959,380	19	25,513,725
20	Tax-exempt bond liabilities .............			86,480,956	20	83,647,571
21	Escrow or custodial account liability. Complete Part IV of Schedule D..			0	21	0
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........			0	22	0
23	Secured mortgages and notes payable to unrelated third parties ..			0	23	0
24	Unsecured notes and loans payable to unrelated third parties ....			0	24	0
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................			5,816,094	25	7,935,144
26	Total liabilities. Add lines 17 through 25.........			210,336,333	26	187,529,630
	Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............			25,843,320	27	36,519,785
28	Temporarily restricted net assets ...........			0	28	0
29	Permanently restricted net assets ...........			0	29	0
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........				30
31	Paid-in or capital surplus, or land, building or equipment fund .....				31
32	Retained earnings, endowment, accumulated income, or other funds				32
33	Total net assets or fund balances ...........			25,843,320	33	36,519,785
34	Total liabilities and net assets/fund balances ........			236,179,653	34	224,049,415

1	Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If “Yes,”the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926)......................................	Yes	No
2	Did the organization have an interest in a foreign trust during the tax year? If “Yes,” the organizationmay be required to file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A).......................................	Yes	No
3	Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471)..............................	Yes	No
4	Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If "Yes," the organization may be required to file Form 8621, Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621)	Yes	No
5	Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships. (see Instructions for Form 8865)....................................	Yes	No
6	Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see Instructions for Form 5713)................................................	Yes	No